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Abstract 
The human gastrointestinal tract is colonised by a diverse range of health-associated 
bacteria, in addition to other microorganisms, termed the intestinal microbiota. 
Sequence-based, culture-independent approaches have revolutionised this field of 
study, however, due to the perception that these bacteria are largely unculturable, in 
vitro phenotypic analysis has been hindered. In this study, an anaerobic culturing 
workflow was developed which revealed that the majority of these bacteria can be 
cultured using one growth medium. In total, 137 characterised and novel bacterial 
species were isolated and whole-genome sequenced. Inter-host transmission of the 
intestinal microbiota may represent a means to maintain a diverse assortment of 
commensal bacteria within individuals, yet it remains a poorly understood process. 
Some anaerobic pathogens utilise resilient aero-tolerant spores to survive externally 
and to facilitate transmission to new hosts. To investigate if commensal spore-
formers utilise similar mechanisms, a phenotypic screen was incorporated into the 
culturing workflow to target spore-forming bacteria. This resulted in the isolation of 
66 phylogenetically diverse, spore-forming species which, through subsequent 
phenotypic characterisation are shown to be specialised for host-to-host transmission 
and intestinal colonisation. Further phylogenetic and evolutionary analysis revealed 
body-site associated, loss of sporulation has occurred in different taxa. Also, loss of 
sporulation is associated with features of host-adaptation that are not present in 
spore-formers such as a smaller genome size and loss of genetic redundancy. This 
suggests that the human intestinal microbiota is populated by commensal bacteria 
that have evolved to engage in opposing lifestyles, either orientated towards inter-
host dispersal or within-host adaptation. 
This study demonstrates the intestinal microbiota is not unculturable. In addition, 
commensal microbial transmission may be more prevalent than once thought as a 
significant proportion of these bacteria can survive outside of a host through the use 
of spores that are intrinsically resistant to environmental stresses. 
 
4 
 
Acknowledgements 
I would like to thank my supervisors Trevor Lawley and Brendan Wren for 
guidance, encouragement and advice and for providing me with the opportunity to 
undertake this study. Thanks also to those at the Wellcome Trust Sanger Institute 
who I have been fortunate to work with and who have contributed through 
discussion, advice and training- members of the Host-Microbiota Interactions 
Laboratory, in particular Anne Neville, Sam Forster, Nitin Kumar, Mark Stares and 
Blessing Anonye and also, Sally Kay and Dave Goulding. Finally, thanks to Ann and 
Cillian for their support and motivation. 
 
 
 
 
 
 
 
 
 
5 
 
Contents 
Declaration ................................................................................................................... 2 
Abstract ........................................................................................................................ 3 
Acknowledgements ...................................................................................................... 4 
Contents ....................................................................................................................... 5 
List of Figures ............................................................................................................ 10 
List of Tables.............................................................................................................. 13 
Glossary ..................................................................................................................... 14 
Chapter 1 Introduction ............................................................................................... 17 
1.1 The human intestinal microbiota ...................................................................... 17 
1.1.1 The microbiota of humans ......................................................................... 17 
1.1.2 The human intestinal microbiota ............................................................... 20 
1.1.3 Defining a healthy intestinal microbiota .................................................... 20 
1.1.4 Host selection of commensal intestinal bacteria ........................................ 21 
1.2 The host-microbiota interactions of other animals ........................................... 23 
1.2.1 The rumen microbiota ................................................................................ 24 
1.2.2 Extreme host adaptation- the insect microbiota ......................................... 25 
1.2.3 Genome reduction of extremely host-adapted bacteria ............................. 28 
1.3 Studying the intestinal microbiota .................................................................... 30 
1.3.1 Culturing and sequence-based approaches ................................................ 30 
1.3.2 The benefits of bacterial culturing ............................................................. 32 
6 
 
1.4 Spore-forming bacteria within the intestinal microbiota .................................. 34 
1.4.1 Sporulation and germination cycle and genetics ....................................... 34 
1.4.2 Clostridium difficile- the model enteric spore-former ............................... 39 
1.5 Transmission of commensal bacteria ............................................................... 42 
1.5.1 Shared transmission routes of commensal and pathogenic intestinal 
bacteria ................................................................................................................ 43 
1.5.2 Distinguishing the routes of transmission of commensal and pathogenic 
intestinal bacteria ................................................................................................ 46 
1.5.3 Survival in the environment ....................................................................... 47 
1.5.4 Reservoirs of commensal bacteria ............................................................. 52 
1.6 Microbiota perturbation and restoration ........................................................... 57 
1.6.1 Microbiota perturbation ............................................................................. 57 
1.6.2 Microbiota restoration................................................................................ 59 
1.6.3 Understanding microbiota perturbation through ecological theory ........... 60 
1.7 Therapeutics based on the intestinal microbiota .............................................. 61 
1.8 Thesis aims ....................................................................................................... 63 
Chapter 2 Materials and Methods .............................................................................. 65 
2.1 Culturing of bacteria from the human intestinal microbiota ............................ 65 
2.1.1 Acquisition of donor faecal samples .......................................................... 65 
2.1.2 Anaerobic culturing ................................................................................... 65 
2.1.3 Microbiota profiling by 16S rRNA gene sequencing ................................ 68 
2.1.4. Submission of cultured bacteria to public repositories ............................. 69 
7 
 
2.2 Generation of whole-genome, metagenomic and 16S rRNA gene amplicon 
sequence data .......................................................................................................... 70 
2.2.1 DNA extraction .......................................................................................... 70 
2.2.2 Generation of whole-genome and metagenomic sequence data ................ 71 
2.2.3 Generation of 16S rRNA gene amplicon sequence data............................ 72 
2.3 Analysis of sequence data generated through anaerobic culturing .................. 72 
2.3.1 Assembly and annotation of whole-genome sequence data ...................... 72 
2.3.2 Analysis of metagenomic sequence data ................................................... 73 
2.3.3 Analysis of 16S rRNA gene amplicon sequence data ............................... 74 
2.3.4 Comparison of culturing studies ................................................................ 74 
2.3.5 Gene sporulation signature ........................................................................ 75 
2.3.6 Comparison of abundance of bacteria in faecal samples and on culture 
plates ................................................................................................................... 76 
2.3.7 Diversity analysis of spore-forming and non-spore-forming bacteria ....... 76 
2.4 Phylogenetic analysis ....................................................................................... 77 
2.4.1 16S rRNA gene sequence phylogeny of cultured bacteria ........................ 77 
2.4.2 Phylogeny of putative novel bacterial family ............................................ 77 
2.4.3 Core gene phylogeny of Firmicutes ........................................................... 78 
2.5 Phenotypic analysis of spore-forming bacteria ................................................ 79 
2.5.1 Oxygen sensitivity assay ............................................................................ 79 
2.5.2 Germination response to intestinal bile acids assay................................... 79 
2.5.3 Transmission electron microscopy ............................................................ 80 
8 
 
2.6 Functional redundancy analysis ....................................................................... 81 
2.6.1 Ortholog analysis ....................................................................................... 81 
2.6.2 Gene per genome analysis: ........................................................................ 83 
2.6.3 Presence and absence of sporulation associated genes .............................. 83 
2.6.4 Functional annotation of unique genes and genes in gene per genome 
analysis................................................................................................................ 84 
Chapter 3 Culturing of the human intestinal microbiota ............................................ 85 
3.1 Introduction ...................................................................................................... 85 
3.2 Results .............................................................................................................. 88 
3.2.1 Establishment and assessment of culture process ...................................... 88 
3.2.2 Extensive culturing and isolation of characterised and novel bacteria ...... 93 
3.2.3 Phylogenetic analysis of an isolate from a putative novel family ........... 102 
3.2.4 Comparison with other culturing studies ................................................. 104 
3.3 Discussion ...................................................................................................... 106 
Chapter 4 Characterisation of intestinal spore-forming bacteria in the context of 
inter-host transmission ............................................................................................. 110 
4.1 Introduction .................................................................................................... 110 
4.2 Results ............................................................................................................ 111 
4.2.1 Phylogenetic analysis of cultured ethanol-resistant spore-forming bacteria
 .......................................................................................................................... 111 
4.2.2 Phenotypic characterisation of intestinal spore-forming bacteria............ 114 
9 
 
4.2.3 Genomic analysis of intestinal spore-forming bacteria and sporulation 
dynamics ........................................................................................................... 120 
4.3 Discussion ...................................................................................................... 128 
Chapter 5 Host-adaptation of commensal bacteria through loss of sporulation and 
reductive genome evolution ..................................................................................... 132 
5.1 Introduction .................................................................................................... 132 
5.2 Results ............................................................................................................ 133 
5.2.1 Large and small scale loss of sporulation within the Firmicutes ............. 133 
5.2.2 Genetic features of host-adaptation in non-spore-forming bacteria ........ 143 
5.3 Discussion ...................................................................................................... 153 
Chapter 6 Summary and future directions ............................................................... 157 
References ................................................................................................................ 169 
Appendix 1 Cultured Isolates ................................................................................... 189 
Appendix 2 Isolates deposited in public culture collections .................................... 206 
Appendix 3 Validation of the sporulation signature ................................................ 216 
Appendix 4 Publications from this thesis ................................................................ 237 
 
  
10 
 
List of Figures 
Figure 1.1 Distribution and abundance of bacteria in the human gastrointestinal tract
 .................................................................................................................................... 19 
Figure 1.2 Rumen anatomy ........................................................................................ 25 
Figure 1.3 Bacterial symbionts of insects .................................................................. 27 
Figure 1.4 Sporulation and germination cycle ........................................................... 35 
Figure 1.5 The two-component master regulator of sporulation Spo0A .................... 38 
Figure 1.6 The transmission and infection life-cycle of Clostridium difficile ........... 40 
Figure 1.7 Transmission of pathogenic and commensal intestinal bacteria............... 45 
Figure 3.1 Schematic diagram of the anaerobic culturing workflow. ........................ 88 
Figure 3.2 Bacteria grown on YCFA agar are representative of the complete faecal 
samples. ...................................................................................................................... 90 
Figure 3.3 Ethanol selection separates spore-forming bacteria from non-spore-
forming bacteria allowing their subsequent isolation. ............................................... 92 
Figure 3.4 The number of bacterial species cultured in this study............................. 94 
Figure 3.5 Phylogenetic tree of bacteria cultured from the six donors constructed 
from full-length 16S rRNA gene sequences. ............................................................. 96 
Figure 3.6 Archiving of bacterial diversity and novelty through anaerobic culturing- 
most abundant genera ................................................................................................. 98 
Figure 3.7 Archiving of bacterial diversity and novelty through anaerobic culturing- 
most abundant species .............................................................................................. 100 
Figure 3.8 Archiving of lowly represented members of the intestinal microbiota .. 101 
11 
 
Figure 3.9 Phylogenetic tree of putatively named novel Falkowia sangerensis isolate 
and closely related species based on 16S rRNA gene sequence .............................. 104 
Figure 4.1 Phylogeny of intestinal spore-forming bacteria ...................................... 113 
Figure 4.2 Spore-forming bacteria are more resilient than non-spore-forming bacteria 
to environmental stresses such as disinfectants. ...................................................... 115 
Figure 4.3 Oxygen tolerance of phylogenetically diverse intestinal spore-forming 
bacteria ..................................................................................................................... 117 
Figure 4.4 Intestinal spore-formers respond to bile-acid germinants. ..................... 119 
Figure 4.5 Intestinal non-spore-formers do not respond to bile-acid germinants. ... 120 
Figure 4.6 A genomic signature for identifying spore-forming bacterial species .... 122 
Figure 4.7 The sporulation signature accurately distinguishes spore-forming and 
non-spore-forming bacteria from this study and from different environments........ 124 
Figure 4.8 Abundance of spore-forming bacteria within the human intestinal 
microbiota ................................................................................................................ 125 
Figure 4.9 Validation of the estimation of the proportion of spore-formers in the 
intestinal microbiota by 16S rRNA gene amplicon sequencing .............................. 126 
Figure 4.10 Dynamic sporulation capacity within the human intestinal microbiota 128 
Figure 4.11 Inter-host transmission dynamics of spore-forming and non-spore-
forming intestinal bacteria........................................................................................ 129 
Figure 5.1 Distribution of the sporulation phenotype within the Firmicutes ........... 136 
Figure 5.2 Loss of sporulation is accompanied with widespread loss of sporulation-
associated genes ....................................................................................................... 139 
Figure 5.3 The sporulation phenotype has not been horizontally transferred. ......... 140 
12 
 
Figure 5.4 Sporulation is maintained in the gut but has been lost from other host-
associated environments........................................................................................... 142 
Figure 5.5 Non-spore-forming bacteria have smaller genomes than spore-forming 
bacteria within the same host-associated family ...................................................... 144 
Figure 5.6 Genome size and gene number are correlated in the Firmicutes. ........... 145 
Figure 5.7 Workflow for genetic redundancy analysis ............................................ 147 
Figure 5.8 Genetic redundancy is greater in spore-forming host-associated 
Firmicutes compared to non-spore-forming bacteria within the same family. ........ 149 
Figure 5.9 Genetic redundancy is associated with shared functions in spore-forming 
bacteria in different families. ................................................................................... 151 
Figure 6.1 A model for transmission of commensal intestinal bacteria and the 
influence of donor health status. .............................................................................. 158 
 
 
  
13 
 
List of Tables 
Table 1.1 Shared features of genome reduction in host-associated symbionts and 
free-living bacteria ..................................................................................................... 29 
Table 1.2 Aerotolerance of non-spore forming intestinal bacteria. ........................... 50 
Table 2.1 YCFA media .............................................................................................. 67 
Table 2.2 Dataset for orthoMCL analysis .................................................................. 82 
Table 3.1 Comparison of culturing studies .............................................................. 106 
 
  
14 
 
Glossary 
ABC  ATP-binding cassette transporter 
ANI  Average Nucleotide Identity  
ATP   Adenosine triphosphate 
BCCM  Belgian Co-ordinated Collection of Micro-organisms  
c.f.u.  Colony-forming units  
CCUG  Culture Collection, University of Gothenburg  
CRAP   Culture, Re-streak, Archive and Phenotype 
DDH   DNA-DNA hybridisation 
DSMZ  Deutsche Sammlung von Mikroorganismen und Zellkulturen Gmbh  
EBI  European Bioinformatics Institute  
FISH  Fluorescence in sitiu hybridisation 
FMT   Faecal Microbiota Transplantation 
GTR  generalized time-reversible  
HMP  Human Microbiome Project 
HPMCD  Human Pan-Microbes Community Database 
IBD   Inflammatory Bowel Disease 
JCM   Japan Collection of Microorganisms  
LPS  Lipopolysaccharide  
15 
 
LSHTM London School of Hygiene and Tropical Medicine 
MALDI-TOF matrix-assisted laser desorption ionisation time-of-flight  
NGAL  neutrophil gelatinase-associated lipocalin  
NOD-like nucleotide-binding oligomerisation domain-like receptors  
NSF  non-spore-forming species 
OTU  Operational Taxonomic Unit 
PaLoc  pathogenicity locus 
PBS  Phosphate Buffer Saline solution  
PCoA  Principle Coordinates Analysis  
PTS   Phosphoenolpyruvate Carbohydrate Phosphotransferase 
RDP  Ribosomal Database Project  
RefSeq NCBI reference sequence database 
ROS  reactive oxygen species  
s.d.  standard deviation  
SCFA  Short Chain Fatty Acids  
SF   spore-forming species 
SPRI  solid phase reversible immobilisation  
TEM  transmission electron microscopy  
Tregs  regulatory T cells  
16 
 
VBNC  Viable but non-culturable  
WTSI   Wellcome Trust Sanger Institute 
  
17 
 
Chapter 1 Introduction 
1.1 The human intestinal microbiota 
1.1.1 The microbiota of humans 
Humans have evolved in a microbial world. Prokaryotes emerged nearly 3.5 billion 
years ago, the first human ancestors only appeared approximately 5 million years 
ago after diverging from chimpanzees [2-4]. During this time, co-evolution has 
occurred; humans and other animals are colonised by stable communities of 
beneficial or non-harmful prokaryotes termed a ‘microbiota’, which includes 
bacteria, fungi, viruses, archaea as well as microscopic eukaryotes [3-6]. Bacteria 
have received the most attention to date as they usually make up the largest 
proportion of biomass and have the largest metabolic activity [7, 8]. The genetic 
repertoire encoded by a microbiota is termed a ‘microbiome’. Through their varied 
and diverse metabolic activity, colonising bacteria augment their hosts by provision 
of functions that the host is incapable of providing or cannot perform as efficiently as 
its microbiota [8-11]. In return for these benefits, the host provides nutrients for their 
microbes and a stable, safe environment to inhabit. In artificial conditions, some 
animals such as mice can survive without a microbiota but these are physiologically 
deficient compared to mice with a microbiota [12]. In other metazoans, such as 
insects, survival can be dependent on transfer of their bacterial symbiont to the 
offspring [13]. Hence, both host and microbes are reliant on each other to varying 
degrees in a relationship that has been described as a symbiosis [14]. 
Microbes colonise humans, both externally and internally [15, 16]. In some habitats 
such as the vagina, a simple community comprised principally of Lactobacillus 
species is indicative of health [15]. Similarly in the respiratory tract, a simple 
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community dominated by Staphylococcus and Streptococcus species represents 
health [17]. In other habitats, such as the gastrointestinal tract, a dense complex 
community is indicative of a healthy state [15]. Even within a particular habitat the 
density of bacteria varies. In the gastrointestinal tract, bacteria are present at low 
abundance (10
4
 cells per ml) in the stomach reflecting the low pH, however in the 
large intestine, they are present at much higher levels (10
11 
cells per ml) (Figure 1.1) 
[7]. These communities vary in their temporal stability but some, such as the gut and 
oral microbiota are generally stable in composition over time [15]. While the species 
composition can vary between individuals, even within the same habitat, the 
functions provided are constant [15, 18]. A common feature of these communities is 
the intrinsic resistance provided to pathogen infection by competition for niches and 
nutrients, termed ‘colonisation resistance’ [7, 17, 19]. 
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Figure 1.1 Distribution and abundance of bacteria in the human 
gastrointestinal tract 
Bacteria within the human gastrointestinal tract differ in their abundance at 
different points with the highest concentration present in the colon (large 
intestine). Within the colon, active fermentation will be driven by substrate 
availability and pH. Figure taken from [7]. 
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1.1.2 The human intestinal microbiota 
The intestinal microbiota of humans is one of the most densely populated microbial 
communities known to exist (Figure 1.1) [20]. This community has important 
metabolic and protective roles in human health through metabolising indigestible 
carbohydrates, preventing infection by pathogenic bacteria and modulating host 
immune responses [6, 11, 21-23]. Accordingly, it is the best characterised microbial 
community in humans. Facultative anaerobic bacteria initially colonise the 
gastrointestinal tract at birth and during the first three years of life. However, these 
bacteria are gradually replaced by obligate anaerobes as the gastrointestinal tract 
becomes more anaerobic and the infant transitions to a solid food diet [24, 25]. The 
majority of bacteria in adults belong to two main phyla - the Bacteroidetes and the 
Firmicutes. These phyla, together with the Proteobacteria, Actinobacteria, 
Synergistetes and Fusobacteria, contain almost all of the bacterial species found in 
the human gastrointestinal tract [15, 26]. Most of these species are obligate 
anaerobes; however, the extent of aerotolerance varies among species in the 
Actinobacteria and Proteobacteria phyla [27-29]. Despite their abundance in the 
human gastrointestinal tract, these species represent only a small subset of all of the 
bacterial taxa on Earth [30]. Furthermore, many of these bacterial taxa are not found 
replicating outside of the intestinal environment, which reflects their adaptation to 
this specific niche [4, 31]. 
1.1.3 Defining a healthy intestinal microbiota 
The factors that determine the optimal intestinal microbial community of an 
individual at any point in time are varied and include age, host genetics, diet and the 
local environment. Therefore, a core 'healthy' microbiota that is common to all 
individuals does not exist. Furthermore, the distinction between health-associated 
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commensal bacteria and harmful pathogenic bacteria is not always clear, as some 
bacterial species can promote health or cause disease depending on the specific strain 
or their location in the body. For example, Bacteroides fragilis produces 
immunomodulatory capsular polysaccharides that stimulate the production of anti-
inflammatory cytokines. If this bacterium translocates from the intestine to the 
peritoneum, then the capsular polysaccharides can cause inflammation, which results 
in the formation of an abscess [32]. Abscesses can be considered as beneficial to the 
host by limiting the spread of disease; however, if left untreated they can cause 
obstructions and further bacterial dissemination if ruptured [33]. Depending on the 
strain and the virulence factors that are present, Escherichia coli is either considered 
to be a normal commensal of the intestinal microbiota or a pathogen [34]. Similarly, 
the gastric bacterium Helicobacter pylori is associated with an increase in the 
incidence of peptic ulcers and stomach cancer, but a decreased incidence of 
oesophageal cancer [35]. In general, a healthy state in the intestinal microbiota can 
be considered to consist of a diverse microbiota that is abundant in beneficial 
species, such as members of the Bacteroidaceae, Ruminococcaceae and 
Lachnospiraceae families in the Bacteroidetes and Firmicutes phyla, and with few 
pathobionts, such as many members of the Proteobacteria phylum [36]. 
1.1.4 Host selection of commensal intestinal bacteria 
There is emerging evidence that hosts preferentially select communities of 
commensal bacteria through the modulation of the intestinal environment by a 
combination of host genetics and immune responses. Variation in genetic profiles 
between individuals is known to alter many aspects of health and disease, and it is 
now clear that it may also influence the composition of commensal bacterial 
communities. Despite initial studies that concluded that human genetics does not 
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substantially contribute to determining the bacterial species acquired [24, 37], recent 
studies have identified the presence of bacterial species that are associated with 
specific genetic polymorphisms, including abundant health-associated 
Faecalibacterium spp. [38, 39]. It has also been demonstrated that specific genes 
influence bacterial colonisation. For example, expression of the fucosyltransferase 2 
(FUT2) gene results in the presentation of fucosylated substrates on intestinal 
epithelial cells, thus enhancing the recruitment of particular species of commensal 
bacteria to the epithelium and protecting against the translocation of pathogenic 
bacteria [40, 41]. The association between host genetics and the community 
composition of the microbiota remains poorly understood; however, it is now 
evident that host genetics may have an essential role in determining the optimal 
microbiota community for promoting health. 
In addition to host genetics, the host immune system can distinguish between 
commensal and pathogenic bacteria to elicit different downstream signalling 
responses, through innate immune receptors, such as Toll-like receptors and 
nucleotide-binding oligomerisation domain-like receptors (NOD-like receptors). The 
recognition of commensal bacteria generally promotes intestinal homeostasis, 
whereas the recognition of pathogens results in a pro-inflammatory response [42]. 
Studies in genetically modified mouse models have shown that the absence of 
caspase 3 and caspase 4, which are involved in cell apoptosis and inflammatory 
responses, can also substantially alter the composition of the microbiota and disease 
susceptibility [43]. Host-derived antimicrobial peptides that are produced as part of a 
pro-inflammatory response to pathogens have been shown to specifically recognise 
pathogen lipopolysaccharide (LPS) structures and do not bind to LPS on commensal 
bacteria, owing to an altered charge on the commensal cell surface that prevents 
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binding [44]. These results demonstrate that host selection of the composition of the 
microbiota could be determined through host genetic background or induced in 
response to the presence of pathogens or commensals. 
Host behaviours, such as dietary choices, may also determine the composition of the 
intestinal microbiota. This selection commences at birth. The presence of 
indigestible human milk oligosaccharides in breast milk promotes the expansion of 
commensal species, in particular Bifidobacterium spp., which have a wide range of 
glycoside hydrolases that can degrade these complex sugars before metabolising 
them [45, 46]. By importing human milk oligosaccharides into the bacterial cell 
before degrading them, Bifidobacterium spp. also limit nutrient availability to any 
pathogens that may be present in the intestinal environment [45, 46]. The 
composition of the microbiota in adults can also vary substantially with diet. For 
example, the prevalence of Ruminococcus bromii is known to increase in people who 
consume diets that are high in resistant starches [23, 47]. Taken together, it is clear 
that the combination of host genetics, responses to bacterial stimuli and 
environmental factors, such as diet, determines the current and optimal microbiota 
for an individual. 
1.2 The host-microbiota interactions of other animals 
Studying the microbiotas of other animals can inform research on the human 
microbiota. For example, by comparing host physiology and diet of humans and 
other animals, or by examining genomic features of host-adaptation present in the 
bacteria colonising other animals, we can gain a better understanding of how these 
processes have shaped the assembly and evolution of the human intestinal 
microbiota. 
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1.2.1 The rumen microbiota 
In other animals, the actions of the microbiota in different parts of the 
gastrointestinal tract play a key role in health and metabolism. Ruminants such as 
cattle and sheep have a multi-chambered stomach that consists of the rumen where 
the majority of bacterial fermentation takes place, the reticulum which accumulates 
dense undigested material, the omasum which absorbs water and finally the 
abomasum or true stomach (Figure 1.2) [48]. These animals are distinct from hind-
gut fermenter animals such as horses and rabbits which are mono-gastric but have an 
enlarged caecum which prolongs digestion of plant material. The rumen contains a 
dense community of prokaryotes with bacterial abundances comparable to the human 
large intestine (10
11
 cells per ml) [49]. These bacteria are specialised at degrading 
complex plant material to generate large amounts of Short Chain Fatty Acids 
(SCFA) which are a major energy source for ruminants, indeed, microbial 
fermentation in cattle can provide over 60% of their energy requirements [48]. This 
anaerobic community is, similar to the human large intestine, dominated by 
Firmicutes and Bacteroidetes but the composition of species within and their relative 
abundance is different [4, 49]. Major species within this community include 
Ruminococcus flavefaciens and Prevotella species [49]. As the rumen precedes the 
stomach and intestines, any bacteria that transit to the stomach are digested. 
Accordingly, the rumen microbiota is a major source of protein for ruminants [48]. 
The composition of the microbiota of fore- and hind-gut fermenters is driven by diet 
and physiology and is distinct from each other [4, 5]. Furthermore, the microbiota of 
the rumen and the small and large intestine within ruminants is also distinct from 
each other [4, 50].  
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Figure 1.2 Rumen anatomy 
Fermentation of plant material by indigenous bacteria in the rumen releases 
energy that can be utilised by the host. The omasum absorbs water and the 
reticulum separates dense particles from the main digesta. The abomasum is the 
true stomach and from this point the digestive anatomy resembles that of 
humans with a small and large intestine. Figure taken from [51]. 
 
1.2.2 Extreme host adaptation- the insect microbiota 
The intestinal microbiota of humans and ruminants are characterised by complex 
microbial communities where the function provided is often more important than the 
species providing it. Many insects are colonised by simple communities of gut 
microbes and in some cases completely lack an intestinal microbiota, instead they 
are colonised by a single intracellular species of bacteria that are transmitted 
maternally [13, 52]. This is an extreme symbiosis, as in most cases neither party can 
survive without the other. Buchnera aphidicola which is a symbiont of pea aphids 
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(Acyrthosiphon pisum) resides in a specialised organ in the insect, termed a 
bacteriocyte (Figure 1.3). B. aphidicola is so host-adapted that it is completely 
reliant on the aphid for transmission and cannot colonise other insect species [13, 53, 
54]. This extreme host-adaptation makes many of these bacteria difficult to study 
because the conditions necessary for survival cannot be replicated in the laboratory. 
In the case of B. aphidicola, the bacterium provides essential amino acids which the 
aphid cannot obtain from the nutrient poor plant phloem it feeds on. In return, the 
aphid provides nutrients and a stable environment to inhabit [55]. Other symbioses 
are not so benign. The Wolbachia genus is extremely abundant and has been 
estimated to colonise over 60% of insect species [56]. Wolbachia can influence the 
fecundity of their hosts to promote their own survival by infecting germ cells. The 
most common means of doing this is through cytoplasmic incompatibility where 
sperm from infected males can only successfully fertilise the eggs of infected 
females carrying the same Wolbachia strain [13]. Infected eggs can successfully be 
fertilised by infected or uninfected sperm. As Wolbachia is transmitted via the egg 
this means infected females will produce infected progeny regardless of the infection 
status of their male partner, while uninfected females can only reproduce with 
uninfected males (Figure 1.3). Although the mechanism behind this remains largely 
unknown, the end result is that the ratio of Wolbachia infected to uninfected progeny 
will increase in a population [57]. 
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Figure 1.3 Bacterial symbionts of insects  
(A) The pea aphid (left) is colonised by Buchnera aphidicola that resides 
within specialised cells called bacteriocytes (right). Both parties are 
completely reliant on each other for survival. In the image of the bacteriocyte 
the central object is the nucleus of the aphid bacteriocyte cell. The circular 
objects surrounding the nucleus in the cytoplasm are the B. aphidicola cells. 
(B) Wolbachia bacteria engage in cytoplasmic incompatibility to promote their 
propagation. Infected female insects can mate with infected and uninfected 
males to produce infected progeny. All other combinat ions do not produce 
infected progeny. Image of pea aphid taken from [58] and image of 
bacteriocyte taken from [59]. 
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1.2.3 Genome reduction of extremely host-adapted bacteria 
These insect symbionts all share similar genetic features that are a result of their long 
adaptation to the host environment, in some cases up to 200 million years of co-
evolution  [13] (Table 1.1). All have small genomes of less than 2 million base pairs 
and in some cases, smaller than 200,000 base pairs [60, 61]. They all encode a low 
level of genetic redundancy (reduction in copy number of genes that carry out the 
same function). Loss of regulatory genes and genes involved in metabolism is also 
common [54]. This process is accelerated by high mutation rates which favour a low 
G/C base content and a reduction in DNA repair genes [13]. Ultimately, these 
genetic changes reflect living in a constant, stable environment. Genome compaction 
has allowed these bacteria to discard unnecessary biosynthetic pathways and genes, 
the functions of which are either no longer required or are provided by their host [60, 
62]. This level of genome reduction has not been observed in human associated 
bacteria but host-adapted Lactobacilli do have smaller genomes compared to 
environmental or plant-associated Lactobacillus species [63]. Some members of the 
Prochlorococcus genus, which are abundant, ocean dwelling Cyanobacteria, have 
also undergone genome reduction, in some cases up to 43% compared to non-
reduced relatives [54] (Table 1.1). Analysis of a metagenomically assembled soil 
bacterium Candidatus Udaeobacter copiosus also reveals features of genome 
reduction [64]; hence while genome reduction is commonly associated with 
extremely adapted insect symbionts it is also found in free-living bacteria in different 
environments. 
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Genome characteristic 
Buchnera spp. versus 
Escherichia coli 
Reduced Prochlorococcus 
spp. versus Non-reduced 
Prochlorococcus spp. 
Genome size Reduced by up to 80 % Reduced by up to 38 % 
% G/C 
Reduced to 26%  
(from 50 %) 
Reduced to between 31 
and 38 % 
Gene number Reduced by up to 80 % Reduced by up to 43 % 
Gene family size Smaller Smaller 
Pseudogenes Higher proportion Possibly higher proportion 
Recombination genes Losses Losses 
DNA replication and 
repair genes 
Losses Losses 
Regulation genes Losses Losses 
Metabolic genes Losses Losses and Gains 
Sequence evolution Faster Faster 
 
Table 1.1 Shared features of genome reduction in host-associated symbionts and 
free-living bacteria 
Some common features of genome reduction for an insect symbiont ( Buchnera 
spp.) and free-living, ocean-dwelling Prochlorococcus spp. Buchnera are 
compared against their closest extant relative Escherichia coli  and 
Prochlorococcus are compared against non-reduced Prochlorococcus species. 
Table adapted from and data taken from [54]. 
 
There are a number of theories to explain why bacterial genomes become reduced in 
size over long time scales. Genome streamlining is a feature of large population sizes 
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in free-living bacteria where unnecessary genes are deleted as they incur a fitness 
cost on the host (this has been proposed for Prochlorococcus species) [65]. In these 
large populations natural selection exerts a larger influence than genetic drift. This is 
accentuated in low-nutrient environments where a beneficial deletion becomes 
quickly fixed in the population [60, 65]. In much smaller population sizes that 
encounter regular population bottlenecks, Muller’s ratchet can take effect where 
deleterious mutations result in an increase of non-functional genes which are 
subsequently deleted [60]. Muller’s ratchet is proposed to be responsible for the 
genome reduction observed in many endosymbiotic bacteria. Other hypothesis 
include the Black Queen Hypothesis which states that microorganisms will lose the 
ability to carry out a function if it can rely on another member of the same 
community to supply the resource (and bear the cost of doing so) [66]. All of these 
theories are underpinned by an evolutionary trend in many studied bacterial genomes 
towards a smaller genome size [67, 68]. 
1.3 Studying the intestinal microbiota 
1.3.1 Culturing and sequence-based approaches 
Escherichia coli was the first bacterium isolated from the human gastrointestinal 
tract in 1885 by Theodor Escherich [26, 69]. Due to a lack of anaerobic culturing 
tools, many of the bacteria subsequently cultured were aero-tolerant. The 
development of anaerobic culturing techniques including those by Robert Hungate in 
the 1940’s through to the 1960’s led to the isolation of many of the dominant species 
of the intestinal microbiota [26, 70, 71]. The application of culture-independent 
methods to identify bacteria by sequencing of the 16S ribosomal RNA gene 
sequence initiated a new interest in the intestinal microbiota and led to the realisation 
that the microbial composition in the gut was more diverse than previously thought 
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[26, 29, 72]. This signalled a shift away from culture-based approaches to study the 
intestinal microbiota. With the development of Illumina-based sequencing 
technology at the start of this century, assessment of the functional capability within 
a microbial community could now be explored through shotgun metagenomic 
sequencing. During this time culturing continued with the isolation of important 
Roseburia and Faecalibacterium species [73-75], but sequence-based, culture-
independent approaches were by now the preferred means to study the intestinal 
microbiota. The plethora of bacteria identified through sequence-based means was 
demonstrated to be far greater than the number isolated by culture-based approaches, 
which further reinforced the assumption that many of these bacteria were inherently 
unculturable [76, 77]. The Human Microbiome Project and the MetaHIT project, 
both launched in 2008, greatly expanded our knowledge of the microbiotas of the 
human body, through primarily sequence-based and computational approaches in 
addition to culturing and generation of whole genome sequences. These studies 
fuelled a further increase in predominately sequence-based analyses of the human 
intestinal microbiota [8, 15, 78]. 
One of the main findings from these sequence-based approaches was the observed 
discrepancy between bacteria identified through culture-independent means and 
those acquired through culturing. This discrepancy is well documented and is termed 
the ‘great plate count anomaly’. Despite this, several research groups have 
successfully cultured many novel species from the intestinal microbiota. These 
groups have utilised different approaches such as a wide variety of media and 
different culture conditions to isolate as many different species as possible, using 
only a few growth media and archiving isolates in a high throughput manner in 96-
well plates or using a single media enriched with rumen fluid [79-81]. One barrier to 
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isolating bacteria in pure culture is that some bacteria are dependent on growth 
factors provided by neighbouring bacteria to grow. Examples of a growth factor are 
siderophores which are used by bacteria to scavenge available iron in the 
environment. This dependency can be overcome by addition of available forms of 
iron to the media which then allows isolation of pure cultures [76, 82]. In some 
situations, the preparation of culture media can be inhibitory to some bacteria. 
Autoclaving agar and phosphate buffer together results in an increase in inhibitory 
compounds such as hydrogen peroxide that prevent the growth of some bacteria. 
Autoclaving these media components separately removed the inhibition [83]. 
1.3.2 The benefits of bacterial culturing 
Despite this progress, culture-independent methods are still utilised more to study 
the intestinal microbiota. Indeed, compared to culture-independent methods, 
culturing is laborious and requires specialised equipment such as anaerobic chambers 
to operate at scale. Despite this, bacterial culturing provides many important uses 
that complement sequence-based approaches. From a clinical perspective, pure 
cultures are necessary as a starting point to satisfy Koch’s postulates and to 
determine if an isolate is causative for disease. It also allows determination of the 
antibiotic susceptibility of a disease causing isolate. Novel antibiotics produced by 
members of the human nasal microbiota have also been discovered through culture-
based approaches [84]. While the intestinal microbiota is linked to many diseases, 
proper characterisation of the role of particular bacterial species cannot take place 
unless there are pure cultures of the implicated species. Culturing of pure isolates 
also permits whole genome sequencing. Not only is the genome sequence valuable in 
itself, but these sequences can also be used to improve the resolution of 16S rRNA 
gene amplicon and metagenomic approaches by adding them to reference databases 
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[77]. In recent years, as the cost of sequencing has decreased, the use of Average 
Nucleotide Identity (ANI) which compares nucleotide similarity based on whole 
genome sequences has being utilised as a means to differentiate species [85]. This is 
a less laborious means to distinguish species compared to the classical approach of 
the DNA-DNA hybridisation technique (DDH) and offers greater resolution and 
more information in comparison to 16S rRNA gene sequencing. 
Culturing can also improve the taxonomy of bacteria through a combination of 
phylogenetic placement and phenotypic characterisation [86]. The taxonomy of 
bacteria within the intestinal microbiota was traditionally defined by broad 
morphological and phenotypic characteristics and did not always reflect correct 
phylogenetic placement. For example, the genus Clostridium was traditionally used 
as a repository for anaerobic spore-forming bacteria while the genus Bacilli was used 
as a repository for aerobic spore-forming bacteria. Over time Clostridia acquired 
more than 200 species [87]. The advent of 16S rRNA gene sequencing technologies 
combined with the culturing of novel bacteria led to the re-naming and movement of 
many species to new taxa to better reflect their phylogeny [88-90]. For example, 
Clostridium orbiscindens and Eubacterium plautii were combined and renamed as 
Flavonifractor plautii and moved to a new genus Flavonifractor [91]. Other name 
changes have not been so widely adapted. The intestinal pathogen Clostridium 
difficile has been renamed to Peptoclostridium difficile and then to Clostridioides 
difficile [90, 92], but due to the public awareness of the species as an important 
pathogen it is still commonly known by its original name. There are still many 
discrepancies in the systematics of the intestinal microbiota, for example, some 
species still have the same Latin prefix despite residing in different bacterial families 
e.g. Ruminococcus gnavus (Lachnospiraceae family) and Ruminococcus bromii 
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(Ruminococcaceae family). While some bacterial systematics will remain confusing, 
culturing can help alleviate this, as it allows phylogenetic placement through the 
generation of sequence data and facilitates the identification of distinguishing 
phenotypic characteristics. 
1.4 Spore-forming bacteria within the intestinal microbiota 
1.4.1 Sporulation and germination cycle and genetics 
Sporulation is a form of bacterial dormancy that is utilised by certain members of the 
Firmicutes phylum which plays an important role in human health and disease. It is 
defined by the production of resilient structures called endospores (called spores 
hereafter) that maintain DNA integrity and ensure survival in unfavourable 
conditions such as paucity of nutrients, desiccation, and for anaerobic bacteria, 
oxygen exposure. Sporulation is believed to be an ancient bacterial phenotype and 
may have arisen when oxygen levels on Earth started to rise due to photosynthesis 
by Cyanobacteria, around the same time that Firmicutes diverged from their 
ancestors 2.7 billion years ago [93, 94]. Some thermophilic bacteria that emerged 
before spore-forming Clostridia and Bacilli classes within the Firmicutes also have 
the capability to form spores and thus sporulation may have evolved to allow 
bacteria to survive changing and hostile conditions in the early Earth’s atmosphere 
[95]. Once a vegetative bacterial cell commits to sporulation (Figure 1.4, onset), the 
process proceeds through well-defined stages. Cell division with partitioning of 
DNA is followed by engulfment of the smaller forespore (Figure 1.4, asymmetric 
cell division and engulfment). The spore DNA is embedded in a dehydrated core 
abundant in dipicolonic acid and small acid-soluble proteins that protect the DNA. 
Surrounding the core is a peptidoglycan-rich cortex and multi-layered spore coat, 
both of which provide resistance to environmental insults (Figure 1.4, cortex 
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formation and coat formation). Sporulation concludes with lysing of the mother cell 
and release of the mature spore (Figure 1.4, mother cell lysis and spore release) [96, 
97].  
 
Figure 1.4 Sporulation and germination cycle 
Sporulation typically commences when a stress in encountered by a vegetative 
cell capable of making spores. The process then proceeds through well-defined 
stages as indicated, that result in a resilient and stable spore that contains the 
DNA necessary to maintain fecundity. Sporulation concludes with the lysing of 
the mother cell and the release of the mature spore. The spore will typically 
germinate when favourable conditions return and a new vegetative cell is 
formed. Figure taken from [1]. 
 
Most spore-forming species produce one spore per vegetative cell, however some 
species can produce several such as Metabacterium polyspora which colonises the 
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guinea pig gastrointestinal tract. M. polyspora is believed to use spore-formation as 
its primary means of reproduction and as a means to transmit between hosts [98, 99]. 
Once formed, spores can remain dormant for long periods, a spore at least 25 million 
years old has been revived from amber, they are also extremely resilient, 
withstanding alcohol, disinfectants and even conditions outside of the Earth’s 
atmosphere [100-102]. Their ability to remain dormant also facilitates transport over 
large distances via air currents, insects or human travel [103-105]. Spores can be 
released from dormancy upon sensing an external cue such as amino acids or 
nutrients that indicate favourable external conditions. Germination then ensues with 
a new vegetative cell emerging [96, 106]. Spore-forming bacteria are found in 
diverse environments such as soil, hot-springs, industrial waste and host-associated 
habitats of many animals [107].  
As sporulation involves drastic changes in cell morphology and the destruction of 
the mother cell it is a tightly regulated process involving transcription of hundreds of 
genes [1, 108]. Spo0A is a transcription factor that is found in all spore-forming 
bacteria. However, presence of the Spo0A gene is not diagnostic for spore-formation, 
some bacteria possess Spo0A, but have not been demonstrated to form spores [109]. 
Spo0A is essential for sporulation as it coordinates hierarchical downstream 
activation of sporulation specific sigma factors, other sporulation specific genes and 
pleiotropic genes recruited for the sporulation process [108, 110, 111]. It is part of a 
two-component regulatory system- upon encountering an external signal, a 
membrane bound histidine kinase initiates a phosphorelay cascade which results in 
phosphorylation and activation of Spo0A. The Spo0A protein consists of a Che-Y-
like signal receiver domain and a transcription activation domain (Figure 1.5). While 
Spo0A and associated sporulation-specific sigma factors are conserved amongst all 
37 
 
studied spore-formers, the genes under their control and their regulation are not 
shared amongst different taxonomic spore-formers [112]. For example, the main 
sigma factors F, E, G and K are activated in a sequential manner but in a different 
order in different species [97]. This flexibility has likely enabled spore-forming 
bacteria to adapt to different environments [109].  
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Figure 1.5 The two-component master regulator of sporulation Spo0A 
The Spo0A gene is the master regulator of sporulation and is found in all spore -
forming bacteria. A membrane bound histidine -kinase receives an external 
signal (e.g. lack of nutrients), this results in the phosphorylation of the  signal-
receiver domain of the Spo0A protein. This in turn activates Spo0A_C which 
initiates sporulation by activating transcription of sporulation -related genes in 
a DNA-binding mediated mechanism.  
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1.4.2 Clostridium difficile- the model enteric spore-former 
Some spore-forming bacteria produce toxins which can cause disease in humans and 
other animals such as Bacillus anthracis (family Bacillaceae) and Clostridium 
botulinum (family Clostridiaceae) [113, 114]. Others are associated with food 
poisoning such as Clostridium perfringens (family Clostridiaceae) and Bacillus 
cereus (family Bacillaceae). C. perfringens has also been associated with necrotizing 
enterocolitis of new-born infants [115]. While the toxins of these bacteria are 
responsible for harming humans, it is the ability of these species to sporulate that 
makes them so resilient and difficult to eradicate. In recent years the anaerobic 
pathogen, C. difficile (family Peptostreptococcaceae) has become a major health 
burden in nosocomial settings.  
Again, spores of C. difficile facilitate survival in external conditions and also make 
eradication in clinical settings difficult [102]. Once spores are ingested, they 
germinate in the small intestine in the presence of intestinal bile acids [97, 116, 117] 
(Figure 1.6). C. difficile has been detected in healthy adults that remain 
asymptomatic [118]. Its pathogenicity is linked to a depleted intestinal microbiota in 
the host, typically following antibiotic usage. People who are most at risk include 
immunocompromised or elderly individuals [119, 120]. The main virulence factors 
of C. difficile are toxins that target epithelial cells resulting in diarrhoea and in severe 
cases toxic megacolon and death [120]. The production of diarrhoea facilitates the 
dissemination of C. difficile through transmission of spores to new susceptible hosts 
(Figure 1.6). Due to its disease severity and the resilience of spores, C. difficile 
infection remains the most expensive infection to treat in the USA with over 29,000 
fatalities occurring in 2011 [121]. It is thus, the most-studied and best-understood 
enteric spore-forming bacterium [105, 110, 119, 122]. 
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Figure 1.6 The transmission and infection life-cycle of Clostridium 
difficile 
Clostridium difficile  utilises resilient spores to survive externally and to 
transmit between hosts. Once ingested, the spores germinate  in the small 
intestine forming vegetative cells which can produce harmful toxins in the 
large intestine, leading to disease. The vegetative cells produce new spores 
which are disseminated via toxin-induced diarrhoea, thus, allowing C. difficile 
to continue its life cycle.  TEM images by David Goulding WTSI.  
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C. difficile is genetically diverse with different lineages or ribotypes being associated 
with different levels of morbidity. These include the 027 lineage which was 
responsible for several nosocomial-associated disease outbreaks globally and the 078 
lineage which is associated with community acquisition and may also be 
zoonotically acquired [105, 123-125]. The C. difficile genome contains a large 
proportion of mobile genetic elements (approximately 11 %) which facilitates 
adaptation through the acquisition of new sequence [119]. Horizontal transfer of the 
toxin-encoding pathogenicity locus (PaLoc) from a toxin-producing to a non-toxin-
producing lineage has been demonstrated with subsequent toxin production in the 
PaLoc recipient [126]. Antibiotic resistance genes are frequently encoded on mobile 
genetic elements and are believed to have contributed to the global spread of the 
pathogen [119, 127]. The spread of the 027 lineage from North America to Europe 
and South Korea is associated with the acquisition of resistance to fluoroquinolone 
which is widely used in North America [105]. Interestingly, this antibiotic is not 
widely used in Australia which may explain the low levels of the 027 lineage in this 
country [125]. 
C. difficile is adapted to the gastrointestinal tract through its ability to metabolise 
available carbohydrates and to compete with the resident microbiota [119, 128]. 
Furthermore, the ability of spores to recognise intestinal bile acids ensures 
germination occurs in a favourable environment. This bile acid recognition is not a 
feature of every spore-former and reflects the adaptation of C. difficile to the 
intestinal environment [97, 122]. Intestinal bile acids are synthesised in the liver 
from cholesterol and aid digestion by acting as emulsifying agents [129]. Cholate 
and its conjugated forms, taurocholate and glycocholate, act as germinants for C. 
difficile spores as does the secondary bile acid deoxycholate which is converted from 
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cholate to deoxycholate by 7-dehydroxylase encoding bacteria such as Clostridium 
scindens. Deoxycholate and other secondary bile acids such as lithocholate are toxic 
to vegetative cells of C. difficile and loss of colonisation resistance through antibiotic 
consumption may therefore occur through depletion of C. scindens and other 7-
dehydroxylase encoding bacteria [116, 117, 130, 131].  
1.5 Transmission of commensal bacteria 
The presence of the intestinal microbiota in the human gut is the result of extensive 
immigration and competition that continues throughout life. The colonisation 
success of these health-associated symbiotic bacteria is attributable to their ability to 
spread and to be maintained in human populations [132]. Thus, transmission is an 
essential feature of the human microbiota that relies on the strategies used by 
bacteria to exit from one host (donor) and stably colonise another (recipient). The 
ubiquitous and sometimes exclusive presence of this select group of enteric bacteria 
in human populations demonstrates the existence of host-adapted colonisation 
processes and refined co-evolved transmission networks [5, 6, 31]. Most of our 
knowledge on the transmission mechanisms used by intestinal bacteria is derived 
from the study of pathogen transmission; this provides a conceptual framework to 
begin to understand commensal transmission [133]. Both commensal and pathogenic 
intestinal bacteria are primarily transmitted between hosts through the faecal–oral 
route. Commensal intestinal bacteria can also be transmitted through the vaginal–
oral route at birth and through breast milk in early life. The transmission routes of 
commensal and pathogenic bacteria are distinguished largely by the colonisation 
strategy that is used once inside the host. Commensal bacteria provide health 
benefits to the host that are a result of their colonisation, whereas, depending on their 
virulence and infectious dose, pathogen colonisation can cause disease. 
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1.5.1 Shared transmission routes of commensal and pathogenic intestinal 
bacteria  
The first step in a typical transmission route for an intestinal pathogen is the 
shedding of the bacterium from the host in faecal matter, which is followed by 
changes in bacterial metabolism or cellular architecture to maximise survival in the 
external environment. The pathogen must then persist in the external environment, 
possibly by using reservoirs, such as animals, the built environment, water sources or 
food chains, to increase the likelihood of entering a new susceptible host. Once the 
bacterium has successfully persisted in the external aerobic environment and has 
been ingested by a new host, it must colonise otherwise it will rapidly transit through 
the gut. Colonisation includes passage through the stomach, the establishment of a 
niche in the intestinal environment, the use of available nutrients, and replication to a 
level that will ensure stability and survival (Figure 1.7). A newly colonised host can 
then become a donor for the onward transmission of that bacterium. The colonising 
species will encounter competition from the resident microbiota, and this 
colonisation resistance has important roles in preventing invasion by pathogenic 
bacteria and in maintaining intestinal homeostasis [7]. The resident microbiota can 
compete directly through the use of available nutrients or by the secretion of toxins 
that target neighbouring bacteria, as has been demonstrated for B. fragilis [7, 134]. In 
addition to competition between bacterial species, the metabolism of available 
dietary substrates can facilitate cross-feeding between species, thus promoting 
cooperation and the colonisation of competing species [11, 135, 136]. 
It is likely that intestinal commensal bacteria use the same, or similar, strategies to 
those used by pathogenic bacteria to transmit between hosts (Figure 1.7). Recent 
evidence indicates that many of the survival mechanisms and environmental 
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reservoirs are also common between pathogenic and commensal bacteria. Moreover, 
colonisation factors, such as flagella and fimbriae, are also shared; these appendages 
are not unique to pathogens and are also a feature of commensal intestinal bacteria, 
including Roseburia spp. and Bifidobacterium spp. [137, 138]. Last, sequence-based 
studies of pathogen transmission networks have revealed that bacteria can 
disseminate both locally and globally through their human hosts, which indicates 
that the transmission of commensal bacteria is not spatially restricted [105, 139]. 
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Figure 1.7 Transmission of pathogenic and commensal intestinal 
bacteria 
Intestinal pathogens and commensal bacteria use similar mechanisms to 
transmit between host. Egestion from the host in faecal matter is the first stage 
in transmission (step 1). To promote dispersal and subsequent ingestion by a 
new host, pathogens may induce diarrhoea in the donor. Once in the external 
environment, survival mechanisms, such as aerotolerance, viable but non -
culturable dormancy and sporulation, are used by these predominately  
anaerobic bacteria to survive and transmit. Environmental reservoirs, such as 
people, food, animals and the built environment, will function as a source or 
sink for transmission (step 2). Once ingested by a new host (step 3), the 
bacterium transits to the intestines (step 4). Competition from the residen t 
microbiota can prevent colonisation (step 5, see colonis ation resistance); 
however, bacteria can colonize if a niche is unoccupied (step 5, see no 
colonisation resistance). The restoration of bacterial species functions to 
maintain colonisation resistance and promote the diversity of health -associated 
bacteria in the gut. Pathogens can overcome colonisation resistance through the 
induction of the expression of virulence factors, such as toxins, which can l ead 
to inflammation and perturb the resident microbiota (step 5, see pathogens). 
Metabolism of nutrients and replication promote persistence and support 
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further replication and subsequent onward transmission as the recipient now 
becomes a donor. Figure taken from [1]. 
 
1.5.2 Distinguishing the routes of transmission of commensal and pathogenic 
intestinal bacteria  
Despite the similarities mentioned above, there are substantial differences between 
the mechanisms used by intestinal pathogens and commensal bacteria to transmit. 
Depending on the colonising dose, host susceptibility and environment, a pathogen 
can exist in a low-level asymptomatic state or can induce a high-level symptomatic 
super-shedding state in the host [140]. The low-level asymptomatic state is typically 
associated with relatively little perturbation of the intestinal microbiota and lower 
levels of transmission, thus rendering the host a silent carrier of potential pathogens. 
Bacteria such as enteropathogenic E. coli, Vibrio cholerae and C. difficile use 
virulence factors, such as toxins, during pathogenesis to maximise their colonisation, 
despite causing severe inflammatory symptoms and intestinal disease. The host can 
restrict pathogen colonisation through the secretion of antimicrobial peptides, such 
as neutrophil gelatinase-associated lipocalin (NGAL), which prevents microbial 
siderophores from binding to essential iron [141]. However, some pathogens can 
circumvent this response by producing modified siderophores, such as salmochelins, 
that are not bound by NGAL. Any resulting intestinal disease typically results in 
substantial perturbation and instability in the commensal microbiota, which often 
results in diarrhoea that may promote rapid pathogen dispersal and transmission at 
the expense of commensal colonisation and host health. Therefore, one distinction 
between pathogen and commensal colonisation in this context is that pathogenic 
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bacteria use a host-derived inflammation state to spread, whereas commensals do 
not, and therefore either decrease in number or are lost during dysbiosis [142, 143]. 
1.5.3 Survival in the environment 
Once excreted from the body in faeces, intestinal bacteria must tolerate the local 
environment to enter and colonise a new host (Figure 1.7). As previously discussed 
spores are the transmission phenotype utilised by C. difficile but not all enteric 
spore-formers are pathogenic. There are also commensals some of which as 
demonstrated for C. scindens, exert protective effects by inhibiting C. difficile 
proliferation [144]. Other human-derived commensal bacteria from the Firmicutes 
have positive immunological effects by inducing regulatory T cells in mice [145]. 
These bacteria were isolated from chloroform-treated faecal samples and many of 
them are known spore-formers from the Erysipelotrichaceae and Lachnospiraceae 
families, including C. scindens again. Other intestinal spore-forming bacteria have 
been isolated from the Erysipelotrichaceae and Lachnospiraceae families in addition 
to other families that contain spore-forming species such as Clostridiaceae, 
Ruminococcaceae and Peptostreptococcaceae [26]. Spore-forming bacteria are 
therefore prevalent within the human intestinal microbiota but their extent remains 
unknown. For these commensals, spores could be utilised as a means to promote 
host-to-host transmission of anaerobic bacteria in a manner similar to C. difficile 
(Figure 1.6 and Figure 1.7). 
Once shed by the host, intestinal bacteria in a vegetative state show varying levels of 
tolerance to atmospheric oxygen [27, 28, 73, 146-148] (Table 1.2). The damaging 
effects of oxygen in bacterial cells are due to the generation of reactive oxygen 
species (ROS), which damage DNA and proteins, and interfere with essential 
metabolic processes [149]. Aerobic bacteria and facultative anaerobic bacteria have 
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evolved mechanisms to avoid and repair the damage caused by ROS, including 
antioxidant enzymes such as catalases, peroxidases or superoxide dismutase [27, 
149]. In a vegetative state, obligate anaerobic bacteria are typically sensitive to 
oxygen and may die within minutes of exposure [146]. Nevertheless, mechanisms to 
counter oxygen stress exist, even in these obligate anaerobes. Faecalibacterium 
prausnitzii relies on an extracellular flavin–thiol electron shuttle to grow in the 
presence of oxygen, which enables its survival in the oxygenated zone at the gut 
mucosa [150]. This oxygenated zone ensures that gut epithelial cells are protected 
from the majority of anaerobic bacteria in the lumen that could compromise the 
integrity of the epithelial cells [151, 152]. The extracellular flavin–thiol electron 
shuttle may also promote the survival of F. prausnitzii when it is exposed to 
atmospheric oxygen in the presence of the antioxidants inulin, cysteine and 
riboflavin [150, 153]. Other abundant intestinal bacteria, such as Roseburia spp., can 
only survive for a few minutes when exposed to atmospheric oxygen concentrations 
(Table 1.2). We hypothesise that Roseburia spp. either use a currently unknown 
survival mechanism or are extremely efficient at colonisation and can readily 
become established in new hosts to which they are in close proximity. 
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 Phylum Family Species 
Survival time in 
ambient oxygen 
Ref. 
1 Proteobacteria Enterobacteriaceae Escherichia coli 
Minimum 21 
days 
[146] 
2 Firmicutes Lachnospiraceae 
Clostridium 
aminovalericum 
45 minutes [27] 
3 Firmicutes Lachnospiraceae Roseburia faecis 2 minutes [73] 
4 Firmicutes Lachnospiraceae Roseburia hominis 2 minutes [73] 
5 Firmicutes Lachnospiraceae Roseburia inulinivorans 2 minutes [73] 
6 Firmicutes Lachnospiraceae Roseburia intestinalis 1 hour [147] 
7 Firmicutes Lachnospiraceae Eubacterium hallii 1 hour [147] 
8 Firmicutes Lachnospiraceae Anaerostipes caccae 
Minimum 1 
hour 
[147] 
9 Firmicutes Ruminococcaceae 
Faecalibacterium 
prausnitzii 
1 hour [147] 
10 Firmicutes Veillonellaceae Veillonella alcalescens 72 hours [148] 
11 Firmicutes 
Clostridiales Incertae 
Sedis XI 
Anaerococcus prevotii ‡ 72 hours [148] 
12 Firmicutes Lactobacillaceae 
Lactobacillus 
plantarum 
Minimum 72 
hours 
[27] 
13 Bacteroidetes Bacteroidaceae Bacteroides uniformis 144 hours [146] 
14 Bacteroidetes Bacteroidaceae Bacteroides coprocola 48 hours [146] 
15 Bacteroidetes Bacteroidaceae Bacteroides vulgatus 8-48 hours 
[27, 
146] 
16 Bacteroidetes Bacteroidaceae Bacteroides caccae 72 hours [146] 
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17 Bacteroidetes Rikenellaceae Alistipes finegoldii 72 hours [146] 
18 Bacteroidetes Bacteroidaceae Bacteroides fragilis 4 - 72 hours 
[27, 
148] 
19 Actinobacteria Bifidobacteriaceae 
Bifidobacterium 
adolescentis 
24-72 hours 
[27, 28, 
146] 
20 Actinobacteria Bifidobacteriaceae Bifidobacterium bifidum 120 hours [146] 
21 Actinobacteria Bifidobacteriaceae Bifidobacterium breve 
Minimum 48 
hours 
[28] 
22 Actinobacteria Bifidobacteriaceae Bifidobacterium longum 
Minimum 48 
hours 
[28] 
23 Actinobacteria Bifidobacteriaceae 
Bifidobacterium 
pseudocatenulatum 
Minimum 48 
hours 
[28] 
24 Actinobacteria Coriobacteriaceae Collinsella aerofaciens 48 hours [146] 
25 Actinobacteria Coriobacteriaceae Eggerthella lenta † 45 minutes [27] 
 ‡ Previously known as Peptococcus prevotii . † Previously known as 
Eubacterium lentum 
Table 1.2 Aerotolerance of non-spore forming intestinal bacteria. 
A compilation of previously published experiments on the aerotolerance ability 
of a diverse selection of non-spore-forming intestinal bacteria. All assays 
involved in vitro inoculation of bacterial cultures on bacterial growth media 
that were exposed to ambient air for different time periods. This lis t is not 
exhaustive but is used to demonstrate broad patterns of varying aerotolerance 
amongst different taxa within the human intestinal microbiota.  Reference 
numbers refer to the publication describing the original experiment.  
 
There are other dormancy states that, unlike sporulation, are not reliant on the 
formation of specialised resistant structures. Viable but non-culturable (VBNC) state 
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is a form of bacterial dormancy that typically involves a decrease in metabolic 
activity and the generation of a strengthened cell wall that is achieved through 
modifications to its peptidoglycan structure. An increase or, more typically, a 
decrease in cell size has also been reported [154, 155]. These strategies all function 
to help bacteria withstand environmental stresses and preserve DNA integrity [154-
156]. Similar to sporulation, the VBNC state is reversible through the removal of the 
inducing stress (for example, nutrient limitation or extreme temperature) or 
following exposure to growth stimulants, such as amino acids for E. coli or contact 
with intestinal cells for V. cholerae [154, 157]. Similar to spores, VBNC bacteria can 
remain dormant for long periods of time. For example, Vibrio fluvialis from marine 
sediment was successfully cultured after six years of dormancy following the 
addition of nutrients [158]. The majority of VBNC bacteria that have been identified 
thus far are human-associated pathogens, including E. coli, Enterococcus faecium, V. 
cholerae, Salmonella enterica subsp. enterica serovar Typhimurium and 
Mycobacterium tuberculosis [154, 159, 160]. Genetic and phenotypic 
characterisation of the VBNC state remains technically challenging, because the 
stimuli that are required to induce or culture bacteria from this dormant state are 
largely unknown or are difficult to simulate in a laboratory [161]. As VBNC 
dormancy is found in phylogenetically diverse bacterial species, it may be 
widespread in the intestinal microbiota and could be used as a strategy by non-spore-
forming oxygen-sensitive commensal bacteria to survive in the environment until 
they are acquired by a new host. However, whether the VBNC state is induced in 
members of the commensal microbiota remains to be determined. 
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1.5.4 Reservoirs of commensal bacteria 
Humans are the main reservoir of commensal intestinal bacteria, with transmission 
occurring readily between individuals. Childbirth is the first major life event in 
which the transmission of bacteria and colonisation occur. Depending on the mode 
of delivery, either the birth canal of the mother, or the hospital environment and the 
skin of the mother provide the initial inoculum of bacteria for the infant [162, 163]. 
Faecal–oral transmission could also occur during vaginal delivery, which would 
enable the immediate transmission of members of the intestinal microbiota to 
neonates at birth [162]. Compared with neonates that are born vaginally, it is thought 
that the composition of the microbiota of infants that are born by caesarean section 
may be more analogous to the skin microbiota than the vaginal microbiota in the 
early days of life [163]. Despite this, by six weeks, differences in the infant 
microbiota are determined by the body site and not the mode of delivery, which 
indicates that microbial convergence occurs early in life [164]. Evidently, there is no 
doubt that bacteria that can only be transmitted during vaginal delivery would be 
unable to colonise infants who are born by caesarean section. If no attempt is made 
to colonise infants who are born by caesarean section with these species, then, over 
generations, these species may be lost from the microbiota [165]. This decrease in 
diversity may have important health implications, as highlighted by reports that have 
associated immune disorders, such as asthma and allergies, in adult life with the 
abnormal development of the infant intestinal microbiota [165, 166]. After 
childbirth, inter-host transmission of intestinal bacteria continues, as shown by 
people who live in the same home sharing more species in common with each other 
than non-residents [24, 167-169]. The transmission rate of a bacterial species is 
affected by the number of hosts, their level of contact and their proximity to each 
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other, as well as by the inherent colonisation resistance of the microbiota in each 
individual, which is largely affected by age. A healthy adult has a broadly stable and 
resilient intestinal microbiota compared with an infant whose intestinal microbiota is 
still developing [167, 170]. 
Outside of family units, the effects of social interactions on the acquisition of the 
microbiota in large groups are best understood in non-human primates [171, 172]. 
Similar to humans, these are social animals that live and interact with each other in 
defined communities, and the composition of their intestinal microbiotas are 
influenced by the interactions of the social group. The higher the incidence of social 
interaction between individuals the more similar the composition of their intestinal 
microbiota, with species diversity increasing accordingly [171, 172]. The prevalence 
of anaerobic non-spore forming bacteria in baboons was associated with close social 
interactions between grooming pairs [171]. Although humans do not engage in social 
grooming, we physically interact through socially acceptable activities such as hand 
shaking, hugging and kissing, the frequency and intimacy of which increase as an 
individual interacts with a close family member or friend compared with a stranger. 
Thus, there is likely to be several social and cultural factors that contribute to the 
transmission of our intestinal microbiota. 
Although the microbiota of an individual is largely structured and influenced by their 
diet, the microorganisms that are carried in food can also contribute to the intestinal 
microbiota [173]. From early life, infants acquire up to 8 × 10
6
 bacteria daily, 
including intestinal-associated bacteria, through breast milk [174-176]. The 
mechanism by which intestinal bacteria translocate from the gut to the breast is 
unknown; however, an entero–mammary pathway that is facilitated by phagocytes 
that sample the gut lumen and subsequently translocate to the breast through the 
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bloodstream has been proposed [177-179]. Studies of various foods by culture-based 
methods have estimated that adults consume between 10
6
 and 10
9
 microorganisms 
daily [180]. Although most of the bacteria that are ingested do not survive transit 
through the stomach, those that do are not thought to colonise the gastrointestinal 
tract long-term [181]. The diversity of the microbiota that is acquired through food is 
dependent on diet [180, 182]; therefore, food provides a source of both exogenous 
bacterial species and genes for the resident microbiota to acquire through horizontal 
gene transfer [183]. 
Probiotics are defined as ‘live microorganisms that, when administered in 
adequate amounts, confer a health benefit on the host’ [184]. Probiotic 
bacteria, typically Bifidobacterium spp. and Lactobacillus spp., have been shown to 
alleviate the symptoms of several illnesses, including infectious diarrhoea, sepsis and 
atopic eczema [185-188]. The long-term colonisation efficiency of most probiotic 
bacterial species is variable [189, 190]; therefore, regular ingestion of probiotics is 
required to make a substantial long-term contribution to health [176, 191]. However, 
stable gut colonisation by Bifidobacterium longum six months after ingestion has 
been observed, which was attributed to the presence of an unoccupied niche that was 
vacated by a species that had similar carbohydrate-metabolising capabilities [192]. 
Overall, the variability in probiotic efficacy, coupled with host-specific responses to 
probiotics, means that the health benefits of ingesting these bacteria are not fully 
understood or predictable [193, 194]. 
Water is a major environmental reservoir for several intestinal bacterial pathogens, 
such as Shigella flexneri, Shigella sonnei and V. cholerae, which can cause 
debilitating gastrointestinal disease [195]. However, little is known about the fate or 
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the effect that commensal intestinal microorganisms that are found in water have on 
human health. The identification of bacteria in drinking water has primarily focused 
on pathogens, especially readily detectable indicator microorganisms, such as E. 
coli; however, the distinction between commensal and pathogenic strains of this 
species is not always made [196]. Despite an emphasis on pathogen detection, 
sequence-based culture-independent approaches have identified human-associated 
Blautia spp. in rivers [197]. Thus, it is clear that these species are transmitted 
through water; however, after the appropriate water treatment procedures, any 
strictly anaerobic non-spore-forming intestinal bacteria are likely to be killed, and 
these bacteria are therefore expected to have a low transmissibility and colonisation 
potential. Nevertheless, the full extent of the transmission of commensal intestinal 
bacteria through water is currently unknown. 
Animals may also act as a reservoir for human microbiota with pets being the main 
source. The microbiotas of dogs and cats include taxa that are also found in the 
human microbiota; for example, genera such as Roseburia, Faecalibacterium, 
Bacteroides, Prevotella and Ruminoccocus [198, 199]. Farm animals are an 
additional source of bacteria. Analysis of the porcine intestinal microbiota has 
revealed similarities in taxonomic groups and functional capabilities with the human 
intestinal microbiota [5, 200]. Several human-associated pathogens, such as 
Salmonella enterica subsp. enterica serovar Enteritidis, Campylobacter jejuni, 
enteropathogenic E. coli and C. difficile [124, 201, 202], are transmitted between 
animals and humans; therefore, the potential for animals to transmit commensal 
species of bacteria is plausible. The treatment of animals that are to be used as food 
with antibiotics has also been linked to the acquisition of antibiotic-resistant strains 
of bacteria in humans [203, 204]. This highlights the need to recognise that human 
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health can be influenced through various diverse sources that are not directly 
connected to our own personal health decisions. 
Interest in the microbes of the built environment has increased in recent years. Both 
buildings and transport systems adsorb our microbiota, which creates opportunities 
for microbial transmission across vast spatial areas and diverse human populations 
[205-208]. Humans are one of the main sources of indoor airborne bacteria that can 
spread through ventilation systems [209]. Outdoor air can also enter a building 
passively [205, 210]. Once bacteria become airborne (for example, through flushing 
a toilet or using a shower), viable bacteria can disperse around a room [211, 212]. In 
the built environment, the greatest density of human-associated bacteria will 
probably be found in bathrooms. Bacteria are abundant on surfaces that have been 
touched by human hands, on toilet seats or on floors [213, 214]. Skin-associated 
bacteria are the most dominant species on bathroom surfaces; however, a high 
proportion of intestinal-associated bacteria have also been found, such as members 
of the Bacteroidaceae, Prevotellaceae, Ruminococcaceae and Lachnospiraceae 
families. The presence of these intestinal-associated bacteria, together with poor 
hand-washing procedures, provides a reservoir for bacteria in the built environment 
that have the potential to transmit to humans [215]. A limitation of most of the 
studies on bacteria in the built environment is the lack of distinction between viable 
bacteria that have the potential to successfully colonise a new host and non-viable 
bacteria, which do not. It is estimated that only 1–10% of bacterial cells that are 
detected by culture-independent methods are viable [216]. Although culture-based 
methods can detect the viability of bacterial cells, the bacteria obtained will be an 
underrepresentation of the overall diversity in the sample. 
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1.6 Microbiota perturbation and restoration 
1.6.1 Microbiota perturbation 
The composition of an individual’s microbiota remains largely stable once 
established after approximately three years [22, 25, 217]. Despite this, our 
microbiota experiences perturbations that can alter or damage its composition and 
functions [18, 181, 218-220]. Depending on the extent of the perturbation in the 
microbiota, and subsequent exposure to bacteria, the composition of the microbiota 
may be restored to a similar state or assume a new stable state that is composed of 
different bacterial species [221]. Therefore, a perturbation in the community will 
provide an opportunity for an externally derived bacterium to establish itself by 
reducing or eliminating competition from a resident species that occupies the same 
niche and requires the same nutrients [192, 222]. Factors that cause a microbiota 
perturbation are varied and range from antibiotic use, infection with a pathogen, a 
change in diet or travel [25, 181, 218, 223]. Changes in the composition of the 
microbiota have mostly been studied at the individual level; however, there is 
increasing evidence that suggests that changes in Western lifestyles and diet are 
altering the intestinal microbiota at larger population levels. Recently, it was 
observed that many traditional rural hunter–gatherer societies and agrarian groups 
that follow non-Western social behaviours and do not commonly use antibiotics or 
disinfectants have a more diverse intestinal microbiota that includes bacterial species 
that are now absent from the intestinal microbiota of developed world populations 
[224]. 
Any perturbation in an individual that eliminates certain bacterial species, or selects 
for some at the expense of other species, will prevent further onward transmission to 
other hosts [165, 225]. If the perturbation happens at the population level then the 
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effects may be compounded at a larger scale. For example, the consumption of a 
high-fat low-fibre diet, which is typical of Western populations, has been shown to 
cause the extinction of intestinal bacteria in mice if the diet is consumed over several 
generations [225]. Similarly, the use of antibiotics can negatively affect the diversity 
of intestinal bacteria, with repeated use preventing the restoration of the microbiota 
[219]. Although antibiotics and disinfection measures are essential for disease 
control and a high-calorie diet has greatly decreased undernutrition in Western 
societies; in this context, these changes may result in the indiscriminate elimination 
of commensal species, which could affect the diversity of the microbiota and 
microbial transmission [165, 226]. Indeed, a study in which the intestinal 
microbiotas of individuals who resided in either the United States or traditional 
agrarian societies in Papua New Guinea were compared attributed a lower α-
diversity within, and higher β-diversity between, individuals in the United States 
cohort to decreased inter-host microbial transmission [227]. 
In addition to the observed decrease in the diversity of the intestinal microbiota in 
Western societies, an increase in autoimmune and allergic diseases in the developed 
world has been observed [165, 228, 229]. Originally termed the 'hygiene hypothesis', 
there is increasing evidence in humans and animal models that exposure to 
microorganisms early in life promotes the maturation of the immune system and 
decreases the incidence of autoimmune-related diseases [228, 230-232]. Consistent 
with this hypothesis, the use of antibiotics in childhood has been associated with an 
increased likelihood of developing paediatric inflammatory bowel disease and a pre-
disposition to asthma and obesity in later life [219, 233]. These examples illustrate 
the importance of efficient microbial transmission networks and the potential effect 
on human health when they fail. 
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1.6.2 Microbiota restoration 
Direct interventions currently provide the most immediate solution to establish or 
restore a diverse and beneficially functional microbiota across all age groups. Recent 
interventions in this area have included swabbing neonates born by caesarean section 
with gauze that has been pre-incubated in the vagina of the mother to mimic the 
natural transmission of the vaginal microbiota to the child [234]. In adults who are 
susceptible to recurrent infections with C. difficile, faecal microbiota transplantation 
(FMT) from a healthy donor has proven extremely effective at resolving such 
infections (see ‘Therapeutics based on the intestinal microbota’ section below) [235]. 
As the number of human gut commensal species that have been isolated and 
archived as pure cultures continues to increase [80, 236, 237], the development of 
live biotherapeutics for the treatment of disorders other than C. difficile infection will 
become feasible. Next-generation probiotics and functional foods that make use of 
the numerous diverse beneficial bacteria other than the widely used Lactobacillus 
spp. and Bifidobacterium spp. could potentially provide health benefits to individuals 
and to the wider interconnected human population. However, until there are 
improvements in culturing processes and an increase in the number of commensal 
bacteria isolated and archived for characterisation, their potential remains unfulfilled.  
At a broader level, changes in living practices can promote the transmission of, and 
colonisation by, health-associated commensals at the expense of pathogen 
colonisation. A course of broad-spectrum antibiotics to treat a gastrointestinal 
infection also eliminates many beneficial commensals, thus rendering the 
microbiota-deficient host susceptible to infections with other pathogens [131, 223]. 
Indeed, narrow-spectrum antibiotics, or antimicrobials that have specific targets, 
such as bacteriocins or phage therapies, are desirable and under development as 
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alternatives to treatment with broad-spectrum antibiotics [238]. The effects of 
antibacterial hygiene products and hand sanitizers on the intestinal microbiota are 
unclear and require further study; however, efforts to use them more selectively may 
reduce the depletion of commensal bacteria [239]. Hygiene practices currently act to 
decrease the total number of bacteria on a surface or individual, whereas a more 
targeted approach that specifically removes pathogenic microorganisms should be 
given greater consideration [240].  
1.6.3 Understanding microbiota perturbation through ecological theory 
The human intestinal microbiota is an ecological community in terms of its 
individual members both cooperating and competing with each other to utilise 
available resources. Ecological theory provides a framework to predict and model 
the human microbiota [221]. This is important not only for our understanding of how 
the microbiota functions and responds to disturbances but also to predict its 
responses to perturbations. Metacommunity theory is defined by local communities 
within a habitat that are spatially separated from each other but are connected by the 
species migrating between them and can be used to understand dispersal and 
transmission of the intestinal microbiota between different human hosts [241]. 
Important processes in metacommunity theory include the dispersal of species 
between local host habitats, which maintains community diversity, the ability of 
species to adapt to a host environment and selection or filtering by the host to ensure 
only beneficial species colonise [221]. These processes are not independent of each 
other, hence, a low dispersal rate within a community will favour high adaptation 
and conversely a high dispersal rate will favour low adaptation [221]. 
A final important process in metacommunity theory is ecological drift which is 
caused by stochastic events that perturb the microbial community. Low-abundance 
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species are more susceptible to these events and are more likely to move towards 
extinction unless they can either adapt to ensure survival within the environment or 
they can disperse to a new host [221, 242, 243]. Examples of stochastic events could 
include a short-term change in diet, antibiotic usage or transient infection by a food-
borne pathogen [181, 218]. Any species that becomes extinct will be replaced by 
another filling the newly vacant niche, hence dispersal is an important component of 
maintaining a diverse and functional microbiota [242]. Ecological drift will result in 
widespread variation of bacterial species amongst different individuals as species 
become extinct and are replaced. Indeed, this is a feature of the intestinal microbiota 
within individuals at lower taxonomic levels [244]. There is evidence to suggest that 
low abundance species possess dormancy mechanisms which either protect against 
ecological drift within a habitat or facilitate dispersal to a new environment if 
expelled [245]. In many microbial communities, a few species are disproportionally 
abundant and most species are rare, hence, ecological drift and dormancy may be 
prevalent in many microbial communities including the intestinal microbiota [245, 
246].  
1.7 Therapeutics based on the intestinal microbiota 
The intestinal microbiota is associated with a considerable number of ailments 
including a wide range of intestinal-associated diseases, inflammation-associated 
disorders and neurological disorders [247]. The extent of the ailments the intestinal 
microbiota is associated with and the lack of substantive evidence demonstrating 
causality has led to calls for more mechanistic studies that demonstrate that the 
differences observed in a healthy verses disease state are not merely incidental [247, 
248]. Until there are carefully designed studies that demonstrate that particular 
bacteria are causative or contributory, then any associative study should be treated 
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with caution. To avoid exaggeration of results, studies should be designed to identify 
bacterial species of interest, not merely examine changes in composition at high 
taxonomic levels which may not be informative. Admittedly, we currently lack 
genetic tools to engineer many species of the intestinal microbiota which would 
allow fulfilment of ‘molecular Koch’s postulates’ necessary to implicate a gene in a 
disease, however this situation is changing [249, 250]. 
Despite the lack of mechanistic studies and genetic tools, there have been several 
important therapeutic breakthroughs, especially for treating C. difficile infection. 
Recurrence of C. difficile infection can occur in the same individual in 20% of cases 
with the chances of subsequent recurrence increasing thereafter. This is primarily 
due to antibiotic-mediated lack of commensal colonisation resistance and sub-
optimal host immunity [251]. In these scenarios, an alternative treatment is faecal 
microbiota transplantation (FMT) from a healthy donor. While the exact mechanism 
remains unknown, it is believed that the microbiota in the donor faecal sample 
rapidly restores colonisation resistance in the form of a healthy functioning intestinal 
microbiota with subsequent displacement of C. difficile. The microbiota profile of 
the recipient post-FMT often resembles that of the donor, however the recipient can 
maintain some of their original strains which were present before C. difficile 
infection [252, 253]. This treatment is extremely effective for resolving C. difficile 
infection and clinical trials have reported success rates of over 90% [235]. As a 
result of its high efficacy, the demand for routine access to safe FMT material has 
stimulated the establishment of companies such as OpenBiome, that have created a 
bank of faecal samples from screened donors [254]. 
While effective, FMT is not an ideal therapeutic as it is not standardised, undetected 
pathogens may be present at low abundances and it will differ in microbial 
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composition from donor to donor. A more desirable treatment is a defined mix of 
bacteria that have the same efficacy at resolving C. difficile infection. Successful 
outcomes using a mix of six phylogenetically diverse bacteria in a mouse model and 
33 phylogenetically diverse bacteria in humans have been reported [223, 255]. 
Defined mixes of bacteria are also used to target inflammatory conditions. These 
therapeutics are utilising bacteria that produce Short Chain Fatty Acids (SCFA) from 
dietary fibre which induce regulatory T cells (Tregs) that dampen down 
inflammation. The efficacy of this approach has been demonstrated using a mix of 
17 human-derived bacteria in mice, and is now being developed as a commercial 
product [145, 254]. C. difficile infection and inflammatory-associated conditions are 
currently the most promising live therapeutic targets but there is also evidence that 
suggests that the intestinal microbiota may play a role in cancer, drug metabolism 
and neurological disorders [254, 256, 257]. Consequently, these ‘live 
biotherapeutics’ are now a commercial target for many microbiota-based companies. 
1.8 Thesis aims 
There were two broad aims in this study. The first aim was to develop a process to 
culture, isolate and archive a representative selection of bacteria from the intestinal 
microbiota of healthy humans. The second aim was to understand the relevance of 
spore-formation to the process of microbiota transmission, to explore the breadth of 
spore-formation in the human gut microbiota, and to evaluate the evolutionary 
dynamics of the phenotype. 
The objectives relevant to the first aim were: (1) to determine the culturability of the 
human intestinal microbiota using a streamlined culturing process e.g. one growth 
medium, (2) to incorporate a phenotypic screen in the culturing process to culture 
64 
 
and isolate spore-forming bacteria and (3) to assess the phylogenetic distribution and 
novelty of the bacteria cultured.  
The objectives relevant to the second aim were: (1) to examine the transmission 
mechanisms of spore-forming bacteria by assessing their ability to survive ex vivo in 
aerobic conditions and to colonise a new host by germination of spores once 
ingested, (2) to establish the extent of sporulation within the human intestinal 
microbiota using whole genome sequencing and metagenomic approaches, (3) to 
explore the phylogenetic and environmental distribution of spore-forming bacteria 
(from all environments, not just the gut) in the Firmicutes and (4) to compare 
genomes of spore-forming and non-spore-forming bacteria to explore genomic 
features of host-adaptation. 
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Chapter 2 Materials and Methods 
2.1 Culturing of bacteria from the human intestinal microbiota 
2.1.1 Acquisition of donor faecal samples 
Ethical approval was obtained for collection of faeces and analysis of microbial 
components from appropriate ethical bodies at the Wellcome Trust Sanger Institute. 
Donors completed a questionnaire to assess their suitability for donation. To be 
included in the donation process, donors must not have experienced any 
gastrointestinal infections six months prior to donation, must not have used 
antibiotics six months prior to donation, must not have suffered from, or be 
recovering from chronic intestinal diseases such as Crohn’s disease, Ulcerative 
colitis, Coeliac disease, Irritable bowel syndrome, stomach ulcers or Colorectal 
cancer. In addition, donors were required to be free of autoimmune diseases or 
allergies such as multiple sclerosis, asthma or psoriasis. 
Metadata was also obtained from the donors including age-range, nationality, 
ethnicity, time resident within the UK and diet consumed (i.e. vegan, vegetarian or 
omnivore). To maintain donor anonymity, no identifying information such as date of 
birth, name or address was requested. Of the six donors who participated, all were 
Caucasian of different nationalities, four were male, two were female with an age 
range from 26 to 45 years old. Five were omnivores and one individual was 
vegetarian. All were resident in the UK for at least 2.5 years. 
2.1.2 Anaerobic culturing 
Fresh faecal samples were obtained from the donors and weighed (one faecal sample 
per donor: minimum 0.5 g per sample) before being placed in anaerobic conditions 
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within one hour of being passed to preserve the viability of anaerobic bacteria. All 
sample processing and culturing took place under anaerobic conditions (gas 
composition was 10 % carbon dioxide, 10 % hydrogen, 80% nitrogen) in a Whitley 
DG250 workstation at 37 °C. Culture media, Phosphate Buffer Saline solution (PBS) 
and all other materials that were used for culturing were placed in the anaerobic 
cabinet for at least 12 hours before use to reduce. The faecal samples were divided in 
two. One part was homogenized in reduced PBS (0.1 g stool per ml PBS) and was 
serially diluted down to 10
-7
 and plated directly onto YCFA
 
agar supplemented with 
0.002 g ml−1 each of glucose, maltose and cellobiose in large (13.5 cm diameter) 
Petri dishes (Table 2.1). The YCFA media was developed by the Rowett Institute in 
Aberdeen, Scotland [75]. Plating was performed by adding 250 µl of the faecal 
solution to the Petri dish and uniformly spreading it over the plate using a disposable 
hockey stick (plate spreader). 
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Ingredient Amount 
 Components of solutions and 
mixes: 
 
Before Autoclaving 
 
 Resazurin Solution  
Agar (optional) 8 g  Resazurin 0.1 g 
Tryptone 5.0 g  d. H2O 100 ml 
Yeast extract 1.25 g    
NaHCO3 2.0 g  Mineral Solution I:  
(D)+Glucose 1.0 g  K2HPO4 3 g 
(D)+Maltose 1.0 g  d.H2O 1 L 
(D)+Cellobiose 1.0 g    
L-cysteine 0.5 g  Mineral Solution II:  
Mineral Solution I 75 ml  KH2PO4 3 g 
Mineral Solution II 75 ml  (NH4)2SO4 6 g 
Resazurin Solution 0.5 ml  NaCl 6 g 
Haemin Solution 5 ml  MgSO4 0.6 g 
Vitamin solution I 0.5 ml  CaCl2 (dry) 0.6 g 
d.H2O up to 500 ml  d.H2O 1 L 
VFA mix 3.1 ml    
NaOH pH to 7.45  VFA mix:  
  
 Acetic acid 17 ml 
After Autoclaving 
 
 Propionic acid 6 ml 
Vitamin solution II 0.5 ml  n-Valeric acid 1 ml 
  
 Isovaleric acid 1 ml 
   Isobutyric acid 1 ml 
     
   Haemin Solution:  
   KOH 0.28 g 
   Ethanol 95 % 25 ml 
   Haemin 0.1 g 
   d.H2O up to 100 ml 
     
   Vitamin Solution I:  
   Biotin 5 mg 
   Cobalamin (Vitamin B12) 5 mg 
   PABA (4-Aminobenzoic Acid) 15 mg 
   Folic acid 25 mg 
   Pyridoxine 75 mg 
   d.H2O up to 500 ml 
     
   Vitamin Solution II:  
   Thiamine hydrochloride 25 mg 
   Riboflavin 25 mg 
   d.H2O up to 500 ml 
 
Table 2.1 YCFA media 
Volumes are to make 500 ml of YCFA media (either agar or broth). The 
solutions and mixes are prepared separately and then added in the requir ed 
volume when the media is being prepared. 
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The other part of the faecal sample was mixed with an equal volume of 70 % (v/v) 
ethanol and was vortexed approximately once every hour, over a four hour period at 
room temperature under ambient aerobic conditions to kill vegetative cells. Then, the 
mix was centrifuged, the ethanol was decanted and the solid material was then 
washed three times with PBS (an equal volume of PBS was added, the mix was 
vortexed, then centrifuged and the PBS was decanted). After washing it was 
resuspended in PBS, again at a concentration of 0.1g stool per ml PBS. Plating was 
performed as described earlier. 
For the ethanol-treated samples, the medium was supplemented with 0.1 % sodium 
taurocholate to stimulate spore germination. Colonies were picked 72 hours after 
plating from a Petri dish of both ethanol-treated and non-ethanol-treated conditions 
harbouring non-confluent growth, (that is, plates on which the colonies were distinct 
and not touching). Approximately 100 colonies were picked from each plate, the aim 
was to pick colonies of different morphologies to ensure a diverse selection was 
isolated. The colonies that were picked were re-streaked onto new YCFA media on 
regular sized Petri dishes (9 cm diameter) to visually confirm purity before 16S 
rRNA gene sequencing profiling (below). Once colonies were identified, they were 
grown overnight in 10 ml YCFA broth and 500 ul of this inoculum was then frozen 
at -80 °C in a solution containing 50 % bacterial culture (500 ul) and 50 % glycerol 
(500 ul) (glycerol was 25 % final concentration). 
2.1.3 Microbiota profiling by 16S rRNA gene sequencing 
Identification of each picked isolate was performed by PCR amplification of the full-
length 16S rRNA gene (using 7F (5′-AGAGTTTGATYMTGGCTCAG-3′) forward 
primer and 1510R (5′-ACGGYTACCTTGTTACGACTT-3′) reverse primer 
followed by capillary sequencing. Full-length 16S rRNA gene sequence reads were 
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aligned in the Ribosomal Database Project (RDP). RDP classifies sequences by 
comparison to a 16S rRNA gene sequence database that has taxonomic information 
assigned based upon Bergey's Taxonomic Outline of the Prokaryotes [258, 259]. 
These sequences were manually curated in ARB and mothur was then used to 
classify reads to operational taxonomic units (OTUs) using the cluster command 
[260, 261]. The R package seqinr version 3.1 was used to determine sequence 
similarity between OTUs and 98.7 % was used as a species-level cut-off [262, 263]. 
The full-length 16S rRNA gene sequence of each species-level OTU was compared 
to the RDP reference database to assign taxonomic designations to the genus 
level and a BLASTn search defined either a characterized or candidate novel species 
[258, 264]. 
Comparisons of 16S rRNA gene sequences with the Human Microbiome Project 
(HMP) were carried out using 97 % sequence similarity of the 16S rRNA gene 
sequence from the cultured bacteria to define a species because only partial 16S 
rRNA gene sequences were available. HMP data regarding the most wanted taxa and 
the completed sequencing projects were downloaded 
from http://hmpdacc.org/most_wanted/#data and http://hmpdacc.org/HMRGD/, 
respectively. 
2.1.4. Submission of cultured bacteria to public repositories 
To make the cultured isolates available to the wider research community, a 
representative species was sent to at least one of the following four public 
repositories- Deutsche Sammlung von Mikroorganismen und Zellkulturen Gmbh 
(DSMZ) in Braunschweig, Germany (http://www.dsmz.de), Japan Collection of 
Microorganisms (JCM) maintained by the Riken BioResource Center in Tsukuba, 
Japan (http://jcm.brc.riken.jp/en/), the Culture Collection, University of Gothenburg 
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(CCUG) maintained by the University of Gothenburg in Sweden 
(http://www.ccug.se/) and the Belgian Co-ordinated Collection of Micro-organisms 
(BCCM/LMG) hosted by the Laboratory of Microbiology at Ghent University, 
Belgium (http://bccm.belspo.be/). These were all sent as frozen glycerol stocks on 
dry ice except for isolates sent to the DSMZ which were sent as viable cultures on 
agar slants in 50 ml Falcon tubes. 110 of the 137 bacterial species cultured in this 
study were deposited in these public repositories. The accession numbers for the 
deposited isolates are listed in Appendix 2. 
2.2 Generation of whole-genome, metagenomic and 16S rRNA gene amplicon 
sequence data 
2.2.1 DNA extraction 
Genomic DNA was extracted from at least one representative of each unique OTU 
using a phenol-chloroform-based DNA isolation procedure. The culture was grown 
in 10 ml YCFA media overnight before being washed three times by repeatedly 
centrifuging to a pellet and re-suspending in 10 ml PBS. The washed pellet was 
stored at -20 °C until DNA was ready to be extracted. DNA extraction involved 
release of DNA from the rest of the components of the bacterial cell using lysozyme, 
proteinase K and RNase A. DNA was then further isolated by repeated mixing with 
Phenol: Chloroform: Isoamyl Alcohol (ratio 25:24:1) (Sigma-Aldrich, Missouri, 
USA) in a phase lock tube (Qiagen, Hilden, Germany), followed by centrifugation to 
separate the aqueous phase (containing the DNA) on top and the denser organic 
phase on the bottom which contained the phenol, chloroform and organic bacterial 
components. Any phenol in the aqueous phase was then removed by phase 
separation using Chloroform: Isoamyl Alcohol (ratio 24:1) (Sigma-Aldrich, 
Missouri, USA), again using phase lock tubes. Cold 100 % ethanol was then added 
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to precipitate the DNA and DNA concentrations were quantified using a Qubit 
Fluorometer (ThermoFischer Scientific, Massachusetts, USA). 
DNA was extracted directly from each faecal sample for whole-community 
metagenomic and 16S rRNA gene amplicon sequencing using the MP Biomedical 
FastDNA SPIN Kit for soil, the protocol was performed according to the 
manufacturer’s recommendations, apart from the following modifications: Sodium 
phosphate buffer was added first to the Lysing Matrix E tube, followed by MT 
buffer, followed by 300 µl of 100 mg/ml of faeces homogenised in PBS. The 
Binding Matrix suspension was allowed to settle for 5 minutes, not 2 minutes and 
700 µl of this mixture was added to SPIN Filters before centrifugation. Finally, 
before air drying the SPIN Filter containing DNA, it was centrifuged twice at 14,000 
g for one minute each with the tube turned 180 degrees before the second spin. To 
enable comparisons with the complete community in the faecal samples, non-
confluent cultures were removed from agar plates by adding sterile PBS as required 
and then scraping the cultures off using a disposable hockey stick into a sterile 
receptacle. DNA was again extracted using the MP Biomedical FastDNA SPIN Kit 
for soil. 
2.2.2 Generation of whole-genome and metagenomic sequence data 
All DNA samples were submitted to the DNA pipelines department at the WTSI for 
library creation and DNA sequencing. Library creation consisted of DNA 
fragmentation to the required size (200-300 bp) using the Covaris ultrasonicator 
(Covaris, Massachusetts, USA), followed by solid phase reversible immobilisation 
(SPRI) cleanup to remove unwanted, smaller fragment and to concentrate the DNA 
fragments of a desired size and then adapter ligation. These fragments were then 
PCR amplified and immobilised to the flow cell where cluster formation took place 
72 
 
according to Illumina’s protocols. DNA was sequenced on the Illumina HiSeq 
platform generating paired-end fragments of between 200 and 300 bp and read 
lengths of 100 bp. Sequence data for whole-genome sequence and metagenomic 
sequence is stored at the ENA under accession number ERP012217. 
2.2.3 Generation of 16S rRNA gene amplicon sequence data 
16S rRNA gene amplicon libraries were made by PCR amplification of variable 
regions 1 and 2 of the 16S rRNA gene using the Q5 High-Fidelity Polymerase Kit 
supplied by New England Biolabs. Primers 27F 
AATGATACGGCGACCACCGAGATCTACAC (first part, Illumina adaptor) 
TATGGTAATT (second part, forward primer pad) CC (third part, forward primer 
linker) AGMGTTYGATYMTGGCTCAG (fourth part, forward primer) and 338R 
CAAGCAGAAGACGGCATACGAGAT (first part, reverse complement of 3′ 
Illumina adaptor) ACGAGACTGATT (second part, golay barcode) 
AGTCAGTCAG (third part, reverse primer pad) AA (fourth part, reverse primer 
linker) GCTGCCTCCCGTAGGAGT (fifth part, reverse primer) were used. Four 
PCR amplification reactions per sample were carried out; products were pooled and 
combined in equimolar amounts for sequencing using the Illumina MiSeq platform, 
generating 150 bp reads. ENA accession numbers are Donor 1 ERR671373, Donor 2 
ERR671374, Donor 3 ERR671375, Donor 4 ERR671376, Donor 5 ERR671377 and 
Donor 6 ERR671378. 
2.3 Analysis of sequence data generated through anaerobic culturing 
2.3.1 Assembly and annotation of whole-genome sequence data 
Assembly and annotation of whole genome sequence was carried out by the 
Pathogen Informatics group at the WTSI (this did not apply to metagenomic 
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sequence) using the methods described in reference [265]. VelvetOptimiser was used 
to assemble the sequence data with the resulting assemblies improved through 
sequence gap closure using GapFiller [266, 267]. The assemblies were annotated 
using the software tools contained in Prokka [268]. In brief, Prodigal was used to 
define coding-sequence boundaries and these were annotated using bacterial proteins 
in UniProt and the NCBI reference sequence (RefSeq) database, followed by protein 
domain annotation using Pfam and TIGRFAMS [269-273]. Non-protein coding 
annotation was also carried out and included rRNA genes, transfer RNA genes, 
signal leader peptides and non-coding RNA [274-277]. 
2.3.2 Analysis of metagenomic sequence data 
Metagenomic sequence reads were analysed by Sam Forster of the WTSI. The 
Human Pan-Microbes Community Database (HPMCD) [278] is a manually curated 
database of metagenomic sequences sourced from the European Bioinformatics 
Institute (EBI) [279]. It also contains the metagenomic sequence generated in this 
study. Metagenomic reads contained in the HPMCD were taxonomically classified 
using Kraken which assigns a taxonomic classification using a custom database 
containing complete, high-quality reference bacterial, DNA viral and archaeal 
genomes in addition to the genomes sequenced in this research [280]. Kraken utilises 
small segments of query sequences (kmers) instead of the entire query sequence 
length to map to references sequences, which speeds up the process. Furthermore, it 
will map reads down a taxonomic classification as far as accurately possible (i.e. 
some reads may be mapped and classified at the phylum level and others may be 
mapped and classified at the species level). Resulting classified reads were log2 
transformed and standardized by total abundance. 
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2.3.3 Analysis of 16S rRNA gene amplicon sequence data 
Analysis of the partial 16S rRNA gene sequence generated from the 16S rRNA gene 
amplicon libraries was carried out using the mothur MiSeq SOP
 
generating 7,549 
OTUs across all samples [261, 281]. An online step by step description of the SOP is 
described here: https://www.mothur.org/wiki/MiSeq_SOP. This pipeline includes a 
screening step to remove ambiguous sequences, a filtering step to remove duplicated 
sequences (this reduces computational requirements), a mapping step in which the 
unique sequences are mapped to a database of taxonomically defined reference 16S 
rRNA gene sequences and a clustering step in which sequences are clustered 
together based on similarity. As these were partial 16S rRNA sequences of 150bp, a 
sequence similarity threshold of 97% was used to define an OTU. The Principle 
Coordinates Analysis (PCoA) plot displaying the separation of donor ethanol-treated 
and ethanol non-treated samples was constructed using the distance matrix (phylip 
format file) produced by this pipeline. The distance matrix captures the differences 
between the donors and culture conditions by comparing every sequence against 
every other sequence and converting the sequence differences to a value. A PCoA 
plot presents multi-dimensional data (in this scenario, the differences in sequences 
from different donors and different culture condition) in a two-dimensional format. 
The taxonomic information obtained by mapping the reads against the reference 
database was used to define the relative abundance of spore-formers at the genus and 
family level. 
2.3.4 Comparison of culturing studies 
The 1172 16S rRNA gene sequences from the Goodman et al. study [79] that were 
archived in 384-well plates were downloaded and clustered using mothur. As the 
reads from this study were ~200-300 bp in length, OTUs were clustered at 97% 
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sequence similarity generating 63 OTUs in total. The number of characterised and 
novel species from the two Lagier et al. studies was obtained directly from these 
papers [80, 282]. 
2.3.5 Gene sporulation signature 
BLASTp was used to identify 21,342 conserved genes within the 694,300 genes 
annotated across the 234 sequenced genomes. A matrix of the conserved genes was 
then constructed populated by the BLASTp scores. Each isolate was assigned an 
ethanol-resistant or ethanol-sensitive status based on the culture condition of the 
isolate it was derived from (ethanol-resistant or ethanol-sensitive). A contrast-set 
machine learning based model was then used to identify a list of genes that best 
differentiated ethanol-resistant from ethanol-sensitive bacteria. This process was 
iterative in that different combinations of genes were tested until the final list of 66 
genes was achieved that best distinguished the two groups. Detection of signature 
genes in a genome was performed using BLAST and the number of genes present 
was calculated as a percentage and presented as a score between 0 and 1 depending 
on the number of genes present. Scores greater than 0.5 were considered true spore-
formers based on comparison to known spore-formers.  
Using the sporulation signature Sam Forster calculated the abundance of spore-
formers in 1351 publically available metagenomic data sets contained in the 
HPMCD. Kraken was used to assign taxonomic labels to the metagenomic 
sequences and the relative abundance of these sequences was then calculated. I 
calculated the abundance of spore-formers in the six donors and their associated 
culture plates using the taxonomically classified (using Kraken) relative abundance 
sequence data that was previously generated by Sam Forster. Genera were 
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considered spore-forming when all known species within that genus had a spore 
forming score greater than 0.5. 
2.3.6 Comparison of abundance of bacteria in faecal samples and on culture 
plates 
The relative abundance of taxonomically defined (by Kraken) metagenomic 
sequence reads generated in Section 2.3.2 from the original donor faecal samples and 
the isolates scraped off the culture plate were compared. There were 17 bacterial 
species detected on culture plates that were not detected in faecal samples, these 
were all less than -7.3(log10) in abundance, hence this was chosen as the limit of 
detection in the faecal sample and the culture plate. The average relative abundance 
across all six donors for a bacterial species detected in both samples above this cut-
off value was plotted. In total there were 1079 species detected using these criteria. 
2.3.7 Diversity analysis of spore-forming and non-spore-forming bacteria 
Inverse Simpson’s diversity index of spore-forming and non-spore-forming bacteria 
was calculated using the summary.single command in mothur. The input was the 
relative abundance of taxonomically defined (by Kraken) metagenomic sequence 
reads generated in Section 2.3.2 from the original donor faecal sample. This data 
included the ability of a bacterial species to make spores based on sporulation 
signature analysis. The Inverse Simpson diversity index is an alpha diversity 
measure that takes into account the number of species present (defined as the 
richness) and their abundance in a sample (defined as the evenness). 
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2.4 Phylogenetic analysis 
2.4.1 16S rRNA gene sequence phylogeny of cultured bacteria 
A maximum likelihood phylogeny of the culture-derived bacteria was generated 
from the RDP aligned full-length 16S rRNA gene sequence using FastTree version 
2.1.3 with the following settings: a generalized time-reversible (GTR) model of 
nucleotide substitution and CAT approximation of the variation in rates across sites 
with 20 rate categories [283]. The ethanol-resistant phylogeny was derived directly 
from the entire culture phylogeny. Both phylogenetic trees were edited in ITOL 
[284]. 
2.4.2 Phylogeny of putative novel bacterial family 
The full-length 16S rRNA gene sequence of Clostridium thermocellum_86% 
(renamed as Falkowia sangerensis) was aligned with 16S rRNA gene sequences 
from this study in addition to closely related sequences downloaded from NCBI. 
Closely-related sequences were determined based on a BLASTn search of the 
Clostridium thermocellum_86% sequence. The other sequences from this study 
provide phylogenetic context. MAFFT was used to align the sequences [285], this 
was visually examined using Seaview [286] and a maximum likelihood phylogeny 
with 1000 bootstrap replicates was generated using MEGA [287]. RDP and FastTree 
were not used for this phylogeny as alignment files and phylogenies produced using 
these methods were not as robust as MAFFT and MEGA and phylogenetic artifacts 
were present in the form of different families incorrectly clustering together. Note- 
regardless of method used the Falkowiaceae family always clustered separately to 
other families. These artifacts are most likely due to the smaller number of sequences 
used in this phylogeny (25) compared to the culture collection phylogeny (137). 
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2.4.3 Core gene phylogeny of Firmicutes 
Using the FetchMG script [288], 40 universal, single-copy marker genes were 
extracted from Firmicutes whole genome sequences from the NCBI reference 
sequence (RefSeq) database (725 in total), the HMP (226 in total), an in-house 
collection of genomes from the Host-Microbiota Interactions Laboratory at the 
WTSI (506 in total) and from a study describing the first 1000 cultured species from 
the human gastrointestinal tract [26] (149 in total). These genomes are all from 
bacteria isolated from the gastrointestinal tract except for the NCBI RefSeq database 
which consists of curated and non-redundant genomes from a wide range of 
environments including host-associated and environmental habitats [289]. The 
resulting amino acid sequences were aligned using MAFFT, gaps representing 
poorly aligned sequence were removed using the Gblocks script and a maximum 
likelihood phylogeny was constructed using FastTree [283, 285, 290]. All support 
values (using the Shimodaira-Hasegawa test which estimates likelihood of local 
branches as opposed to resampling from the entire tree using a bootstrap approach) 
down to the family level of the phylogeny are greater than 0.8 (1 is maximum) 
except for the branch that divides Staphlococcaceae and Bacillaceae (0.39) and the 
branch that divides Veillonellaceae and Erysipelotrichaceae and the Bacilli (0.76). 
Actinobacteria, Fusobacteria and Proteobacteria sequences were used to root the tree.  
 For the comparison of the species phylogeny verses the Spo0A_C phylogeny, the 
amino acid sequences of the sporulation specific C-terminus domain sequence of the 
Spo0A gene (termed Spo0A_C) was extracted from the genomes, aligned using 
MAFFT, gaps representing poorly aligned sequence were removed using the 
Gblocks script and a maximum likelihood phylogeny was constructed using FastTree 
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[283, 285, 290]. Further details on acquisition of Spo0A_C sequence is described in 
Section 2.6.3. Both phylogenetic trees were edited in ITOL [284]. 
2.5 Phenotypic analysis of spore-forming bacteria 
2.5.1 Oxygen sensitivity assay 
Pure cultures were grown overnight in YCFA broth under anaerobic culture 
conditions as described above. The cultures were then spotted in a dilution series 
onto YCFA agar containing 0.1 % sodium taurocholate. Plates were incubated under 
ambient (aerobic) conditions at room temperature for specified time periods before 
being returned to the anaerobic cabinet. Colony-forming units (CFU) were counted 
72 hours later. Cultures that were incubated anaerobically, and which were therefore 
not exposed to oxygen, acted as controls. Prior to the assay, all species were 
subjected to ethanol shock and were cultured anaerobically to determine their ability 
to sporulate. The viability of the oxygen-exposed cultures was expressed as a 
percentage of the viability of the anaerobic control cultures. 
2.5.2 Germination response to intestinal bile acids assay 
Pure cultures were grown overnight in YCFA broth under anaerobic conditions and 
were then washed three times by repeatedly centrifuging to a pellet and re-
suspending in PBS. Vegetative cells were killed using an ethanol shock treatment as 
previously described and the cultures were then serially diluted and plated on YCFA 
agar with and without 0.1 % intestinal bile salts (taurocholate, cholate and 
glycocholate). CFU were counted 72 hours later and the fold change of the number 
of CFU present on plates in the presence of a particular germinant with respect to the 
number of CFU present on plates in the absence of a germinant was calculated. The 
limit of detection (200 CFU ml−1) was used for the number of CFU recovered 
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from Clostridium hathewayi plated without any germinants to allow a fold-change 
calculation. The experiment to determine the response of non-spore-formers to 
germinants was carried out similarly, except that vegetative cells were not treated 
with ethanol but rather were serially diluted and plated directly after washing. 
2.5.3 Transmission electron microscopy 
Spore images were generated using transmission electron microscopy (TEM) as 
previously described [291]. Bacterial isolates for imaging were prepared by streaking 
pure cultures from frozen glycerol stocks and confirming purity by full-length 16S 
rRNA gene sequencing after one round of sub-culture to obtain visible and isolated 
single colonies. TEM images were prepared from culture plates 72 hours after 
inoculation. Cultures were fixed using a solution containing 2 % paraformaldehyde 
and 2 % glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.42). The cultures 
were then washed three times in sodium cacodylate buffer and were further fixed 
using 1 % osmium tetroxide, mordanted with 1 % tannic acid and rinsed in 1 % 
sodium sulphite. Repeated ethanol washes using increasing concentrations of ethanol 
were used to dehydrate the cultures, followed by staining with 2 % uranyl acetate 
before being embedded in Epon resin at 65 ˚C for 24 hours. Ultrathin sections of 40 
nm thickness were cut on a Leica UC6 ultramicrotome, contrasted with uranyl 
acetate and lead citrate and viewed using a 120-kV FEI Spirit BioTWIN 
transmission electron microscope and a F415 Tietz charge-coupled device camera. 
The number of spore bodies visible in the TEM images was expressed as a 
percentage of the number of vegetative cells present and this ranged from 1 % 
for Ruminococcus flavefaciens_93% to 4 % for Turicibacter sanguinis. 
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2.6 Functional redundancy analysis 
2.6.1 Ortholog analysis 
A workflow outlining this process is described in Figure 5.7. Average Nucleotide 
Identity (ANI) was used to group genomes into species based on a whole genome 
sequence similarity cut-off of 95 % [292]. The associated environment of each ANI 
species was determined using the source of isolation of each species and a broader 
literature search. One genome from each representative ANI species was used for 
subsequent analysis. Using orthoMCL, the genes from the genomes were then 
clustered based on sequence similarity into homologous groups (all protein 
sequences were concatenated together into a single file and then all proteins were 
blasted back against this file. The output from the blast analysis was then used as the 
input for OrthoMCL- default settings: 1e-05 e-value for clustering, --mode3) [293]. 
The genes of each of the Peptostreptococcaceae, Lachnospiraceae and the 
Erysipelotrichaceae families were clustered separately. Details on the number of 
genomes and ANI species in each comparator group are contained in Table 2.2. This 
produced a list of clusters (homologous groups) comprised of genes with similar 
sequence. Each gene that comprised each homologous group was categorised 
according to the ANI species it was derived from, the associated environment of that 
species and the ability of that species to form spores. Genes in a homologous cluster 
can be from the same genome (paralogue) or from different genomes (orthologue). 
Spore-formation ability was determined by the presence of the Spo0A_C domain and 
separation of genomes based on sporulation signature score presented in Figure 5.4. 
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 Erysipelotrichaceae Peptostreptococcaceae Lachnospiraceae 
Number of genomes 69 36 430 
Number ANI species 34 24 197 
Spore-forming gut 
species 
21 12 139 
Non-spore-forming 
gut species 
9 1* 1* 
Spore-forming oral 0 0 1* 
Non-spore-forming 
oral species 
2* 5 9 
Non-spore-forming 
rumen species 
2* 0 44 
Spore-forming 
environmental 
0 4* 2* 
Spore-forming rumen 0 0 1* 
Non-spore-forming 
environmental 
species 
0 2* 0* 
Total number genes 87599 59357 655862 
Total number 
homologous groups 
7299 5125 24994 
 
Table 2.2 Dataset for orthoMCL analysis 
These genomes (and the genes within) were used to compare spore-forming 
species against non-spore-forming species within the same bacterial family.  
Species marked with an asterisk were not included as there were insufficient 
numbers to compare.  
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2.6.2 Gene per genome analysis: 
For each homologous group produced using orthoMCL, the gene per genome ratio 
was calculated according to the number of genes in that homologous group and the 
number of genomes the genes were derived from. Genomes were categorised 
according to their ability to form spores resulting in a gene per genome ratio for 
spore-forming and non-spore-forming genomes. Only homologous groups that 
contained genes from at least 50 % of spore-forming and/or 50 % of non-spore-
forming ANI species from each taxonomic family were included. To compare within 
both spore-forming and non-spore-forming groups genes from greater than 50 % of 
ANI species of both groups had to be present in a homologous group for it to be 
included in the analysis. Only ratios equal to or greater than two were selected (i.e. 
the ratio of gene per genome value of a spore-forming group compared to the gene 
per genome value of a non-spore-forming group within the same homologous group 
was equal to or greater than two or vice versa when comparing non-spore-formers to 
spore-formers). 
2.6.3 Presence and absence of sporulation associated genes 
The sporulation specific C-terminus domain sequence of the C. difficile CD630 
Spo0A gene (Pfam entry: PF08769), termed Spo0A_C, was used to search the 
genomes for the presence of the Spo0A_C sequence. tBLASTn performed the 
search- the amino acid sequence of the Spo0A_C domain was searched against the 
nucleotide sequence of the genomes. The presence of the sporulation signature genes 
in the genomes was determined by using tBLASTn- the amino acid sequences of the 
sporulation signature genes were searched against the nucleotide sequences of the 
genomes. An e-value cut-off of 1e-40 was used in both cases. The heatmap 
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displaying presence or absence of sporulation signature genes was made using the 
package ‘gplots’ in R. 
2.6.4 Functional annotation of unique genes and genes in gene per genome 
analysis 
Gene sequences were extracted from a homologous group, aligned using muscle 
[294] and a consensus sequence was created using the cons script described in 
EMBOSS [295]. Each of these homologous groups was then annotated by using the 
annotation already present in the genes that comprised the homologous group, by 
comparison against the well annotated Clostridium difficile CD630 genome and by 
searches against the Pfam and KEGG databases [110, 119, 272, 296]. To compare 
genes across different groups for similarity BLASTp using an e-value cutoff of 1e-20 
was used [264]. Functional classes were manually assigned using the functional 
classification scheme developed for E. coli [297].  
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Chapter 3 Culturing of the human intestinal 
microbiota 
3.1 Introduction 
Our knowledge of the human intestinal microbiota and the role it plays in health and 
disease has greatly improved due to culture-independent, sequence-based approaches 
such as 16S rRNA gene amplicon sequencing and whole genome shotgun 
metagenomic sequencing [8, 15, 29]. While 16S rRNA gene amplicon sequencing is 
primarily a quantitative approach, metagenomic sequencing provides additional 
functional context. Despite the ability of these approaches to quickly generate large 
amounts of data and to reveal the composition of a microbial community, they are 
not without their drawbacks. 16S rRNA gene amplicon sequencing can reveal the 
taxa present to the genus level, but lacks the resolution needed to delineate species or 
strains. Inferences of functional capability can be made from the taxonomic 
information but this will be associated with a reference species and not with the 
strain in question [298]. Metagenomic sequencing is capable of sequencing the entire 
genetic repertoire of a sample and thus can provide both detailed compositional and 
functional information. However, while annotated reference databases continue to 
improve as the volume of sequence data increases, many sequenced genes are still of 
unknown function (hypothetical) [282, 299].  
Many culture-independent studies of the intestinal microbiota are based upon 
comparison of sequenced data-sets from samples obtained from healthy and diseased 
individuals. From this, inferences about the role played by various microorganisms 
in health and disease can be made based upon the enrichment or depletion of a 
bacterial species in an individual. This approach is very informative and can identify 
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bacterial taxa that may be associated with the disease in question (enriched in 
disease-state compared to health-state) or that may protect against the disease 
(enriched in health-state compared to health-state). However, these approaches do 
not confirm causality and do not lead to a deeper mechanistic understanding of the 
underlying biology [247, 248]. Having the implicated bacterial species or strain as a 
pure culture allows progression from identification of a health or disease-associated 
species to confirming causality using animal models or laboratory studies. A recent 
study in adult mice focused on identifying bacteria responsible for conferring 
colonisation resistance against intestinal pathogens. Through a 16S rRNA gene 
amplicon sequencing approach, chloroform-resistant spore-forming members of the 
Lachnospiraceae and Ruminococcaceae families were identified [300]. These 
bacteria are not abundant in neonates and their absence may contribute to the high 
rate of pathogen infections which are not observed in adults. It is reasonable to 
assume a subset of these spore-forming bacteria are sufficient to restore colonisation 
resistance, however until the individual species are isolated and characterised, the 
identity of the bacteria in question and the underlying mechanism will remain 
unknown. 
Culturing of bacteria therefore enables phenotypic characterisation to be carried out 
to validate results generated purely through genomics. Despite these benefits, 
culturing has inherent drawbacks compared to sequence-based approaches. It is a 
laborious process and ill-suited to studying the dynamics of an entire microbial 
community. The culturing of anaerobic bacteria also requires specialised equipment 
to maintain anaerobic atmospheric conditions, ideally using anaerobic cabinets if 
culturing is to be done at scale. However, when used in combination, culturing and 
genomics offers a powerful approach that can proceed from genomic analysis of an 
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entire community to characterisation of important individual species [77]. 
Furthermore, isolation of pure cultures also improves the resolution of reference 
genome datasets used by metagenomic approaches to assign taxonomic and 
functional information to a sequence [278].  
While a large number of species have been cultured from the human gut since 
Escherichia coli was isolated over 130 years ago [26], microscopic analyses and 
more recently culture-independent, sequence-based approaches have revealed the 
complexity of the intestinal microbiota. This has contributed to the prevailing belief 
that the majority of these bacteria are unculturable. As a result of this, much of the 
underlying biology and phenotypes of the intestinal microbiota remains poorly 
understood. For example, enteric spore-forming bacteria can be pathogenic (such as 
C. difficile) or commensal (such as the colonisation resistance restoring bacteria 
discussed above) and the ability to form spores could aid in the transmission of 
oxygen-sensitive bacteria between human hosts [95, 131, 301]. Despite this, the 
extent of sporulation within the gut and the role it plays in the commensal intestinal 
microbiota remains unknown. In recent years, there have been a number of culturing 
studies that have isolated many novel taxa [79, 282]. As such, the issue is not that the 
majority of the intestinal microbiota is inherently unculturable but rather that 
perhaps, they have not yet been cultured [76, 77].  
I therefore sought to establish a methodology to culture a representative selection of 
the human intestinal microbiota and to gain insights into the extent of sporulation 
(Figure 3.1). The workflow incorporates several steps, which are Culture, Re-streak, 
Archive and Phenotype (CRAP). Fresh faecal samples are left untreated or are 
treated to select for bacteria with a desired phenotype, in this case, sporulation. The 
stool sample is homogenised and serially diluted and then aliquots of the 
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homogenate are inoculated on YCFA agar to culture bacteria. Isolates are then 
identified by selecting single colonies that are streaked to purity and full-length 16S 
rRNA genes are amplified and sequenced. Each unique, novel and desired isolate is 
archived frozen in a culture collection and a whole-genome sequence is generated for 
each. Phenotypic characterisation of the isolates can then be carried out. 
 
Figure 3.1 Schematic diagram of the anaerobic culturing workflow.  
Schematic diagram of the culturing workflow, encompassing bacterial cultur ing 
and genomics to isolate and characterize bacterial species from the human 
intestinal microbiota.  
 
3.2 Results 
3.2.1 Establishment and assessment of culture process 
Faecal samples were obtained from six healthy human donors. The aim was to 
culture health-associated intestinal bacteria, therefore, the donors initially completed 
a questionnaire which assessed their suitability and gave informed consent to 
participate in the study. To participate, donors should not have taken antibiotics in 
the six months prior to donation and should have no history of gastrointestinal 
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disorders. All six donors were adults and resident in the UK. Faecal samples were 
immediately processed upon receipt to ensure viability of anaerobic bacteria (see 
Materials and Methods). Faecal samples were either plated onto YCFA media (broad 
range culturing) or were immersed in ethanol to kill vegetative cells leaving bacterial 
spores (targeted phenotype culturing) (Figure 3.1) [302]. To enhance recovery, the 
spores were plated on YCFA media with sodium taurocholate, a known germinant 
for C. difficile  [303].  
The YCFA media was developed by the Rowett Institute in Aberdeen and was 
chosen as it is a broad-range media containing carbohydrates and fatty acids that are 
utilised by the intestinal microbiota (see Chapter 2- Materials and Methods for 
constituents) [75]. We first wished to assess how suitable YCFA was as a medium 
for culturing intestinal anaerobic bacteria. Accordingly, we compared the bacterial 
species in the original faecal sample to the bacterial species growing on the culture 
plates without selection.  
DNA was extracted from both the faecal samples and the bacteria growing on the 
culture plate for all six donors. Metagenomic sequencing was carried out by the 
DNA pipelines department (core facility of the Wellcome Trust Sanger Institute). 
Sam Forster of the Host-Microbiota Interactions Laboratory added the sequence 
generated to the Human Pan-Microbes Community Database (HPMCD) and used 
Kraken to assign taxonomic information to the sequence. Following this, the relative 
abundances of the sequences were calculated (see Chapter 2- Materials and Methods 
for a full description). I then used the taxonomic and abundance information to 
perform the subsequent analysis described here. There was a strong correlation 
between the relative abundances of the taxa in the two samples indicating that 
bacteria growing on the culture plate were representative of the original faecal 
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sample (Figure 3.2). Therefore, the majority of intestinal bacteria, present in faecal 
samples can be isolated in culture if picked from the culture plate. 
 
Figure 3.2 Bacteria grown on YCFA agar are representative of the 
complete faecal samples.  
Relative abundance of bacteria in faecal samples (x axis) compared with 
relative abundance of bacteria growing on YCFA agar plates (y axis) as 
determined by metagenomic sequencing. Bacteria grown on YCFA agar are 
representative of the complete faecal samples as indicated by Spearman 
ρ = 0.72 (n = 6 donors).  
 
To isolate spore-forming bacteria, faecal samples were immersed in 70 % ethanol for 
four hours to kill vegetative cells. During this time period, the immersed faecal 
samples were regularly vortexed. To assess the suitability of ethanol to isolate spore-
forming bacteria, 16S rRNA gene amplicon sequencing of the original faecal sample, 
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the bacterial cultures recovered from the untreated culture plates (no ethanol 
treatment) and the ethanol treated plates was carried out. Principal Coordinates 
analysis (PCoA) of the 16S rRNA gene amplicon sequences showed a clear 
separation between sequences derived from ethanol treated samples and those of 
untreated samples and the original faecal samples (Figure 3.3). 
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Figure 3.3 Ethanol selection separates spore-forming bacteria from 
non-spore-forming bacteria allowing their subsequent isolation.  
Principal coordinates analysis plot of 16S rRNA gene sequences detected from 
six donor faecal samples (n = 6), representing bacteria in complete faecal 
samples (green), faecal bacterial colonies recovered from YCFA agar plates 
without ethanol pre-treatment (black) or with ethanol pre-treatment to select 
for ethanol-resistant spore-forming bacteria (red). Culturing without ethanol 
selection is representative of the complete faecal sample, ethanol treatment 
shifts the profile, enriching for ethanol -resistant spore-forming bacteria and 
allowing their subsequent isolation.  The percentage of variation displayed by 
each axis is shown in brackets.  
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3.2.2 Extensive culturing and isolation of characterised and novel bacteria 
Knowing that the culturing process using YCFA as the growth media would allow 
the growth of a representative proportion of the intestinal microbiota and that ethanol 
selection facilitated isolation of spore-forming bacteria, the samples were processed 
through the remainder of the CRAP protocol. Approximately 2000 colonies were 
picked from plates containing distinct, non-confluent colonies from the six donors. 
Colonies were picked from the original plate and streaked onto new plates (six 
colonies per petri dish) and received a unique identifier. PCR amplification of the 
full-length 16S rRNA gene was carried out, followed by capillary sequencing. The 
resulting sequences were then aligned using the Ribosomal Database Project (RDP) 
[304], edited in ARB [260] and clustered into Operational Taxonomic Units (OTUs) 
using mothur [261]. An isolate was considered a unique species using a 98.7% cut-
off sequence identity over the full length of the 16S rRNA gene sequence [262, 263]. 
For each unique OTU identified, a representative isolate was selected and re-streaked 
on a full petri-dish to ensure purity. The RDP classifier was used to assign 
taxonomic information to the genus level and a BLASTn search defined an isolate as 
either a novel or previously characterised species [264]. All unique isolates were 
then archived as frozen stocks for future whole genome sequencing and phenotypic 
analysis. 
In total, 137 unique species were isolated and archived from the six donors (Figure 
3.4 and Appendix 1). 110 of these species were deposited in public culture 
collections (Appendix 2). 66 species were isolated from the ethanol-resistant culture 
condition and 71 from the untreated condition. 68 of the 137 species are novel and 
69 are previously characterised. Thus, over 40 % of the species isolated from both 
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conditions had not been previously identified further undermining the notion that the 
intestinal microbiota is unculturable. 
 
Figure 3.4 The number of bacterial species cultured in this study.  
In total, approximately 2000 isolates were picked and 137 species were 
cultured. Over 40 % of bacteria isolated from both ethanol -resistant (38 out of 
66) and non-ethanol-resistant (ethanol-sensitive) (30 out of 71) conditions were 
novel. 
 
These species belong to the main phyla of the intestinal microbiota, the Firmicutes, 
Bacteroidetes and Actinobacteria (Figure 3.5 and Appendix 1). Proteobacteria were 
not isolated probably as they are not abundant in the intestinal microbiota and may 
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have been outcompeted on the culture plate by obligate anaerobes. Of the 68 novel 
species isolated, 45 are characterised as members of novel genera and a further three 
are classified as members of novel families by RDP (two species belong to the same 
novel family). The novelty captured is agnostic of taxonomy as there are novel 
isolates present in all of the families indicated on the phylogeny which includes the 
major families of the intestinal microbiota, the Bacteroidaceae, Ruminococcaceae 
and the Lachnospiraceae. A major aim of the HMP was to create a catalogue of 
reference genomes from human-associated bacteria. As part of this process they 
defined a list of ‘most wanted’ bacteria which represent novel taxa or taxa with few 
cultured representatives based upon 16S rRNA gene amplicon sequencing studies 
[78, 305]. Of the 137 species cultured here, 90 are part of the HMP’s most wanted 
list (Appendix 1). 
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Figure 3.5 Phylogenetic tree of bacteria cultured from the six donors 
constructed from full-length 16S rRNA gene sequences.  
137 bacterial species were cultured in total. Novel candidate species (red), 
genera (blue) and families (green) are shown by dot colours. Majo r phyla and 
family names are indicated. Proteobacteria were not cultured, but are included 
for context. 
 
Each cultured and isolated species was whole genome sequenced, assembled and 
annotated by the DNA pipelines department and by bioinformatics pipelines 
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developed by the Pathogen Informatics team at the WTSI. The assembled whole 
genome sequences were added to the previously described Kraken database created 
by Sam Forster and this information was used to taxonomically classify the faecal-
derived metagenomic sequences. The relative proportions of the taxonomically 
classified metagenomic sequence were again calculated by Sam Forster [280]. I then 
used this database to assess the proportions of bacterial genera and species in each of 
the six donors. Based on the average relative abundance across the six donors 96 % 
of the bacterial abundance at the genus level was cultured (Figure 3.6) and 90 % of 
the bacterial abundance at the species level was cultured (Figure 3.7). 
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Figure 3.6 Archiving of bacterial diversity and novelty through 
anaerobic culturing- most abundant genera  
Representative species from 21 of the 25 most abundant bacterial genera were 
isolated and archived (abundance was determined by metagenomic sequencing 
and based on average relative abundance across the six donors (n = 6)). This 
represents 96 % of the average relative abundance at the genus level across the 
six donors. A red dot indicates the number of species archived from each 
genus. Lachnospiraceae incertae sedis , unclassified Lachnospiraceae, 
Clostridium IV and Clostridium XI are not strict genera and represent currently 
unclassified species. Median and range is presented for the above with taxa 
ranked by median.  
 
The most abundant genera in the six donors represent common genera typically 
found in other cohorts derived from Western populations, including Bacteroides, 
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Faecalibacterium, Roseburia and Bifidobacterium [15, 306]. Prevotella was highly 
abundant in one donor, hence the wide range present in Figure 3.6 and Figure 3.7. 
The most abundant species across the six donors are also representative of larger 
populations with species such as Bacteroides vulgatus, Faecalibacterium prasunitzii 
and Roseburia faecis prevalent and abundant in the gut microbiota of Western 
individuals [77]. 
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Figure 3.7 Archiving of bacterial diversity and novelty through 
anaerobic culturing- most abundant species 
Representative species from 23 of the 24 most abundant species were isolated 
and archived (abundance was determined by metagenomic sequencing and 
based on average relative abundance across the six donors (n = 6)). This 
represents 90 % of the average relative abundance at the species level across 
the six donors. Odoribacter splanchnicus  was the only species not archived. 
Median and range is presented for the above  with taxa ranked by median value.   
 
Genera that were present at low average relative abundance (<0.1 %) were also 
isolated (Figure 3.8). These are not restricted to any readily-culturable taxonomic 
groups but are distributed across different bacterial classes. For example, 
Turicibacter and Erysipelotrichaceae incertae sedis belong to the Erysipelotrichia 
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class, Clostridium sensu stricto, Oscollibacter and Sarcina belong to the Clostridia 
class, while Megasphaera belongs to the Negativicutes class.  
 
 
Figure 3.8 Archiving of lowly represented members of the intestinal 
microbiota 
Lowly represented intestinal microbiota members were also cultured from the 
six donors. At least one representative species from each of the genera 
presented were cultured. Median and range is presented for the above with taxa 
ranked by median value.   
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3.2.3 Phylogenetic analysis of an isolate from a putative novel family 
Next, one of the isolates belonging to a novel taxonomic family, Clostridium 
thermocellum_86% was examined in more detail (86 % denotes the 16S rRNA gene 
nucleotide sequence similarity to the nearest characterised species, in this case, 
Clostridium thermocellum). This isolate is putatively named here as Falkowia 
sangerensis, in honour of Professor Stanley Falkow of Stanford University for his 
pioneering work on molecular microbial pathogenesis and the Wellcome Trust 
Sanger Institute where the isolate was first cultured and described. A BLASTn 
search of the full length 16S rRNA gene sequence revealed the nearest characterised 
species to F. sangerensis was Christensenella minuta strain YIT (accession no. 
NR_112900) with 88 % nucleotide sequence identity over 97 % query coverage. The 
next nearest characterised species was Catabacter hongkongensis strain JCM 17853 
(accession no. AB671763) with 88 % sequence identity over 97 % sequence 
coverage). C. hongkongenesis has been implicated in sepsis, however like C. minuta, 
its natural environment is believed to be the human gut [307]. Both C. 
hongkongenesis and C. minuta are characterised as species belonging to two 
different families, however, previous reports suggest that they may belong to the 
same family [26]. Using full-length 16S rRNA gene sequence, Yarza et al. defined 
the cut-off for defining a novel family as 86.5 % by examination of over 200 taxa 
[308]. This places F. sangerensis at the threshold for defining a new family based on 
16S rRNA gene sequence comparison which is putatively name here Falkowiaceae. 
This is the most stringent cut-off with other reports placing the cut-off for novel 
families at 95 % [309].   
Phylogenetic analysis based on full length 16S rRNA gene sequence established that 
this isolate does form a distinct clade, separate from other characterised families, that 
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resides within the Clostridiales order of the Firmicutes phylum (Figure 3.9). 
The  Christensenellaceae and Catabacteriaceae families do cluster together and may 
indeed be part of the same family but they are distinct from Falkowiaceae. Also 
distinct from Falkowiaceae is the Gracilibacteraceae family which contains isolates 
of environmental origin [310]. Similar 16S rRNA gene sequences from uncultured 
bacteria were identified which cluster with F. sangerensis which are gastrointestinal 
in origin. While further phenotypic analysis would be required to properly 
characterise this isolate, comparison of the 16S rRNA gene sequence and 
phylogenetic analysis does indicate F. sangerensis is a member of a novel family. 
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Figure 3.9 Phylogenetic tree of putatively named novel Falkowia 
sangerensis isolate and closely related species based on 16S rRNA 
gene sequence 
To provide context, other species from human intestinal microbiota families 
were included (Lachnospiraceae , Ruminococcaceae,  Peptostreptococcaceae  
and Erysipelotrichaceae) in addition to the isolates identified as the closest 
relatives based on a BLASTn search. Taxonomic families are indicated on right 
hand side of the phylogenetic tree. Bootstrap values are present where 
indicated. 
 
3.2.4 Comparison with other culturing studies 
To put the extent of the culturing into context I compared my results with other 
recent studies that have cultured from the human intestinal microbiota. In this 
comparison, I considered the number of whole genome sequences generated. Ease of 
reproduction is also important, while culturing of enteric anaerobic bacteria does 
require anaerobic culturing facilities; a streamlined approach as chosen here by using 
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one growth medium will alleviate the work required. The isolates cultured in this 
study were compared with other large-scale culturing studies [79, 80, 282] (Table 
3.1). The two Lagier et al. studies cultured more characterised species than this study 
but they used 70-200 different culture conditions including different growth media, 
growth temperatures and filtration steps. In comparison, I used one growth medium 
(YCFA) combined with and without an ethanol treatment step to enrich for spore-
forming bacteria. Despite the range of culture conditions used in the Lagier et al 
2012 study they did not culture more novel species than obtained here. They used 
matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) to identify 
known species, and any species unidentified by the MALDI-TOF were subjected to 
16S rRNA gene sequencing using the same species level cut-off of 98.7%. Selection 
for spore-forming bacteria was included in their culturing protocol so the reason for 
the low number of novel bacteria cultured is not clear. Two of the three stool 
samples were frozen at -20 ˚C and then -80 ˚C before culturing commenced, hence 
some loss of bacterial viability may have occurred during this period. In summary, 
the culturing results reported here compare favourably with other studies, especially 
when considering the number of species cultured per culture conditions. Using one 
growth medium and two culture conditions can isolate a large number of bacterial 
species, including many that are novel.  
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Culturing 
study 
No. 
characterised 
species 
cultured 
No. 
novel 
species 
cultured 
No. 
samples 
No. culture 
conditions 
No. whole 
genome 
sequences 
generated 
No. 
isolates 
deposited 
in public 
culture 
collections 
No. 
species 
isolated 
per culture 
condition 
This study 69 68 6 2 137 110 68.5 
Goodman 
et al. 2011 
[79] 
48 15 1 1 0 0 63 
Lagier et 
al. 2012 
[282] 
309 31 2 212 31 0 1.6 
Lagier et 
al. 2016 
[80] 
860 197 973 70 197 
 
197 
 
15.1 
 
Table 3.1 Comparison of culturing studies 
Culturing results of this study was compared to other recent culturing studies 
(references are in culturing study column). The number of species isolated per 
culture condition column reflects how streamlined the culturing was in terms of 
number of culture conditions used. For this study ethanol treated and non -
ethanol treated samples count as two culture conditions.  
 
3.3 Discussion 
In this study I utilised a streamlined approach to culture, isolate, archive and whole 
genome sequence 137 characterised and novel bacteria from the human 
gastrointestinal tract. The bacteria cultured are representative of the samples they 
were derived from and consist of species present at high and low abundances in the 
gut. Incorporated in the culturing workflow was a “targeted phenotypic” screen 
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designed to select for ethanol-resistant spore-forming bacteria, from which 66 
characterised and novel bacterial species were isolated. Using one of the novel 
species isolated, a phylogenetic approach determined that this isolate is a member of 
a novel bacterial family. This demonstrates the ability of this approach to culture and 
isolate highly novel members of the human intestinal microbiota. 
While other studies have utilised a large number of culture conditions and media to 
isolate as many species as possible [80, 282], the focus here was to design a 
streamlined workflow that was effective (Figure 3.1). Hence, one broad culture 
medium was used that would support the growth of bacteria with different nutritional 
requirements. The combination of this broad range culture media with the 
phenotypic selection of spore-forming bacteria contributed to the large number of 
novel species isolated. There were more novel bacterial species isolated from the 
ethanol-resistant condition compared to the non-ethanol-resistant condition, 
highlighting the value of a targeted approach to enrich for bacteria that may be less 
abundant and therefore less likely to be picked from a plate under normal 
circumstances. The isolation of bacteria displaying an ethanol-resistant phenotype 
allows for subsequent in vitro characterisation and genotypic analysis which will be 
explored in Chapter 4.  
The novelty captured here extended to novel bacteria genera and even novel bacterial 
families. In this study, the RDP classifier was chosen to classify sequences to the 
genus level and comparison of full-length 16S rRNA sequence was used to classify 
to the species level. Taxonomic classification of bacteria has always been inherently 
problematic. For example the traditional assignment of anaerobic spore-forming 
bacteria to the genus Clostridium has resulted in a large number of bacterial species 
with the Clostridium prefix that now reside in different genera or families [88]. 
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Correcting the nomenclature by renaming these species is difficult as new names are 
often not adopted by the scientific community [89]. The isolation, whole genome 
sequencing and archival of novel bacterial species can help improve taxonomic 
assignments.  
First, it helps to fill in the taxonomic gaps between species that have been already 
characterised. As more species are added to the Christensellaceae and 
Catabacteriaceae families, it may become clear that they should merged into a 
single family. C. minuta was only characterised in 2012 as the type species of a 
novel family isolated from the human gut [311]. Only three years later its abundance 
in people was shown to be influenced by human genetics, highlighting the value of 
culturing and characterising novel bacteria [38]. Second, it clarifies the boundaries of 
a particular taxon. As more species are added to the Falkowenciae family, a clearer 
picture will emerge of the extent of this family and the genera contained within. 
Third, whole genome sequencing and archival of cultured bacteria allows analysis to 
be carried out at the genome and phenotype level, this adds further granularity to the 
defining characteristics of a given taxon. 
The majority of the isolates cultured were deposited in public culture collections. 
The deposition of isolates from this and other large-scale culturing studies [80] 
(Table 3.1) provides a valuable resource for other members of the scientific 
community to access. In addition, the whole genome sequences generated from these 
isolates improved the resolution of the Kraken database allowing detailed 
identification of metagenomic sequences. Ultimately, the novelty archived here 
provides a means to move from a sequence-based, quantitative approach to proceed 
to a more phenotypic and mechanistic understanding of this microbial community 
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[312]. In the next chapter, using the bacteria cultured here, the sporulation phenotype 
will be examined in the context of inter-host transmission and colonisation. 
  
110 
 
Chapter 4 Characterisation of intestinal spore-
forming bacteria in the context of inter-host 
transmission 
4.1 Introduction  
Assembly of the intestinal microbiota begins at birth and develops rapidly during the 
first three years of life, at which point a stable microbial community is attained [22, 
24, 25, 163]. Individuals living in close contact have a more similar microbiota than 
more removed individuals which indicates transmission and acquisition of new 
species occurs beyond childhood throughout life [167, 168, 170]. As the majority of 
the intestinal microbiota cannot tolerate extended periods in aerobic conditions, 
transmission between individuals in close contact is more likely [73, 148, 170]. A 
colonising bacterium in this scenario is more likely to be quickly ingested by a new 
host in close proximity. Regardless of proximity to new hosts and the length of time 
exposed to aerobic conditions, any means to prolong viability outside of a host will 
be advantageous. As discussed in Chapter 1 (Introduction) some of these survival 
mechanisms could include aerotolerance, spore-formation and other dormancy 
mechanisms. Transmission of bacteria between human hosts is best understood 
during birth, however the extent of transmission between older individuals is poorly 
understood as are the mechanisms of how this could occur. 
C. difficile utilises resilient spores that can tolerate disinfectants and aerobic 
conditions to survive outside of a host for extended time periods [291]. In addition to 
promoting external survival, C. difficile spores can recognise intestinal bile acids 
once ingested by a new host [122]. This acts as a signal that the spores are back in 
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the intestinal environment which triggers germination and subsequent colonisation 
[116]. In the previous chapter I cultured and isolated 66 spore-forming species which 
constituted nearly half of the bacterial species cultured (66 out of 137). I hypothesise 
that the enteric commensal spore-formers isolated may exhibit similar transmission 
and colonisation patterns to C. difficile. If true, this would provide a means for 
oxygen-sensitive bacteria to survive outside of a host and to colonise a new host.  
In this chapter I place the large number of spore-formers cultured in a phylogenetic 
context to ascertain the extent of the sporulation phenotype in the gut. Then, using 
the well-studied C. difficile as a comparator, I examine the ability of these enteric 
spore-formers to survive in external aerobic conditions and to recognise the presence 
of intestinal bile-acids, both of which are necessary to ensure transmission and 
colonisation. Examination of publicly available metagenomic data-sets is then used 
to ascertain the extent of intestinal spore-forming bacteria within individuals. 
4.2 Results 
4.2.1 Phylogenetic analysis of cultured ethanol-resistant spore-forming bacteria 
Ethanol-resistant bacteria were isolated from five characterised taxonomic families 
that belong to two taxonomic classes. These are the Erysipelotrichaceae family 
within the Erysipelotrichia class, and the Clostridiaceae, Peptostreptococcaceae, 
Ruminococcaceae and Lachnospiraceae families all within the Clostridia class. 
Ethanol-resistant bacteria were also isolated from two putative novel families (Figure 
4.1). Some of the bacteria displaying an ethanol-resistant phenotype include species 
previously classified as non-spore-formers such as Turicibacter sanguinis within the 
Erysipelotrichaceae family [313]. Other ethanol-resistant bacteria are closely related 
to non-spore-forming bacteria. For example, novel bacteria closely related to non-
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spore-forming members of the Roseburia genus were isolated [11, 74]. The 
Roseburia genus contains species abundant within the intestinal microbiota that are 
known butyrate producers. Butyrate is a SCFA that acts not only as an energy source 
for epithelial cells, but also has anti-inflammatory properties [11]. Finally, other 
ethanol-resistant bacteria have been suspected of making spores but until now have 
never been demonstrated to do so. These include Eubacterium eligens, Eubacterium 
rectale and Coprococcus comes [106]. Traditionally, spore-forming bacteria are 
associated with a rod-like bacillus morphology such as Bacillus subtilis or C. 
difficile. The TEM images, which were generated by David Goulding of the WTSI, 
show ethanol-resistant bacteria with the typical rod morphology in addition to cocci 
or variants of cocci such as Coprococcus eutactus. Hence, the sporulation phenotype 
is phylogenetically diverse within the Firmicutes and is morphologically 
heterogeneous. 
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Figure 4.1 Phylogeny of intestinal spore-forming bacteria 
Full length 16S rRNA gene sequence phylogeny illustrating the taxonomic 
relationship of ethanol-resistant bacteria within the Firmicutes cultured from 
the donor faecal samples. Branch colours indicate distinct families. Shaded text 
indicates species cultured from an ethanol -treated faecal sample and unshaded 
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text indicates species cultured from a non-ethanol-treated faecal sample. 
Percentage values represent closest identity to a characterized species. 
Transmission electron micrographs (TEMs) of spore ultrastructures for a 
phylogenetically diverse selection of cultured bacteria are shown with an arrow 
in images and include a candidate novel family with 86  % identity to the 16S 
rRNA gene sequence from Clostridium thermocellum  which is the isolate 
putatively named as Falkowia sangerensis in Chapter 3. Typical spore 
structures are defined and illustrated in the same image. TEMs are ordered 
according to boxes next to the species name. Scale bars are shown at the 
bottom of each image . C. difficile  is included for context and was not cultured 
in this study. TEM Images were generated by David Goulding (WTSI). 
 
4.2.2 Phenotypic characterisation of intestinal spore-forming bacteria 
I next wanted to assess if the ability to produce ethanol-resistant spores would 
provide an advantage for transmission. To successfully transmit between hosts, a 
bacterial species must exit from a host in faecal matter, and then survive adverse 
environmental conditions which will potentially include disinfectants used in 
cleaning regimes and the presence of oxygen before being ingested by a new host 
[1]. Accordingly, the number of plated spores that germinated following exposure to 
a disinfectant was measured (colony forming units quantified on culture plates after 
ethanol exposure was used as a proxy for germinated spores). Ethanol was chosen as 
a disinfectant as it is readily available and widely used in hand sanitisers. A 
taxonomically diverse range of spore-forming and non-spore-forming bacteria 
cultured in the previous chapter (in addition to C. difficile and E. coli) were exposed 
to a 70 % ethanol solution for four hours before being washed and plated under 
anaerobic conditions. This concentration of ethanol is within the range considered 
effective and  recommended by the Food and Drug Administration (FDA) for hand 
sanitisers [314]. Only spore-forming bacteria survived prolonged exposure to ethanol 
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(Figure 4.2). The non-spore-forming Bacteroides uniformis, Bifidobacterium bifidum 
and E. coli all failed to grow post exposure. 
 
Figure 4.2 Spore-forming bacteria are more resilient than non-spore-
forming bacteria to environmental stresses such as disinfectants.  
Pure bacterial cultures were immersed in ethanol for 4  hours before being 
washed and inoculated onto YCFA growth medium with sodium taurocholate as 
a germinant. Only spore-forming bacteria survived. Taxonomic family names 
are shown in brackets. The dashed line indicates the culture detection limit of 
50 CFU  ml−1. Mean ± s.d., n = 3 biological replicates for each species tested. 
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Next, the ability of spore-forming bacteria to survive exposure to aerobic conditions 
was tested. Again, a taxonomically diverse range of spore-forming and non-spore-
forming bacteria cultured in the previous chapter, in addition to C. difficile and E. 
coli were utilised. These bacteria were inoculated onto media plates in different 
concentrations as spot dilutions and were then exposed to ambient aerobic and 
temperature conditions on the laboratory bench for varying time periods. They were 
then returned to anaerobic conditions. The number of colonies recovered for each 
time point were counted and compared as a percentage to a control group which was 
not exposed to aerobic conditions. The spore-forming bacteria survived to the end of 
the experiment which was 504 hours (21 days) (Figure 4.3). The non-spore-forming 
bacteria survived a maximum of 144 hours (6 days) apart from E. coli which is a 
facultative anaerobe. Hence, anaerobic enteric spore-forming bacteria are able to 
survive for longer in aerobic conditions than anaerobic enteric non-spore-forming 
bacteria. Interestingly, for many of the spore-forming bacteria, a sudden decrease in 
the percentage of viable cells recovered can be observed between 24 and 96 hours, 
after which the percentage of viable cells recovered remains constant. This could 
represent the point at which the vegetative cells of these spore-formers died. Any 
spores present would remain dormant in aerobic conditions. Once returned to 
anaerobic conditions, the spores would germinate, forming vegetative cells and 
allowing a colony count to be made. 
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Figure 4.3 Oxygen tolerance of phylogenetically diverse intestinal 
spore-forming bacteria 
Once exposed to oxygen, only 1 % of the original inoculum of non-spore-
forming bacteria (dashed lines) were viable after 96 hours (4 days) and none 
were viable after 144 hours (6 days). Spore-forming bacteria (solid lines) 
persist owing to spore formation. The experiment was stopped after 504 hours 
(21 days). Taxonomic families of each species tested are shown in brackets 
(n = 3 biological replicates for each strain) . 
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The ability to survive oxygen exposure and disinfectants such as ethanol enables 
enteric spores to survive in the external environment. Once ingested by a new host 
the spores need to recognise the intestinal environment in order to germinate and 
commence colonisation. I next tested if the spores utilise intestinal bile-acids as a 
germinant in a manner similar to that used by C. difficile. A selection of spore-
forming and non-spore-forming bacteria were subjected to an ethanol shock 
treatment and were then plated on media with the common bile acids taurocholate, 
glycocholate and cholate. Taurocholate was extremely effective at increasing the 
number of colonies recovered following plating, termed ‘germination potency’ in 
Figure 4.4. Taurocholate in the media increased the number of colonies recovered by 
between 8 and 70,000 fold. Glycocholate and cholate were not as effective as 
taurocholate but did significantly increase the germination potency for Clostridium 
innocuum. Non-spore-forming bacteria did not survive the ethanol shock treatment 
and are not presented in Figure 4.4. 
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Figure 4.4 Intestinal spore-formers respond to bile-acid germinants.  
The number of colony-forming units (CFU) (representing germinated spores) 
present on plates in the presence of a particular germinant is expressed as a 
fold change with respect to the number of CFU recovered on plates in the 
absence of a germinant. Spore-formers and non-spore-formers were subjected 
to ethanol shock before being plated (n = 6 biological replicates for each 
strain). A fold change of one (dashed line) would indicate that a germinant had 
no effect on the number of CFU recovered. Schematic summarises the cholate-
derived bile acid metabolism in the mammalian intestine. Mean and range, 
Welch’s unpaired two-tailed t-test (*P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001).  
 
Next, the non-spore-forming bacteria Collinsella aerofaciens and Bacteroides 
uniformis were plated on media containing the same intestinal bile acids but were not 
subjected to ethanol shock treatment beforehand. No significant difference in the 
germination potency was observed for any of the three bile-acids (Figure 4.5). 
Hence, the response to intestinal bile-acids is unique to spore-forming bacteria and is 
based upon germination of spores following bile-acid recognition.  
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Figure 4.5 Intestinal non-spore-formers do not respond to bile-acid 
germinants. 
The number of CFU present on plates in the presence of a particular germinant 
expressed as a fold change with respect to the number of CFU present on plates 
in the absence of a germinant. No ethanol shock treatment was performed 
beforehand. A fold change of one (dashed line) would indicate that a germinant 
had no effect on the number of CFU recovered from the bacteria. Mean and 
range, n = 3 biological replicates for both species.  
 
4.2.3 Genomic analysis of intestinal spore-forming bacteria and sporulation 
dynamics 
Next, the genotypic pathways that underlie these resistant phenotypes were 
examined. In total 234 ethanol-resistant and ethanol-sensitive bacteria were cultured. 
These were whole genome sequenced using the DNA pipeline department of the 
WTSI and assembled and annotated using bioinformatics pipelines developed by the 
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Pathogen Informatics team at the WTSI. Sam Forster of the Host-Microbiota 
Interactions Laboratory then used a machine learning approach to identify from the 
694,300 genes in this dataset, a list of 66 genes that were enriched in the ethanol-
resistant bacteria compared to the ethanol-sensitive bacteria (see Chapter 2 Material 
and Methods for details). I then used this sporulation signature for the subsequent 
analysis described here. Unlike previous studies that relied on prior biological 
assumptions, this gene list was unbiased in its approach [95, 112, 315]. This 
sporulation signature is enriched with known sporulation-associated genes from 
stages I–V of the spore formation and germination cycles (significant 
at q < 3.0 × 10−37, Fisher’s exact test) (Figure 4.6). Genes associated with regulation 
are present with at least 10 genes coding for regulatory or DNA-binding roles 
(q < 1.4 × 10−5, Fisher’s exact test). Genes not previously associated with sporulation 
are also present and these have putative roles as heat shock, membrane-associated 
proteins and DNA-polymerase-associated proteins. 
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Figure 4.6 A genomic signature for identifying spore-forming 
bacterial species  
The sporulation signature contains 66 sporulation- and germination-associated 
genes and genes not previously associated with sporulation. Characterised 
sporulation genes are on the outer circle, genes not associated with a specific 
sporulation cycle or uncharacterised genes are in the inside rectangle.  C. 
difficile strain 630 gene names are used when possible, otherwise locus tag 
identifiers are shown. Bacillus subtilis  gene names are used when no C. 
difficile homologue is available.   
 
The presence of these genes in a genome can now be used to predict the likelihood of 
a species being a spore-former. Interrogating the genomes of known spore formers, 
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known non-spore-formers and the bacteria cultured in this study with the signature 
reveals a clear separation between spore-formers and non-spore-formers (Figure 4.7 
and Appendix 3). The signature also accurately identifies spore-formers from 
different environments. For example, included in the ‘known spore formers’ group 
are bacteria normally resident in the soil such as Bacillus pumilus and 
Thermosediminibacter oceani, a  thermophilic species isolated from sediment on the 
seafloor [316]. This suggests that the genetic machinery of spore-formers is broadly 
conserved amongst extant species regardless of habitat. 
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Figure 4.7 The sporulation signature accurately distinguishes spore -
forming and non-spore-forming bacteria from this study and from 
different environments.  
The higher the score the more likely a species is to be a spore -former (known 
spore-formers n  = 57, known non-spore-formers n  = 50, cultured after ethanol 
treatment n  = 69, cultured after no ethanol treatment  n  = 149). Mean ± s.d.   
 
The sporulation signature was next used to assess the abundance of spore-forming 
bacteria in metagenomic datasets. Taxonomic classification of the metagenomic 
sequences contained in the HPMCD was performed using Kraken [280]. The relative 
abundance of the taxonomically identified metagenomic reads was determined and 
the sporulation signature was then applied to the whole genomes of the species 
identified by Kraken. Sam Forster performed the analysis of the metagenomic data-
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sets in Figure 4.8. I performed the analysis of the donor faecal samples and the 
culture plate samples using the relative abundance data generated by Sam Forster. 
On average, across the metagenomic datasets, spore-forming bacteria comprised 
approximately 60 % of the genera (Figure 4.8a).  When these genera were weighted 
by their abundance, spore-forming bacteria comprise 30 % of the microbial 
abundance in the intestinal microbiota (Figure 4.8b). These proportions are 
consistent in both the metagenomic sequence derived from the donor faecal samples 
in our study and the 1351 public samples.  
 
Figure 4.8 Abundance of spore-forming bacteria within the human 
intestinal microbiota 
Using the genomic signature to interrogate public (n = 1,351) and complete 
faecal sample metagenomic data sets from this study (n = 6) reveals the 
proportion of spore-formers as a count of the total number of genera (a) and as 
total microbial abundance (b). Mean ± standard deviation (s.d.).   
 
To validate the abundance of enteric spore-formers as derived by metagenomic 
sequencing, 16S rRNA gene amplicon sequencing of the six donor faecal samples 
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was carried out (Figure 4.9). The spore-formers cultured were assigned to their 
respective taxonomic genera and families. The abundance of these genera and 
families as estimated by 16S rRNA gene amplicon sequencing was then used as the 
lower and upper limit for calculating the proportion of spore-formers at a taxonomic 
level. Specific genera and families were only included if they contained a species 
that was cultured after ethanol shock treatment. Based on these parameters the 
relative abundance of spore-formers closely matches the metagenomics based 
estimate of 30 %. 
 
Figure 4.9 Validation of the estimation of the proportion of spore -
formers in the intestinal microbiota by 16S rRNA gene amplicon 
sequencing 
The genus (circle) and family (square) taxonomic ranks were designated as the 
lower and upper limits of intestinal spore-formers. Mean ± s.d.  
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The higher than expected abundance of spore-forming bacteria in the intestinal 
microbiota indicates that spore-formation may provide an advantage for transmission 
of aero-sensitive bacteria. If spore-formers can transmit more readily then they could 
be more diverse and dynamic within individuals compared to non-spore forming 
bacteria. Indeed, spore-forming bacteria were more diverse than non-spore forming 
bacteria in our dataset (Figure 4.10a). To assess if spore-formers were more dynamic 
over time I sampled from the six donors a year after their initial donation. 
Comparison of the metagenomic sequence generated a year later with the original 
sequence revealed that spore-forming bacteria change more in abundance than non-
spore forming bacteria over time (Figure 4.10b). These results indicate that spore-
forming and non-spore-forming bacteria in the intestinal microbiota display different 
transmission and colonisation dynamics that influence the overall composition of the 
intestinal microbiota.  
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Figure 4.10 Dynamic sporulation capacity within the human intestinal 
microbiota 
Metagenomic sequencing of donor faecal samples (n = 6) one  year later 
demonstrates that spore-forming bacteria are more diverse than non-spore-
forming bacteria (a) and that a significantly increased proportion of species 
show two-fold or greater change over the same time period (b). 
Mean ± standard deviation (s.d .), two-tailed paired t-test (*P < 0.05, 
***P < 0.001).   
 
4.3 Discussion 
In this study, I characterised the enteric spore-forming bacteria cultured in Chapter 3. 
Using in vitro phenotypic characterisation and analysis of metagenomic data-sets the 
ability of spore-forming bacteria to readily transmit via resilient spores and how this 
impacts the composition of the intestinal microbiota in individuals was explored. 
Based on these results a hypothetical model can be formed that predicts the different 
transmission dynamics of spore-forming and non-spore-forming bacteria (Figure 
4.11). Owing to their resistance to environmental stresses and aerotolerance, spore-
forming bacteria are not as spatially and temporally restricted during transmission as 
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non-spore-forming bacteria. For individuals who are in regular contact with, and 
close proximity to, each other (for example, co-residents) both spore-forming 
bacteria and non-spore-forming bacteria can transmit with the same efficiency. 
However, as spatial and temporal distances increase, non-spore-forming oxygen-
sensitive bacteria will become restricted in their ability to transmit until eventually 
transmission will not be possible. As spore-forming bacteria can remain viable for 
extended periods of time in external aerobic environments, they are not reliant on 
close contact between individuals to transmit. For example, spores that are shed by 
an individual can potentially be acquired by other individuals several weeks later. 
 
Figure 4.11 Inter-host transmission dynamics of spore-forming and 
non-spore-forming intestinal bacteria.  
A hypothetical model exploring the different transmission dynamics of spore -
forming and non-spore-forming intestinal bacteria.  See main text for details. 
Figure taken from [1]. 
 
Here, tolerance to ethanol exposure was used to test resistance to disinfectants. Other 
studies have shown that, compared to non-spore-forming bacteria, C. difficile spores 
are more resistant to other disinfectants too [102]. We now spend up to 90 % of our 
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time indoors; therefore our homes, work places and other built environments and the 
cleaning regimes we use within them, play an important role in how we interact with 
the microbes that surround us [209, 317, 318]. This is not the environment our 
microbiota initially evolved with. For example, increasing urbanisation has led to 
cleaner, more sterile living spaces with more rooms for individuals which affords 
greater privacy and correspondingly less contact time with co-residents [319]. In this 
scenario spore-forming bacteria could prevail to the detriment of extremely aero-
sensitive bacteria that may rely more on closer contact between individuals to 
transmit and are more sensitive to disinfectants. Other studies have highlighted the 
high microbiota diversity of people from traditional rural-gatherer societies and 
agrarian groups compared to developed Western populations [224, 320]. While diet 
may drive a large part of this diversity the differences in the built environment 
utilised by both groups may also play a role. As such, the full influence of the built 
environment on transmission of the intestinal microbiota is currently unknown, 
however as research in this discipline increases, its importance will become more 
apparent [209]. 
All of the anaerobic non-spore-forming bacteria tested remained viable for at least 48 
hours. While this experimental scenario probably does not reflect real life conditions 
it does indicate that anaerobic non-spore-forming bacteria may survive long enough 
in order to successfully transmit. While not quantified, the oxygen exposure 
experiment will also have incorporated other environmental stresses such as being 
exposed to temperatures other than body temperature and ultraviolet radiation. Thus, 
while spore-forming bacteria have an advantage over non-spore-formers in terms of 
transmission, non-spore forming anaerobic bacteria may be able to survive long 
enough in order to successfully colonise a new host in close proximity. As discussed 
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in Chapter 1 (Introduction Chapter), other survival mechanisms are utilised by 
bacteria which could be a feature of non-spore-forming anaerobic bacteria.  
There was a big difference in the response of spores to different bile acids with some 
responding to sodium taurocholate, cholate and glycocholate while others only 
responded to sodium taurocholate, such as Clostridium hathewayi (Figure 4.4). This 
suggests that the germination response of intestinal commensal spores is not uniform 
and reinforces the fact that much remains to be learned about intestinal spore-
forming bacteria. The spores that were cultured and germinated in Chapter 3 were all 
from healthy individuals with no recent antibiotic exposure. Hence, they were 
probably produced under normal homeostatic conditions in the intestinal 
environment and not as a result of encountering a stress. Intestinal spore-formation 
may therefore be a normal feature of the life cycle of these bacteria that occurs 
independently of external perturbations. 
Despite their abundance at the genus level, spore-formers are less abundant than 
non-spore-formers and change more in composition than non-spore-formers. 
Perhaps, as spore-formers are less abundant they are more at risk of encountering 
extinction or expulsion from the host due to ecological drift. In this scenario spore-
formation provides a reliable escape mechanism and ensures survival [245]. More 
abundant or more persistent species are not as dependent on dispersal to survive, 
indeed a trade-off can be envisaged where adaptation to the gut environment ensures 
sufficient abundancy to negate the need to concentrate resources on dispersal [221]. 
The ability to form spores could be a means to disperse to the outside environment 
and survive in aerobic conditions before being ingested by a new host. In the next 
chapter I will explore the hypothesis that if adept at dispersal, spore-forming bacteria 
are not as reliant on host-adaptation.  
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Chapter 5 Host-adaptation of commensal bacteria 
through loss of sporulation and reductive genome 
evolution 
5.1 Introduction 
Human intestinal spore-formers present a dichotomy for bacteria within the intestinal 
microbiota. On the one hand they are extremely adapted and evolved to the host 
environment. As demonstrated in the previous chapter, they utilise intestinal bile 
acids to trigger germination and initiate colonisation. Furthermore, they interact with 
the host through their immunomodulatory properties [131, 145]. On the other hand, 
they are independent of the host because they are capable of surviving ex vivo as 
spores for extended periods of time. Speciation of non-spore-forming 
Bacteroidaceae and Bifidobacteriaceae align with the speciation events of our early 
Hominidae ancestors over 15 million years ago to modern humans today [3]. 
However, spore-forming Lachnospiraceae do not display the same patterns of co-
speciation [3]. This suggests that host-associated spore-forming bacteria may have a 
different evolutionary history that is not as connected to their host as the 
evolutionary history of non-spore-forming bacteria. In addition, spore-formation is a 
metabolically expensive process requiring the orchestration of hundreds of genes and 
resulting in the destruction of the original vegetative cell [108, 110]. As such, little is 
known of the ecological forces that maintain sporulation within host-associated 
bacteria.  
Here, I explore the differences between host-associated spore-forming and non-
spore-forming bacteria in the context of host adaptation. I demonstrate that loss of 
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sporulation within commensal host-associated bacterial families is habitat dependent, 
with the sporulation phenotype broadly maintained in the gut and lost in other body 
habitats. Loss of sporulation within these bacteria leads to genetic features associated 
with host adaptation. These include a reduction in genome size and a reduction in 
genetic redundancy defined by loss of paralogous genes within a genome. 
Conversely, spore-forming bacteria within the same family maintain larger genomes 
and a greater genetic redundancy which could provide the flexibility to respond to 
different environmental conditions in vivo and ex vivo.  
5.2 Results  
5.2.1 Large and small scale loss of sporulation within the Firmicutes 
Currently, there are five defined taxonomic classes within the Firmicutes, the 
Clostridia, Bacilli, Erysipelotrichia, Negativicutes and Thermolithobacteria [321-
324]. All contain spore-forming species, except for Thermolithobacteria, however, 
only two species have been isolated from this class and no whole genome sequences 
are currently available [107]. I first sought to establish a robust phylogeny of the 
Firmicutes to investigate the distribution of the sporulation phenotype. Thus, 715 
Firmicute genomes from the NCBI curated RefSeq database, in addition to whole 
genome sequences from intestinal isolates from the HMP, whole genome sequences 
from a comprehensive study describing the first 1000 intestinal cultured species and 
an in-house collection of 506 sequences derived from our bacterial culture collection 
were used to construct a phylogeny based on 40 universal genes present in each 
genome [26, 146, 271, 288, 325].      
In total, 1658 whole genome sequences from over 45 bacterial families within the 
Firmicutes were included, from environments as diverse as salt mines, hot-springs, 
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fermented foods, soil and host-associated environments such as the intestine and 
mouth. Based on its proximity to the root, this phylogeny (Figure 5.1), places the 
order Halanaerobiales (family Halobacteroidaceae) as an early emerging member 
of the Firmicutes. These halophilic bacteria are currently placed within the Clostridia 
class, but based on this phylogenetic placement, which is also supported by previous 
studies, supports movement to a distinct class of their own [26, 326]. Also, based on 
this phylogeny, the Negativicutes and the Thermolithobacteria are not true 
phylogenetic classes, but are clustered within the Clostridia, and again, this is 
supported by other studies [26, 326]. To assess sporulation ability, the 66 genes that 
comprise the sporulation signature identified in Chapter 4 were mapped onto the 
phylogeny [146]. Using the previously established parameters, a species is 
considered capable of spore-formation if its genome has a sporulation signature 
score greater than 50 %. The three Halanaerobiales within the phylogeny, 
Halonatronum saccharophilum, Halanaerobium saccharolyticum and Orenia 
marismortui are spore-formers based on these criteria and have been characterised as 
spore-forming suggesting that the early ancestor of the Firmicutes was a spore-
former [327-329].  
The sporulation phenotype is not distributed throughout the Firmicutes but is absent 
within certain taxa including some contained within the Erysipelotrichaceae, Bacilli 
and Clostridia classes. This indicates subsequent loss of the phenotype as the 
Firmicutes evolved. The Bacilli class has large-scale absences of sporulation within 
the Staphylococcaceae family and within the Lactobacillales order which contains 
the Lactobacillaceae and Streptococcaceae families. The presence of the sporulation 
specific C-terminal domain of the Spo0A gene (Spo0A_C) was also mapped onto the 
phylogeny (Figure 5.1). There is a strong concordance with the presence of 
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Spo0A_C and a high sporulation signature score. Conversely, an absence of 
Spo0A_C is associated with a low sporulation score. There are a few exceptions, 
some species have maintained Spo0A_C but have a low sporulation score (<40 %). 
These include some Staphylococcus species and some Exiguobacterium species in 
the Bacillales. However, the low sporulation score combined with no reports in the 
literature of spore-formation suggests these species do not make spores [330, 331]. 
In summary, this phylogeny demonstrates that sporulation evolved in an early 
ancestor of the Firmicutes with subsequent large and small scale loss of the 
phenotype occurring. 
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Figure 5.1 Distribution of the sporulation phenotype within the 
Firmicutes 
Sporulation has been lost at large and small scales within the Firmicutes. 
Phylogeny of the Firmicutes constructed from 40 universal protein coding 
genes extracted from 1658 whole genome sequences. Sporulation has been lost 
at large (Lactobacillales) and small taxonomic scales (within the 
Erysipelotrichaceae , Peptostreptococcaceae  and Lachnospiraceae  families). 
Major taxonomic orders are indicated by branch colours within the phylogeny 
and major families within these orders are indicated by text. The 
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Thermolithobacteria are classified as a distinct class but cluster here within the 
Clostridiales  in addition to the Negativicutes, both of which are annotated on 
the tree. Non-Firmicutes bacteria were used to root the tree. Sporulation ability 
is defined a sporulation signature score of greater than 50  %. The presence of 
the Spo0A_C protein domain in a genome is also indicated.  
 
The association of a low sporulation score combined with an absence of Spo0A_C 
suggests that once the sporulation phenotype is lost, sporulation-associated genes are 
not retained, but are globally degraded as there is no advantage in maintaining them. 
Also of note is that sporulation-specific genes in the sporulation signature belonging 
to Stages II (asymmetric cell division), III (engulfment), IV (cortex-formation), V 
(coat-formation) and germination are largely absent from species within host-
adapted families that also lack Spo0A_C (Figure 5.2) (Ruminococcaceae and 
Clostridiaceae genomes were not included in this analysis due to the low number of 
non-spore-forming genomes present).  
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Figure 5.2 Loss of sporulation is accompanied with widespread loss of 
sporulation-associated genes.  
Heatmaps displaying presence (green) or absence (white) of 66 genes in 
sporulation signature within genomes of species from gut associated bacterial 
families. Genomes are clustered (cladogram on top) by presence of the 66 
genes (grouped according to sporulation stage on vertical plane) . Bacterial 
species that lack the Spo0A_C domain and are therefore non-spore-formers 
also lack many of the sporulation signature genes.  
As sporulation is a complex process requiring synchronisation of many genes acting 
in a hierarchical fashion it is unlikely the phenotype has been transferred 
horizontally. However, to investigate this possibility a phylogeny using the 
Spo0A_C domain sequence was constructed. The architecture of this phylogeny is 
broadly congruent with the species tree (Figure 5.3). This supports the hypothesis 
that sporulation has evolved in tandem with the Firmicutes and has not been 
transferred horizontally amongst taxa [95]. 
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Figure 5.3 The sporulation phenotype has not been horizontally 
transferred.  
Species phylogeny from Figure 5.1 and phylogeny of the Spo0A_C sequence 
extracted from the species where present. The two phylogenies are broadly 
congruent as indicated by the line linking taxa in both phylogenies which 
indicates sporulation has not been horizontally transferred amongst the 
Firmicutes. For conciseness, the phylogeny is compressed to only display 
major families. 
 
I next sought to explore the phylogenetic small scale loss of sporulation within host-
associated Firmicutes families. As these bacteria colonise multiple body sites, 
genomes from spore-forming (SF) and non-spore-forming (NSF) bacteria were 
assigned to their host habitat (Figure 5.4). There is a clear boundary between 
genomes with and without Spo0A_C and for Peptostreptococcaceae and 
141 
 
Lachnospiraceae, the habitat the bacteria reside in. This boundary does not fall on 
the 50 % sporulation signature score previously used. As the presence of Spo0A_C 
is a good proxy for sporulation ability (Figure 5.1) and the absence of Spo0A_C 
corresponds to an inability to make spores, I chose to use this boundary to define 
spore-forming and non-spore-forming species within each family. Hence, in Figure 
5.4 genomes above the dotted line represent a spore-forming species while those 
below the dotted line represent non-spore-forming species. 
Sporulation is broadly maintained in the gut amongst all families examined (Figure 
5.4). Erysipelotrichaceae are the exception with bacteria containing gut-associated 
SF and NSF species. Unlike the Erysipelotrichaceae, gut-associated 
Lactobacillaceae are exclusively NSF. While some species are host-associated, this 
family is principally found in a wide range of environmental habitats and is not 
abundant within the human gut. Based on this analysis it appears sporulation 
provides a selective advantage in the large intestine, which is absent in other host-
associated environments such as the rumen or mouth, resulting in the loss of the 
phenotype. Interestingly, only one of the top ten most abundant species in the 
intestinal microbiota of the six donors presented in Figure 3.7 were classified as 
spore-forming. Therefore, as discussed in the Introduction chapter, spore-formation 
may act as a means to negate elimination through ecological drift for these species 
that are present at lower abundances. 
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Figure 5.4 Sporulation is maintained in the gut but has been lost from 
other host-associated environments.  
The habitat of Firmicutes families that contain spore-forming and non-spore-
forming host-associated species is presented. Each dot represents a genome  
(Erysipelotrichaceae n=69, Peptostreptococcaceae n=36, Lachnospiraceae 
n=430, Lactobacillaceae n=230). Genomes above the dotted line  represent 
spore-forming bacteria, genomes below the dotted line represent non-spore-
forming bacteria. There is a clear delineation between spore-formers and non-
spore-formers and their associated host habitat based on the presence or 
absence of Spo0A_C. Lactobacillaceae are exclusively non-spore-forming. 
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5.2.2 Genetic features of host-adaptation in non-spore-forming bacteria 
Bacterial genomes reflect the environmental and evolutionary selective forces acting 
on them. Bacteria that inhabit dynamic, unstable or multiple environments often 
have large genomes which encode the functional capabilities required to survive and 
respond to different scenarios. A reduction in genome size is often associated with 
bacteria that are host-adapted and rely on their host for nutrients and survival [68]. 
Comparisons of genome sizes between closely related bacterial taxa can therefore 
provide insights into the functional capabilities of these groups and the evolutionary 
forces driving these differences. Within the same host-associated Firmicutes family, 
NSF genomes are significantly smaller than SF genomes regardless of the habitat 
they reside in (Figure 5.5). Lachnospiraceae NSF rumen genomes are reduced on 
average by 12 % in size, Lachnospiraceae NSF oral genomes by 39 %, 
Peptostreptococcaceae oral genomes by 39 % and Erysipelotrichaceae NSF gut 
genomes by 37 %. Notably, ocean dwelling Prochlorococcus bacteria have 
undergone similar levels of genome reduction of 38 % compared to closely related 
bacteria that have not undergone genome reduction [54]. Therefore, while best 
understood in endosymbiotic bacteria, genome reduction also features in free-living 
bacteria. Other studies have reported the genomes of oral and rumen-associated 
bacteria are smaller than gut-associated bacteria, regardless of sporulation status. The 
oral and rumen-associated genome sizes in this dataset are comparable with other 
datasets [332] suggesting there may be an optimum genome size for bacteria that is 
influenced by the habitat they reside in. 
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Figure 5.5 Non-spore-forming bacteria have smaller genomes than 
spore-forming bacteria within the same host-associated family 
Absence of sporulation is associated with a reduced genome size within host -
associated Firmicutes families. The genome sizes of non-spore-forming (NSF) 
Lachnospiraceae, Peptostreptococcaceae and Erysipelotrichaceae  bacteria are 
smaller than spore-forming (SF) bacteria from the same family (Mann-Whitney 
test to compare genome size of spore -forming and non-spore-forming bacteria 
within the same family, * = P< 0.05 & ****= P < 0.0001, Mean with SD).  
 
Coping with a varied or challenging environments requires the ability to maintain 
functionality despite perturbations faced [333]. A feature of a robust genome is 
genetic redundancy where more than one gene encodes the same or related function 
in a genome (paralogue). This ensures that even if one gene is inactivated the 
function is maintained. Conversely, if robustness is no longer required due to a stable 
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and constant environment, then loss of genetic redundancy can be expected where 
the function is maintained in the genome but there is no longer a back-up gene 
encoding the same function [60]. There is a strong correlation between genome size 
and gene number in the Firmicutes dataset as has been previously reported [67] 
(Spearman’s rho= 0.9842) (Figure 5.6). This correlation applies regardless of the 
sporulation capabilities of the bacterial species. Hence, I next sought to investigate if 
there was a difference in genetic redundancy at the family taxonomic level, between 
the genomes of spore-forming and non-spore-forming bacteria which could account 
for some of the difference in genome size reported in Figure 5.5. 
 
Figure 5.6 Genome size and gene number are correlated in the 
Firmicutes.  
Genome size and gene number are strongly correlated. Each dot represents a 
genome from the entire Firmicutes dataset, hence, this correlation applies  
regardless of habitat or sporulation ability, Spearman rho correlation 
coefficient = 0.9842. 
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Figure 5.7 below outlines the workflow used for this analysis. The genomes were 
first grouped into species using Average Nucleotide Identity (ANI). ANI groups 
genomes based on nucleotide similarity, a threshold of 95 % similarity is used to 
denote genomes of the same species [292]. A representative genome from each ANI 
species was then utilised for further analysis. For each of the Erysipelotrichaceae, 
Peptostreptococcaceae and Lachnospiraceae families,  orthoMCL was used to 
cluster genes from the representative genomes into homologous groups based on 
their sequence similarity [293]. The genes in a homologous group can be from the 
same spore-forming or non-spore-forming genome (paralogue) or from different 
spore-forming or non-spore-forming genomes (orthologue). Regardless of which 
genome the genes are derived from, each gene in a homologous group will encode 
the same function as determined by their sequence similarity. I compared genomes 
from Erysipelotrichaceae SF gut (n=21 ANI species) against Erysipelotrichaceae 
NSF gut (n=9 ANI species), Peptostreptococcaceae SF gut (n=12 ANI species) 
against Peptostreptocacceae NSF oral (n=5 ANI species) and Lachnospiraceae SF 
gut (n= ANI 139 species) against Lachnospiraceae NSF rumen (n= ANI 44 species) 
and Lachnospiraceae NSF oral (n= ANI 9 species). Other genomes from bacteria in 
different environments were not included due to their low numbers. Further details 
on the number of genes and homologous groups are described in Table 2.2. 
147 
 
 
Figure 5.7 Workflow for genetic redundancy analysis  
A simplified version of the workflow used to create Figures 5.8 and 5.9 . For 
brevity, in this scenario only three homologous groups were identified  and no 
distinction is made between genes from bacteria found in different 
environments. This workflow was carried out separately on genomes from 
Erysipelotrichaceae, Peptostreptococcaceae and Lachnospiraceae  families. 
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To examine the genetic redundancy within SF and NSF bacteria in a particular 
family, the number of genes per genome for each homologous group was calculated. 
Homologous groups that did not contain genes from at least 50 % of the SF or NSF 
ANI species in that family were excluded (for example, if a homologous group 
contained genes from four or less of the nine Erysipelotrichaceae NSF gut ANI 
species, it was excluded). Next, the gene per genome value for each remaining 
homologous group was calculated, (i.e. the number of genes from SF or NSF 
bacteria in a homologous group compared to the number of SF or NSF genomes 
those genes were derived from). SF bacteria have a higher average gene per genome 
value compared to the NSF bacteria within the same family (i.e. greater genetic 
redundancy) (Figure 5.8). This applies to all the families examined. 
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Figure 5.8 Genetic redundancy is greater in spore-forming host-
associated Firmicutes compared to non-spore-forming bacteria within 
the same family. 
Spore-forming (SF) host-associated bacteria have more genetic redundancy 
compared to non-spore-forming bacteria (NSF) from the same family as 
determined by the gene per genome value of a homologous group. The mean of 
all the genes per genome values for each homologous group is presented. (error 
bars- SEM. Paired t-test comparing gene per genome value of spore -formers 
within a homologous group against the gene per genome value of non -spore-
formers within the same homologous group. P<0.01 for Erysipelotrichaceae 
and P<0.0001 for Peptostreptococcaceae  and Lachnospiraceae). 
 
Next, the functions of homologous groups that are shared by both spore-forming and 
non-spore-forming bacteria but which have different levels of genetic redundancy 
were determined (Figure 5.9). A homologous group was included in the analysis if it 
contained genes present in greater than 50 % of species from both SF and NSF 
bacteria within the same family, i.e. the homologous group is present in the majority 
of the species in that family. For each homologous group that passed this criterion, 
the ratio of the gene per genome value for both SF and NSF bacteria was calculated. 
A ratio of 2 or greater was considered significant, i.e. in a homologous group, the 
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gene per genome value of genes derived from SF (or NSF) bacteria compared to the 
gene per genome value of the other group is two or greater. SF bacteria are present in 
a higher number of homologous groups that contain more genetic redundancy 
compared to NSF bacteria (Figure 5.9). There are a wide range of functions encoded 
in the different homologous groups but regulatory functions and transport and 
binding functions are predominant in all four comparisons. 
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Figure 5.9 Genetic redundancy is associated with shared functions in 
spore-forming bacteria in different families.  
Spore-forming bacteria (SF) have a greater level of  genetic redundancy 
compared to non-spore-forming bacteria (NSF) within shared homologous 
groups. These homologous groups encode different functions but tra nsport and 
binding and regulatory functions are predominant .  
 
Within the Erysipelotrichaceae SF bacteria there are ten homologous groups with a 
high level of genetic redundancy with transport and binding functions. Of these, 
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seven are associated with the phosphoenolpyruvate carbohydrate phosphotransferase 
(PTS) system which is involved in transport of carbohydrates into the bacterial cell. 
This is a multi-enzyme system that involves phosphorylation of the imported 
carbohydrate which prevents diffusion back out of the cell [334]. The PTS system 
consists of carbohydrate-general cytoplasmic proteins and membrane bound 
carbohydrate-specific proteins. The seven redundant homologous groups are all 
annotated as carbohydrate-specific and are specific for lactose, cellobiose, mannose, 
fructose and sorbose. Of the 18 homologous groups with a high level of genetic 
redundancy annotated with regulatory roles, five are annotated as part of two-
component regulatory systems. Similar to the PTS system, this is also a sensory 
system used by bacteria to sense and respond to external stimuli [335]. The Spo0A 
protein is the response regulator of a two-component system. 
Within the Peptostreptococcaceae SF group, redundant homologous groups of note 
include the pleiotropic transcriptional regulator ccpA which plays a role in 
colonisation, virulence, biofilm formation and plays a major role in glucose 
metabolism mediating transcription of several hundred genes in C. difficile [336]. Of 
the 17 homologous groups annotated as involved in transport and binding roles, there 
are nine homologous groups annotated as ATP-binding cassette (ABC) transporters. 
These are ubiquitous proteins found in eukaryotes and prokaryotes that transport 
solutes either in or out of the cell. They function by binding solutes to a 
transmembrane protein, this is followed by an ATP-driven conformational change in 
the protein which imports or exports the solute [337]. The annotation of the 
homologous groups suggest they are involved in the importation of solutes, the 
function of which could include carbohydrates, vitamins or metals [337]. Of these 
ABC annotated homologous groups, two are siderophores with homology to fhuB 
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and fhuC. Similar to the Erysipelotrichaceae SF genomes, two-component 
regulatory system genes are prevalent (7 out of 20 redundant regulatory homologous 
groups). 
The redundant Lachnospiraceae homologous groups follow a similar pattern. Most 
are redundant in SF bacteria, and PTS system associated and ABC transporters 
comprise the majority of the redundant transport and binding homologous groups. 
Again, there are redundant two-component system homologous groups present in the 
SF bacteria when compared to both rumen and oral genomes. Finally, there were no 
redundant NSF Erysipelotrichaceae homologous groups and only three redundant 
Peptostreptoccocaceae NSF oral and three Lachnospiraceae NSF rumen 
homologous groups. Interestingly, of the six redundant Lachnospiraceae NSF oral 
homologous groups, four are ABC-type genes, two of which are annotated as 
involved with cobalt transport. 
 
5.3 Discussion 
In this study, I used a robust phylogeny based on 40 universal genes found in over 
1600 Firmicutes genomes to demonstrate that the sporulation phenotype most likely 
evolved once in an early ancestor. Since then, sporulation has been lost multiple 
times, in entire families and also within families. Examination of genomes where 
sporulation has been lost within families demonstrates that within two families (the 
Peptostreptococcaceae and the Lachnospiraceae) this loss is habitat dependent. 
Sporulation is maintained in gut-associated bacteria within these families but lost in 
oral and rumen-associated bacteria. Sporulation has also been lost amongst members 
of the Erysipelotrichaceae family but these bacteria still reside in the gut. 
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Examination of the genomes of bacteria that are non-spore-forming reveals that these 
bacteria display genetic features of host adaptation such as smaller genome size and 
lower genetic redundancy.  
The complete absence of sporulation within Lactobacillaceae, Staphylococcaceae 
and Streptococcaceae families has been proposed to occur as a result of adaptation to 
nutrient-rich environments. In this scenario, sporulation is lost as it is no longer 
required [107, 338, 339]. Some studies have reported the lack of sporulation within 
Lachnospiraceae residing in the mouth and rumen [31], but to the best of my 
knowledge this is the first report of loss of sporulation occurring within some, but 
not all, taxa within multiple host-associated families. There was a remarkable divide, 
determined by habitat, within the Lachnospiraceae and the Peptostreptococcaceae 
spore-forming and non-spore-forming bacteria. The digestive physiology of 
ruminants and mono-gastric animals such as humans differs in terms of diet and the 
site of primary microbial fermentation. These differences likely drive differences in 
the microbial composition within [5]. Microbial fermentation in the rumen precedes 
passaging of food material to the stomach and large intestine whereas the majority of 
microbial fermentation in humans takes place in the large intestine. The longer 
retention time of digesta in the gut of ruminants allows degradation of recalcitrant 
plant material by the rumen microbiota. Perhaps, rumen-associated bacteria are not 
exposed to aerobic conditions as often as intestinal-associated bacteria due to their 
location in the digestive tract, as such, sporulation is under reduced selection 
pressure in these conditions compared to mono-gastric associated animals where 
regular expulsion of microbes in faeces occurs.  
Sporulation is advantageous in unstable dynamic environments as it provides a 
mechanism to ensure survival if prevailing conditions become deleterious. The oral 
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and intestinal microbiotas are stable in composition both in abundance and over time 
compared to other body sites, suggesting another factor is important for maintaining 
the phenotype in the gut but not in the mouth [217, 340, 341]. The oral cavity, 
similar to the gut, is initially colonised at birth with a mature and stable community 
developing during childhood [342]. Horizontal transfer between individuals also 
occurs [342, 343], and as transmission between oral habitats can occur directly and 
immediately through kissing or through hand to mouth contact, then exposure to 
aerobic conditions may be limited for colonising anaerobic bacteria. In this scenario, 
as opposed to the gut environment, sporulation is not required for transmission and 
may be selected against. The reason behind the absence of sporulation within 
Erysipelotrichaceae bacteria that reside in the gut remains unknown. Little is known 
of the role of this bacterial family within the intestinal microbiota, and most reports 
focus on their association with disease, as such, their role as commensals and how 
they differ in functionality from other host-adapted bacterial families (and classes) is 
unclear [344, 345].  
Loss of genetic redundancy is associated with host adaptation. Features of loss of 
genetic redundancy include a reduced genome size, a reduction in paralogues within 
genomes, and a loss of metabolic and regulatory genes [54, 60, 62, 68]. The absence 
of these features in spore-forming bacteria reflects a lifestyle that incorporates 
regular exposure to adverse environmental conditions, perhaps due to their lower 
abundance. Spore-formation provides a means to survive these adverse conditions, 
regulatory genes such as two-component regulatory system genes provide a means to 
assess and respond to the changing conditions. In a similar fashion, the greater 
redundancy of PTS and ABC transporter genes within spore-forming genomes may 
provide these bacteria with the flexibility to transport carbohydrates and nutrients in 
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different environmental conditions or different hosts. For non-spore-forming bacteria 
this may not be as relevant if their environment is constant, hence they can afford to 
lose extra copies of these genes. Interestingly, the ccpA gene which is redundant in 
Peptostreptococcaceae spore-forming bacteria is involved in carbon catabolite 
repression and regulates toxin production in C. difficile depending on PTS system 
mediated carbohydrate availability [336]. In summary, this study reveals that the 
human intestinal microbiota is populated by bacteria, that depending on their ability 
to form resilient spores, have evolved to engage in opposing lifestyles either 
orientated towards inter-host dispersal or within-host adaptation. 
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Chapter 6 Summary and future directions 
The factors that influence our intestinal microbiota are becoming more apparent, 
partly owing to technological advances in microbiology, genomics and 
bioinformatics, and partly owing to the realisation that assembling and maintaining a 
healthy intestinal microbiota may depend not only on our diet, lifestyle choices and 
general health, but through inter-host transmission, may also depend on the 
microbiota and the health of others. The health status of the donors that we acquire 
our microbiota from may affect the composition of our own intestinal microbiota. In 
theory, donors that have the greatest diversity of commensal bacteria in the highest 
numbers are most likely to replenish the depleted microbiota of potential recipients 
(Figure 6.1). Suboptimal donors are people that were once healthy donors, but 
through antibiotic exposure or other disease conditions have lost intestinal 
microbiota diversity. The microbiota of suboptimal donors may potentially include 
higher levels of pathogens, which may be transmitted at a higher frequency than in 
healthy donors [1]. The culturing, computational analysis and in vitro analysis 
described in this thesis provides a platform to validate a model for transmission of 
the intestinal microbiota as described in Figure 6.1.  
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Figure 6.1 A model for transmission of commensal intestinal bacteria 
and the influence of donor health status.  
Healthy donors who have no history of intestinal disorders or recent antibiotic 
treatment will typically have a diverse intestinal microbiota that exhibits high 
colonisation resistance. Healthy donors are optimal donors of commensal 
microorganisms because they will regularly contribute health -associated 
bacteria to their environment. Conversely, donors who have lower levels of 
commensal diversity, decreased colonisation resistance and a higher propor tion 
of pathogenic bacteria are not considered optimal donors. These suboptimal 
and unsuitable donors would be more likely to shed pathogenic bacteria into 
the external environment that are not beneficial to human health. The signature 
species that categorise donors in this model are not comprehensive and are 
included on the basis of current research in the field. IBD, inflammatory bowel 
disease; IBS, irritable bowel syndrome. Figure taken from [1].  
 
During my PhD thesis, an anaerobic culturing workflow was developed to culture 
and isolate a broad range of bacteria from the human intestinal microbiota. Using 
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metagenomic sequencing of the donor’s faecal samples it was established that the 
bacteria growing on the culture plate are representative of the same bacteria in faecal 
samples with a strong concordance in abundance. This resulted in the isolation of 
137 distinct bacterial species [146]. Just under half of these species (68 in total) were 
novel and included bacteria from novel genera and novel families. Incorporated in 
the workflow was a targeted phenotypic screen to isolate ethanol-resistant spore-
forming bacteria. The phenotypic screen was successful and resulted in the isolation 
of 66 ethanol-resistant spore-forming bacteria. Analysis of metagenomic sequence 
demonstrated that intestinal spore-forming bacteria are more abundant than 
previously thought, comprising up to 30% of the microbial abundance. In vitro 
analysis demonstrated that these bacteria are resistant to aerobic conditions and 
germinate in the presence of bile-acids commonly found in the human 
gastrointestinal tract, thus explaining how a significant proportion of the intestinal 
microbiota can exploit spore-formation to transmit between individuals.  
Phylogenetic and evolutionary analysis of host-associated bacteria from the 
Firmicutes revealed that sporulation is highly maintained in gut bacteria but has been 
lost in bacteria from other host-associated environments such as the oral cavity of 
humans and the rumen of ruminants. Genomic analysis of spore-forming and non-
spore-forming bacteria from the same host-associated taxonomic family showed that 
non-spore-forming bacteria have undergone genome reduction which could reflect 
adaptation to the host. Conversely spore-forming bacteria may not be as reliant on 
host adaptation as they can readily survive ex vivo. This raises interesting questions 
as to the role of spore-forming bacteria within the gut. The host selects for bacteria 
that are beneficial [1, 40, 42], in addition, while an individual’s microbiota profile is 
unique, the same species (both spore-forming and non-spore-forming) are 
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consistently observed in different people [8, 15, 16]. While normally considered a 
response to stress, under normal conditions, C. difficile continuously produces spores 
at a low rate, which are able to persist by adhering to intestinal epithelial cells and 
mucin [346, 347]. Furthermore, spores of B. subtilis have been demonstrated to 
germinate stochastically without an external cue. While risky for the germinating 
spore in question, if environmental conditions are favourable it allows the population 
to quickly expand and occupy available niches [348]. Hence, the presence of 
intestinal bile acids may not always be necessary to stimulate germination, especially 
considering bile acids are present at lower concentrations in the large intestine where 
the majority of the intestinal microbiota reside [117, 129]. Therefore, spore-
formation may, in addition to facilitating transmission, promote colonisation 
resistance by ensuring that the diversity of the community is maintained through 
spore germination and expansion into vacant niches, especially following a 
perturbation [349].  
Mixtures of spore-formers from intestinal bacteria are being developed as a 
commercial therapeutic to treat C. difficile infection. In theory, spores provide a 
stable delivery system that should require a low level of processing to maintain 
viability. While initial studies looked promising, the recent failure of clinical trials 
raises questions regarding their suitability [350, 351]. Other studies suggest intestinal 
spore-forming bacteria are not as proficient at colonising as non-spore-forming 
bacteria, both in the scenario of FMT to treat C. difficile infection and in early 
colonisation of infants with bacteria derived from their mothers [169, 352]. This 
highlights the need for continued study to better understand the role of spore-forming 
bacteria in the intestinal microbiota.  
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The large number of different bacterial species isolated in this study using a single 
growth medium and carried out by one individual, demonstrates that the human 
intestinal microbiota is readily culturable. The limiting factor in culturing bacteria 
from the intestinal microbiota is the number of colonies picked and not any intrinsic 
media requirements or technological limitations. While other studies have cultured 
novel bacteria [79-81, 282], this is the first study to culture a large number using a 
streamlined workflow with a single growth medium, to quantify the bacteria cultured 
in terms of their abundance in the intestinal microbiota, to deposit the bacteria in 
public repositories and to then characterise a phenotype that is shared by a large 
number of these cultured bacteria. As such, this study unlocks the intestinal 
microbiota for future phenotypic analysis and facilitates more mechanistic 
experiments which can make the connection between a change in abundance in a 
disease state and an actual causative role for the implicated bacteria.  
Another means to untangle the relationship between the intestinal microbiota and a 
disease condition is by using gnotobiotic mice which are germ-free mice colonised 
with known bacteria, in some cases, originally derived from humans. These 
gnotobiotic mice allow many variables to be controlled including diet, genetics, the 
external environment and most importantly, the intestinal microbiota. Gnotobiotic 
mice stably maintain their microbial communities across generations, hence they 
provide a powerful tool to understand the functioning of the intestinal microbiota and 
their response to perturbations in vivo [353, 354]. Using these mouse models, 
investigators have examined the effect of pathogen infection on a defined 
community of bacteria [355], the response of individual bacterial species to a change 
in diet [353] or the production of metabolites following introduction of a single 
bacterial species [356]. The spatial distribution of a defined bacterial community 
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along the gastrointestinal tract of mice has also been examined using Fluorescence in 
sitiu hybridisation (FISH) [357]. Other studies have colonised germ-free mice with 
bacteria engineered with fluorescent markers [249].  
The ability to manipulate bacterial genomes through inactivation of genes or 
increased transcription of genes allows important insights to be gained on the 
functional capabilities of a bacterial species and how it responds to the surrounding 
environment [110, 250]. Many of the studies in gnotobiotic mice described above 
have utilised members of the Bacteroides genus, which are abundant in the human 
gut and are tractable to genetic engineering [249, 358]. While methods for 
engineering C. difficile are available [359, 360], there are few existing genetic tools 
that can engineer a broad selection of commensal species of the Firmicutes [361]. 
However, the availability of a wide range of commensal Firmicutes cultured here 
along with their whole genome sequences is a starting point to alleviate this 
bottleneck. Furthermore, the large number of Firmicutes cultured in this study 
provides a valuable resource to use for gnotobiotic mice experiments. 
The bacteria cultured in this study also provide a valuable resource to develop 
bacterial based therapeutics. FMT has been extremely effective at resolving C. 
difficile infection [235], but a more likely therapeutic in the future and a more 
acceptable alternative will be one composed of a defined mix of bacteria [223, 362]. 
While C. difficile infection may transpire to be the most amenable to a bacterial-
based therapeutic, other promising applications include the treatment of 
Inflammatory Bowel Disease (IBD) through the use of regulatory T-cell inducing 
bacteria which dampen down intestinal inflammation [145, 362]. 
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The whole-genome sequences generated from these isolates will also complement 
culture-independent, sequence-based studies. There were 694,300 genes sequenced 
from 234 genomes of cultured bacteria in this study. Elucidating the functions of 
sequenced genes has always been problematic [77], however linking genes back to a 
cultured isolate allows a more detailed exploration of functionality to be made, using 
RNA-seq for example. These cultured isolates will also improve reference databases 
that are used to classify sequences in metagenomic studies. There were 90 genomes 
generated here that are part of the Human Microbiome Project’s (HMP) ‘most 
wanted’ list of underrepresented taxa [305]. Included in this this list and cultured in 
this study is Eubacterium rectale which was noted in the recent HMP paper as an 
isolate requiring reference genomes [16]. Finally, while computational assemblies of 
genomes directly from metagenomic sequences can now assemble hundreds of 
genomes from different species and represents a significant computational advance, 
it is still not as accurate or complete as generating a whole genome sequence from a 
cultured isolate [77, 363]. 
Resistance to ethanol exposure was used as the phenotypic screen in the culturing 
process to isolate spore-forming bacteria. This approach was based on starting with a 
phenotype (ethanol-resistance) and working back to the genotype (sporulation 
signature and subsequent analysis of metagenomic sequence). When combined, 
inferences were made on the transmission dynamics of intestinal spore-forming 
bacteria. This culturing workflow is modular as the phenotypic screen can be altered 
to examine different phenotypes important in the intestinal microbiota. For example, 
plating faecal samples on growth media with different antibiotics would allow 
isolation of bacteria resistant to those antibiotics. Increasing levels of antibiotics in 
the growth media could be utilised to examine the level of resistance. Utilisation of 
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carbon sources is an important function of intestinal bacteria and plays a key role in 
the assembly and stability of the microbial community [23, 181, 364]. The host 
exploits preferential utilisation of carbons sources such as fucose or sialic acid by 
commensal bacteria at the epithelial layer as a means to restrict pathogen growth [40, 
358]. Hence, plating faecal samples in minimal media with different carbon sources 
could be a means to isolate commensal bacteria with these protective effects. 
Furthermore, in both of these examples, the generation of genomes of bacteria that 
are isolated through the phenotypic screen would allow exploration of the genetic 
mechanisms underlying the phenotype. 
Based on the topics discussed above, studies to build on the work described in this 
thesis should include: 
1. Transmission of the intestinal microbiota 
In Chapter 4 it was established that intestinal spores promote inter-host transmission 
as a result of their resistant nature and response to intestinal bile acids. Related 
avenues of research include: 
A. Experimental examination of the transmission dynamics of spore-formers and 
non-spore-formers: 
To further explore the transmission dynamics of spore-formers and non-spore-
formers, mice could be left in cages for a few days and then removed. The uncleaned 
cages are then sealed for defined periods of time at which point, gnotobiotic mice are 
introduced. Longitudinal faecal sampling and sequencing from the gnotobiotic mice 
would provide information on the colonisation patterns- which spore-formers 
165 
 
colonise first and which non-spore-forming bacteria can colonise and upto what time 
point. 
B. Aerotolerance of vegetative cells: 
Are vegetative cells of non-spore-formers more aero-tolerant than vegetative cells of 
spore-formers? This would be expected as they cannot rely on a spore phenotype to 
aid transmission. Experiments to elucidate this would be designed on the oxygen 
tolerance test in Figure 4.3 and would include a larger selection of intestinal bacteria. 
For spore-formers in the experiment it will be necessary to distinguish between 
spores and vegetative cells. The rapid initial drop in viability will be due to 
vegetative cells dying. As the curve levels off only spores will be viable and this 
provides a means to differentiate between a mixed population of spores and 
vegetative cells from the same species.  
C. The effect of the donor health-status on microbiota transmission: 
Individuals living in the same house have a more similar microbiota than individuals 
living separately. Therefore, as presented above in Figure 6.1 the health status of the 
donor could influence whether beneficial or potentially pathogenic bacteria are 
transmitted. Experiments to investigate this would utilise mice colonised with a 
microbiota that would make them optimal, suboptimal or unsuitable donors. 
Placement of gnotobiotic or germ-free mice in the same cage and longitudinal 
sequencing of faecal samples would determine if the recipient mice also acquire a 
‘healthy’ or ‘unhealthy’ microbiota.  
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2. Characterisation of a novel or understudied taxa 
The culturing of a large number of novel taxa provides an opportunity to better 
characterise members of the intestinal microbiota. 
A. Further characterisation of Falkowia sangerensis: 
Continued characterisation of this isolate would include the generation of phenotypic 
data. To investigate substrate utilisation, the Biolog System could be employed. This 
platform involves 96 well plates each containing a different growth substrate (such 
as different carbon sources) and a reducing dye for high-throughput phenotypic 
screening. Respiration by the inoculated bacterium in the presence of the substrate 
reduces the dye causing a measurable colour change which indicates a positive 
result. Additional characterisation could also include the use of Etest strips to 
determine antibiotic resistance profiles. 
B. Characterisation of a taxonomic group 
Similar to the characterisation of F. sangernesis, taxa could be selected for further 
characterisation. Two candidates are the Erysipelotrichaceae family or the Blautia 
genus within the Lachnospiraceae family. Six Erysipelotrichaceae were cultured in 
this study, of which three were novel. Twelve Blautia were cultured, of which eight 
were novel. Both of these taxonomic groups remain understudied. Characterisation 
would start with the establishment of a phylogeny using the whole genome 
sequences generated in this study and publicly available ones. Using the genomes, a 
core and accessory genome for the taxa could be established. This could then be 
followed by phenotypic characterisation similar to F. sangerensis such as utilisation 
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of the Biolog system. This would allow determination of which substrates are 
utilised by all members of the taxon and which are unique to certain species. 
3. Germination and colonisation dynamics of intestinal spore formers 
Intestinal spores were shown to germinate in response to different bile-acids and at 
different levels (Figure 4.4). This demonstrates much remains to be learnt about the 
germination and colonisation patterns of intestinal spore-formers. Experiments to 
increase knowledge in this area would include: 
A. Bile acid response experiments: 
A larger selection of intestinal spore-formers could be tested using the same 
experimental design presented in Figure 4.4. In addition, a larger selection of bile 
acids could be tested to assess their germination potency. A literature search on the 
abundance and presence of different bile acids in different parts of the 
gastrointestinal tract could then be used to link the response of different bacterial 
spores with their intestinal ecology. 
B. Genetics of intestinal spore-formers: 
Many spore-formers utilise Ger-type genes to recognise an environmental germinant 
(for example GerA in B. subtilis), however, C. difficile utilises Cspc to recognise bile 
acids [122, 365]. Besides the sporulation signature used to identify spore-formers in 
this study, little is known of the genetics of intestinal spore-formers. BLAST 
searches of these and other sporulation genes could be used to build a picture of the 
shared and unique sporulation genes and to link this to a phylogenetic signal within 
the intestinal microbiota. 
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Given the importance of the intestinal microbiota and the role transmission may play 
in maintaining microbial diversity within individuals, a greater understanding of the 
transmission of commensal and symbiotic microbiota is required. Traditionally, the 
study of bacterial transmission networks has focused on pathogens because 
restricting pathogen transmission is important for preventing the spread of disease. 
The bacterial isolates cultured in this study and the knowledge gained on the 
transmission capabilities of spore-forming bacteria can be applied in the future to the 
study of intestinal commensal transmission. The challenge moving forward will be 
to use these resources to validate the hypothesis that commensal bacteria spread 
health [1]. 
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Appendix 1 Cultured Isolates 
The table summarises details of the isolates cultured in this study. It includes their 
taxonomic placement, novelty based on 16S rRNA gene sequence similarity, ethanol 
resistance, sporulation signature score and if they are included in the Human 
Microbiome Projects most wanted list of underrepresented taxa in cultured isolates. 
The isolates are listed according to their order on Figure 3.5 and therefore include 
three Proteobacteria species which were not cultured but were included to provide 
phylogenetic context. Hence, the total number listed here is 140 (three Proteobacteria 
and 137 cultured in this study).
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order 
on 
Fig. 
3.5 
Phylum Class Family† Genus† 
closest 16S BLAST match to 
named bacterium- ≥99% 
unless otherwise stated 
novelty 
etoh 
resistance 
spore 
sig. 
score 
HMP 
most 
wanted 
1 Proteobacteria 
Betaproteobacte
ria 
Oxalobacteraceae Oxalobacter Oxalobacter formigenes 
    
2 Proteobacteria 
Gammaproteoba
cteria 
Enterobacteriaceae Proteus Proteus mirabilis 
    
3 Proteobacteria 
Gammaproteoba
cteria 
Enterobacteriaceae Escherichia Escherichia coli 
    
4 Bacteroidetes Bacteroidia Rikenellaceae Alistipes Alistipes finegoldii characterised 
ethanol-
sensitive 
0.185 low 
5 Bacteroidetes Bacteroidia Rikenellaceae Alistipes Alistipes finegoldii characterised 
ethanol-
sensitive 
0.1846 medium 
6 Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides Parabacteroides merdae characterised 
ethanol-
sensitive 
0.215 low 
7 Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides Parabacteroides distasonis characterised 
ethanol-
sensitive 
0.2 low 
8 Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides Parabacteroides distasonis characterised ethanol- 0.215 low 
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sensitive 
9 Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides Parabacteroides distasonis characterised 
ethanol-
sensitive 
0.2 low 
10 Bacteroidetes Bacteroidia Prevotellaceae Prevotella Prevotella copri characterised 
ethanol-
sensitive 
0.046 low 
11 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides coprocola_94% novel species 
ethanol-
sensitive 
0.185 no 
12 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides plebius_95% novel species 
ethanol-
sensitive 
0.169 no 
13 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides vulgatus characterised 
ethanol-
sensitive 
0.185 medium 
14 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides uniformis characterised 
ethanol-
sensitive 
0.185 low 
15 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides intestinalis_98% novel species 
ethanol-
sensitive 
0.185 low 
16 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides salyersiae characterised 
ethanol-
sensitive 
0.185 low 
17 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides caccae characterised 
ethanol-
sensitive 
0.2 low 
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18 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides xylanisolvens characterised 
ethanol-
sensitive 
0.2 low 
19 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides ovatus characterised 
ethanol-
sensitive 
0.185 low 
20 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides finegoldi characterised 
ethanol-
sensitive 
0.185 low 
21 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides thetaiotaomicron characterised 
ethanol-
sensitive 
0.2 medium 
22 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides thetaiotaomicron characterised 
ethanol-
sensitive 
0.2 medium 
23 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides finegoldii_98% novel species 
ethanol-
sensitive 
0.185 low 
24 Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides Bacteroides thetaiotaomicron characterised 
ethanol-
sensitive 
0.2 medium 
25 Actinobacteria Actinobacteria Coriobacteriaceae Collinsella Collinsella aerofaciens_92% novel species 
ethanol-
sensitive 
0.215 no 
26 Actinobacteria Actinobacteria Coriobacteriaceae Collinsella Collinsella aerofaciens characterised 
ethanol-
sensitive 
0.185 low 
27 Actinobacteria Actinobacteria Coriobacteriaceae Collinsella Collinsella aerofaciens characterised ethanol- 0.2 low 
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sensitive 
28 Actinobacteria Actinobacteria Bifidobacteriaceae Bifidobacterium Bifidobacterium adolescentis characterised 
ethanol-
sensitive 
0.138 low 
29 Actinobacteria Actinobacteria Bifidobacteriaceae Bifidobacterium Bifidobacterium adolescentis characterised 
ethanol-
sensitive 
0.138 low 
30 Actinobacteria Actinobacteria Bifidobacteriaceae Bifidobacterium Bifidobacterium bifidum characterised 
ethanol-
sensitive 
0.138 no 
31 Actinobacteria Actinobacteria Bifidobacteriaceae Bifidobacterium 
Bifidobacterium 
pseudocatenulatum 
characterised 
ethanol-
sensitive 
0.123 low 
32 Firmicutes Negativicutes Veillonellaceae Mitsuokella Mitsuokella jalaludinii characterised 
ethanol-
sensitive 
0.292 no 
33 Firmicutes Negativicutes Veillonellaceae Megasphaera Megasphaera elsdenii_95% novel species 
ethanol-
sensitive 
0.262 no 
34 Firmicutes Erysipelotrichia Erysipelotrichaceae Turicibacter Turicibacter sanguinis characterised 
ethanol-
resistant 
0.569 low 
35 Firmicutes Erysipelotrichia Erysipelotrichaceae 
Erysipelotrichacea
e_incertae_sedis 
Clostridium innocuum characterised 
ethanol-
resistant 
0.492 no 
36 Firmicutes Erysipelotrichia Erysipelotrichaceae 
Erysipelotrichacea
e_incertae_sedis 
Clostridium innocuum_95% novel species 
ethanol-
resistant 
0.477 low 
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37 Firmicutes Erysipelotrichia Erysipelotrichaceae Catenibacterium Catenibacterium mitsuokai characterised 
ethanol-
sensitive 
0.262 no 
38 Firmicutes Erysipelotrichia Erysipelotrichaceae 
Clostridium 
XVIII 
Clostridium cocleatum_93% novel species 
ethanol-
sensitive 
0.415 no 
39 Firmicutes Erysipelotrichia Erysipelotrichaceae 
Clostridium 
XVIII 
Clostridium 
saccharogumia_93% 
novel species 
ethanol-
sensitive 
0.415 low 
40 Firmicutes Clostridia unclassified 
 
Eubacterium infirmum_91% novel family 1 
ethanol-
resistant 
0.538 no 
41 Firmicutes Clostridia unclassified 
 
Eubacterium infirmum_94% novel family 1 
ethanol-
resistant 
0.662 no 
42 Firmicutes Clostridia Peptostreptococcaceae Clostridium XI Clostridium ghonii_98% novel species 
ethanol-
resistant 
0.831 no 
43 Firmicutes Clostridia Peptostreptococcaceae Clostridium XI 
Clostridium 
lituseburense_98% 
novel species 
ethanol-
resistant 
0.862 medium 
44 Firmicutes Clostridia Peptostreptococcaceae Clostridium XI Clostridium bartlettii characterised 
ethanol-
resistant 
0.877 low 
45 Firmicutes Clostridia Clostridiaceae Sarcina Sarcina ventriculi characterised 
ethanol-
resistant 
0.692 no 
46 Firmicutes Clostridia Clostridiaceae Clostridium sensu Clostridium baratti characterised ethanol- 0.769 no 
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stricto resistant 
47 Firmicutes Clostridia Clostridiaceae 
Clostridium sensu 
stricto 
Clostridium paraputrificum characterised 
ethanol-
resistant 
0.769 no 
48 Firmicutes Clostridia Clostridiaceae 
Clostridium sensu 
stricto 
Clostridium disporicum characterised 
ethanol-
resistant 
0.723 no 
49 Firmicutes Clostridia Clostridiaceae 
Clostridium sensu 
stricto 
Clostridium disporicum characterised 
ethanol-
resistant 
0.785 medium 
50 Firmicutes Clostridia Clostridiaceae 
Clostridium sensu 
stricto 
Clostridium perfringens characterised 
ethanol-
resistant 
0.8 medium 
51 Firmicutes Clostridia Clostridiaceae 
Clostridium sensu 
stricto 
Clostridium disporicum_98% novel species 
ethanol-
resistant 
0.8 medium 
52 Firmicutes Clostridia unclassified 
 
Clostridium 
thermocellum_86% 
novel family 2 
ethanol-
resistant 
0.646 no 
53 Firmicutes Clostridia Ruminococcaceae Acetivibrio 
Clostridium 
thermocellum_87% 
novel genus 
ethanol-
resistant 
0.662 high 
54 Firmicutes Clostridia Ruminococcaceae Butyricicoccus 
Butyricicoccus 
pullicaecorum_94% 
novel species 
ethanol-
resistant 
0.569 no 
55 Firmicutes Clostridia Ruminococcaceae Butyricicoccus 
Butyricicoccus 
pullicaecorum_94% 
novel species 
ethanol-
resistant 
0.569 high 
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56 Firmicutes Clostridia Ruminococcaceae Flavonifractor Flavonifractor plautii_95% novel species 
ethanol-
sensitive 
0.662 medium 
57 Firmicutes Clostridia Ruminococcaceae unclassified Flavonifractor plautii_95% novel genus 
ethanol-
resistant 
0.585 low 
58 Firmicutes Clostridia Ruminococcaceae unclassified Flavonifractor plautii_94% novel species 
ethanol-
resistant 
0.646 medium 
59 Firmicutes Clostridia Ruminococcaceae unclassified Flavonifractor plautii_96% novel genus 
ethanol-
resistant 
0.677 no 
60 Firmicutes Clostridia Ruminococcaceae Oscillibacter 
Oscillibacter 
valericigenes_96% 
novel species 
ethanol-
resistant 
0.646 low 
61 Firmicutes Clostridia Ruminococcaceae 
Pseudoflavonifrac
tor 
Flavonifractor plautii_95% novel species 
ethanol-
sensitive 
0.646 no 
62 Firmicutes Clostridia Ruminococcaceae unclassified Flavonifractor plautii_97% novel genus 
ethanol-
resistant 
0.62 medium 
63 Firmicutes Clostridia Ruminococcaceae Flavonifractor Flavonifractor plautii characterised 
ethanol-
resistant 
0.723 low 
64 Firmicutes Clostridia Ruminococcaceae Flavonifractor Flavonifractor plautii characterised 
ethanol-
resistant 
0.692 low 
65 Firmicutes Clostridia Ruminococcaceae Flavonifractor Flavonifractor plautii characterised ethanol- 0.692 low 
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resistant 
66 Firmicutes Clostridia Ruminococcaceae Flavonifractor Flavonifractor plautii characterised 
ethanol-
resistant 
0.508 low 
67 Firmicutes Clostridia Ruminococcaceae Clostridium IV Eubacterium siraeum characterised 
ethanol-
sensitive 
0.477 low 
68 Firmicutes Clostridia Ruminococcaceae Clostridium IV Ruminococcus bromii characterised 
ethanol-
sensitive 
0.569 low 
69 Firmicutes Clostridia Ruminococcaceae Clostridium IV Ruminococcus bromii_93% novel species 
ethanol-
resistant 
0.585 low 
70 Firmicutes Clostridia Ruminococcaceae Clostridium IV Ruminococcus bromii_94% novel species 
ethanol-
resistant 
0.662 low 
71 Firmicutes Clostridia Ruminococcaceae unclassified 
Ruminococcus 
flavefaciens_93% 
novel genus 
ethanol-
sensitive 
0.538 low 
72 Firmicutes Clostridia Ruminococcaceae Ruminococcus 
Ruminococcus 
flavefaciens_95% 
novel species 
ethanol-
resistant 
0.477 no 
73 Firmicutes Clostridia Ruminococcaceae Ruminococcus Ruminococcus albus_98% novel species 
ethanol-
resistant 
0.585 no 
74 Firmicutes Clostridia Ruminococcaceae Ruminococcus Ruminococcus albus_95% novel species 
ethanol-
resistant 
0.508 medium 
198 
 
75 Firmicutes Clostridia Ruminococcaceae Clostridium XIV 
Clostridium 
methylpentosum_92% 
novel species 
ethanol-
resistant 
0.646 no 
76 Firmicutes Clostridia Ruminococcaceae unclassified Anaerotruncus colihominis characterised 
ethanol-
resistant 
0.662 no 
77 Firmicutes Clostridia Ruminococcaceae unclassified 
Anaerotruncus 
colihominis_91% 
novel genus 
ethanol-
resistant 
0.662 no 
78 Firmicutes Clostridia Ruminococcaceae Faecalibacterium Faecalibacterium prausnitzii characterised 
ethanol-
sensitive 
0.138 medium 
79 Firmicutes Clostridia Ruminococcaceae Faecalibacterium Faecalibacterium prausnitzii characterised 
ethanol-
sensitive 
0.462 medium 
80 Firmicutes Clostridia Ruminococcaceae Faecalibacterium 
Faecalibacterium 
prausnitzii_98% 
novel species 
ethanol-
sensitive 
0.462 medium 
81 Firmicutes Clostridia Ruminococcaceae Faecalibacterium Faecalibacterium prausnitzii characterised 
ethanol-
sensitive 
0.462 medium 
82 Firmicutes Clostridia Lachnospiraceae unclassified 
Clostridium 
xylanolyticum_95% 
novel genus 
ethanol-
sensitive 
0.569 low 
83 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Clostridium nexile_94% novel species 
ethanol-
resistant 
0.677 no 
84 Firmicutes Clostridia Lachnospiraceae Lachnospiraceae_ Eubacterium fissicatens_95% novel species ethanol- 0.646 no 
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incertae_sedis resistant 
85 Firmicutes Clostridia Lachnospiraceae Anaerostipes Anaerostipes hadrus characterised 
ethanol-
sensitive 
0.554 no 
86 Firmicutes Clostridia Lachnospiraceae Anaerostipes Anaerostipes hadrus_98% novel species 
ethanol-
sensitive 
0.569 no 
87 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Ruminococcus gnavus characterised 
ethanol-
resistant 
0.585 no 
88 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Ruminococcus gnavus_98% novel species 
ethanol-
sensitive 
0.615 low 
89 Firmicutes Clostridia Lachnospiraceae Dorea Dorea formicigenerans_98% novel species 
ethanol-
sensitive 
0.554 no 
90 Firmicutes Clostridia Lachnospiraceae Dorea Dorea longicatena characterised 
ethanol-
sensitive 
0.523 no 
91 Firmicutes Clostridia Lachnospiraceae unclassified Clostridium oroticum_95% novel genus 
ethanol-
resistant 
0.569 no 
92 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Clostridium oroticum_96% novel species 
ethanol-
resistant 
0.523 no 
93 Firmicutes Clostridia Lachnospiraceae unclassified Eubacterium contortum characterised 
ethanol-
resistant 
0.631 no 
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94 Firmicutes Clostridia Lachnospiraceae unclassified Eubacterium contortum_97% novel genus 
ethanol-
sensitive 
0.585 no 
95 Firmicutes Clostridia Lachnospiraceae unclassified Ruminococcus torques characterised 
ethanol-
sensitive 
0.585 low 
96 Firmicutes Clostridia Lachnospiraceae unclassified Clostridium oroticum_95% novel genus 
ethanol-
resistant 
0.615 no 
97 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Ruminococcus torques characterised 
ethanol-
sensitive 
0.554 low 
98 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Eubacterium ramulus characterised 
ethanol-
sensitive 
0.523 low 
99 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Roseburia inulinivorans_94% novel species 
ethanol-
resistant 
0.615 no 
100 Firmicutes Clostridia Lachnospiraceae Roseburia Roseburia inulinvorans characterised 
ethanol-
sensitive 
0.631 low 
101 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Eubacterium rectale characterised 
ethanol-
resistant 
0.477 low 
102 Firmicutes Clostridia Lachnospiraceae Roseburia Roseburia faecis characterised 
ethanol-
sensitive 
0.554 low 
103 Firmicutes Clostridia Lachnospiraceae unclassified Roseburia faecis_95% novel genus ethanol- 0.631 medium 
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sensitive 
104 Firmicutes Clostridia Lachnospiraceae Roseburia Roseburia intestinalis characterised 
ethanol-
sensitive 
0.615 low 
105 Firmicutes Clostridia Lachnospiraceae Roseburia Roseburia hominis characterised 
ethanol-
resistant 
0.6 low 
106 Firmicutes Clostridia Lachnospiraceae unclassified 
Lachnospira 
pectinoschiza_91% 
novel genus 
ethanol-
sensitive 
0.508 high 
107 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Eubacterium eligens characterised 
ethanol-
resistant 
0.554 medium 
108 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Lachnospira pectinoschiza characterised 
ethanol-
sensitive 
0.523 low 
109 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Lachnospira pectinoschiza characterised 
ethanol-
resistant 
0.523 low 
110 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Eubacterium hallii_97% novel species 
ethanol-
sensitive 
0.554 low 
111 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Eubacterium hallii characterised 
ethanol-
resistant 
0.585 low 
112 Firmicutes Clostridia Lachnospiraceae Coprococcus Coprococcus comes characterised 
ethanol-
resistant 
0.523 low 
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113 Firmicutes Clostridia Lachnospiraceae Coprococcus Coprococcus eutactus_97% novel species 
ethanol-
resistant 
0.538 low 
114 Firmicutes Clostridia Lachnospiraceae Coprococcus Coprococcus eutactus characterised 
ethanol-
resistant 
0.523 low 
115 Firmicutes Clostridia Lachnospiraceae unclassified 
Blautia 
hydrogenotrophica_96% 
novel genus 
ethanol-
resistant 
0.615 no 
116 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Blautia hydrogenotrophica characterised 
ethanol-
resistant 
0.6 no 
117 Firmicutes Clostridia Lachnospiraceae Blautia Balutia luti_96% novel species 
ethanol-
sensitive 
0.462 no 
118 Firmicutes Clostridia Lachnospiraceae Blautia Blautia wexlerae characterised 
ethanol-
sensitive 
0.492 low 
119 Firmicutes Clostridia Lachnospiraceae Blautia Blautia obeum characterised 
ethanol-
resistant 
0.508 low 
120 Firmicutes Clostridia Lachnospiraceae Blautia Blautia luti_96% novel species 
ethanol-
sensitive 
0.554 medium 
121 Firmicutes Clostridia Lachnospiraceae Blautia Ruminococcus obeum_96% novel species 
ethanol-
sensitive 
0.492 medium 
122 Firmicutes Clostridia Lachnospiraceae Lachnospiraceae_ Ruminococcus obeum characterised ethanol- 0.492 low 
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incertae_sedis sensitive 
123 Firmicutes Clostridia Lachnospiraceae Blautia Ruminococcus obeum_98% novel species 
ethanol-
sensitive 
0.538 low 
124 Firmicutes Clostridia Lachnospiraceae Blautia Blautia luti_95% novel species 
ethanol-
resistant 
0.538 medium 
125 Firmicutes Clostridia Lachnospiraceae Blautia Blautia luti_98% novel species 
ethanol-
sensitive 
0.538 medium 
126 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Blautia producta_94% novel species 
ethanol-
sensitive 
0.585 no 
127 Firmicutes Clostridia Lachnospiraceae unclassified 
Fusicatenibacter 
saccharivorans 
novel genus 
ethanol-
resistant 
0.538 low 
128 Firmicutes Clostridia Lachnospiraceae unclassified 
Fusicatenibacter 
saccharivorans_93% 
novel genus 
ethanol-
resistant 
0.6 medium 
129 Firmicutes Clostridia Lachnospiraceae unclassified 
Clostridium 
clostridioforme_93% 
novel genus 
ethanol-
sensitive 
0.523 medium 
130 Firmicutes Clostridia Lachnospiraceae unclassified Clostridium hathewayi_92% novel genus 
ethanol-
sensitive 
0.538 no 
131 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Clostridium 
xylanolyticum_96% 
novel species 
ethanol-
resistant 
0.585 medium 
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132 Firmicutes Clostridia Lachnospiraceae 
Lachnospiraceae_
incertae_sedis 
Clostridium 
saccharolyticum_94% 
novel species 
ethanol-
sensitive 
0.538 no 
133 Firmicutes Clostridia Lachnospiraceae unclassified Ruminococcus torques_97% novel genus 
ethanol-
resistant 
0.538 medium 
134 Firmicutes Clostridia Lachnospiraceae unclassified 
Clostridium 
celerecrescens_93% 
novel genus 
ethanol-
resistant 
0.569 medium 
135 Firmicutes Clostridia Lachnospiraceae unclassified Clostridium celerescens_93% novel genus 
ethanol-
sensitive 
0.569 medium 
136 Firmicutes Clostridia Lachnospiraceae Clostridium XIVa Clostridium clostridioforme characterised 
ethanol-
resistant 
0.646 low 
137 Firmicutes Clostridia Lachnospiraceae Clostridium XIVa 
Clostridium 
clostridioforme_98% 
novel species 
ethanol-
resistant 
0.677 low 
138 Firmicutes Clostridia Lachnospiraceae Clostridium XIVa Clostridium boltae_94% novel species 
ethanol-
resistant 
0.677 no 
139 Firmicutes Clostridia Lachnospiraceae Clostridium XIVa Clostridium hathewayi characterised 
ethanol-
resistant 
0.646 no 
140 Firmicutes Clostridia Lachnospiraceae Clostridium XIVa Clostridium hathewayi characterised 
ethanol-
resistant 
0.677 no 
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†Incerate sedis refers to an uncertain taxonomic placement within a taxonomic class. Unclassified – isolate is novel at this taxonomic 
level. 
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Appendix 2 Isolates deposited in public culture 1 
collections 2 
110 of 137 isolates were deposited in the following public culture collections: 3 
DSMZ: Deutsche Sammlung von Mikroorganismen und Zellkulturen Gmbh 4 
(DSMZ) in Braunschweig, Germany, JCM: Japan Collection of Microorganisms 5 
(JCM) maintained by the Riken BioResource Center in Tsukuba, Japan, CCUG: the 6 
Culture Collection, University of Gothenburg (CCUG) maintained by the University 7 
of Gothenburg in Sweden, BCCM: Belgian Co-ordinated Collection of Micro-8 
organisms (BCCM/LMG) hosted by the Laboratory of Microbiology at Ghent 9 
University, Belgium. The isolates are listed according to their order on Figure 3.5 10 
and therefore include three Proteobacteria species which were not cultured but were 11 
included to provide phylogenetic context. Hence, the total number listed here is 140 12 
(three Proteobacteria and 137 cultured in this study).13 
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order on tree 
Fig. 3.5 
closest 16S BLAST match to named bacterium-99 or 100% 
match unless otherwise stated 
Culture collection Public strain 
designation 
Culture collection accession 
number 
1 Oxalobacter formigenes n/a   n/a 
2 Proteus mirabilis n/a   n/a 
3 Escherichia coli n/a   n/a 
4 Alistipes finegoldii       
5 Alistipes finegoldii CCUG Sanger_38 CCUG 68735 
6 Parabacteroides merdae CCUG Sanger_39 CCUG 68661 
7 Parabacteroides distasonis CCUG Sanger_40 CCUG 68616 
8 Parabacteroides distasonis CCUG Sanger_41 CCUG 68699 
9 Parabacteroides distasonis CCUG Sanger_42 CCUG 68700 
10 Prevotella copri CCUG Sanger_43 CCUG 68549 
11 Bacteroides coprocola_94% DSMZ Sanger_22 DSM 102145 
12 Bacteroides plebius_95% DSMZ Sanger_21 DSM 102146 
13 Bacteroides vulgatus CCUG Sanger_44 CCUG 68662 
14 Bacteroides uniformis CCUG Sanger_45 CCUG 68683 
15 Bacteroides intestinalis_98% JCM Sanger_46 JCM 31249 
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16 Bacteroides salyersiae BCCM Sanger_47 LMG 29389 
17 Bacteroides caccae BCCM  Sanger_48 LMG 29390 
18 Bacteroides xylanisolvens CCUG Sanger_49 CCUG 68584 
19 Bacteroides ovatus CCUG Sanger_50 CCUG 68701 
20 Bacteroides finegoldi CCUG Sanger_52 CCUG 68636 
21 Bacteroides thetaiotaomicron CCUG Sanger_53 CCUG 68702 
22 Bacteroides thetaiotaomicron CCUG Sanger_54 CCUG 68684 
23 Bacteroides finegoldii_98% BCCM  Sanger_51 LMG 29391 
24 Bacteroides thetaiotaomicron CCUG Sanger_55 CCUG 68746 
25 Collinsella aerofaciens_92% BCCM  Sanger_56 LMG 29392 
26 Collinsella aerofaciens BCCM & CCUG Sanger_57 LMG 29393 & CCUG 68712 
27 Collinsella aerofaciens       
28 Bifidobacterium adolescentis BCCM Sanger_59 LMG 29394 
29 Bifidobacterium adolescentis BCCM Sanger_60 LMG 29395 
30 Bifidobacterium bifidum BCCM Sanger_61 LMG 29396 
31 Bifidobacterium pseudocatenulatum BCCM Sanger_62 LMG 29397 
32 Mitsuokella jalaludinii BCCM & CCUG Sanger_63 LMG 29398 & CCUG 68585 
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33 Megasphaera elsdenii_95% DSMZ Sanger_24 DSM 102144 
34 Turibacter sanguinis CCUG Sanger_64 CCUG 68586 
35 Clostridium innocuum CCUG Sanger_65 CCUG 68747 
36 Clostridium innocuum_95% BCCM  Sanger_66 LMG 29399 
37 Catenibacterium mitsuokai JCM Sanger_67 JCM 31250  
38 Clostridium cocleatum_93 BCCM  Sanger_68 LMG 29400 
39 Clostridium saccharogumia_93% BCCM  Sanger_69 LMG 29401 
40 Eubacterium infirmum_91%       
41 Eubacterium infirmum_94%       
42 Clostridium ghonii_98% BCCM  Sanger_70 LMG 29402 
43 Clostridium lituseburense_98% CCUG Sanger_73 CCUG 68538 
44 Clostridium bartlettii BCCM  Sanger_71 LMG 29403 
45 Sarcina ventriculi JCM Sanger_74 JCM 31252 
46 Clostridium baratti JCM Sanger_75 JCM 31253 
47 Clostridium paraputrificum JCM Sanger_76 JCM 31254 
48 Clostridium disporicum JCM Sanger_72 JCM 31251 
49 Clostridium disporicum       
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50 Clostridium perfringens       
51 Clostridium disporicum_98% CCUG Sanger_79 CCUG 68587 
52 Clostridium thermocellum_86%       
53 Clostridium thermocellum_87%       
54 Butyricicoccus pullicaecorum_94% DSMZ Sanger_34 DSM 102882 
55 Butyricicoccus pullicaecorum_94% BCCM & CCUG Sanger_80 LMG 29404 & CCUG 68588 
56 Flavonifractor plautii_95%       
57 Flavonifractor plautii_95% DSMZ Sanger_09 DSM 102137 
58 Flavonifractor plautii_94% DSMZ Sanger_35 DSM 102175 
59 Flavonifractor plautii_96% DSMZ  Sanger_08 DSM 102116 
60 Oscillibacter valericigenes_96% DSMZ Sanger_26 DSM 102152 
61 Flavonifractor plautii_95% CCUG Sanger_82 CCUG 68613 
62 Flavonifractor plautii_97%       
63 Flavonifractor plautii BCCM Sanger_83 LMG 29405 
64 Flavonifractor plautii BCCM Sanger_84 LMG 29406 
65 Flavonifractor plautii BCCM & CCUG Sanger_85 CCUG 68710 & LMG 29407 
66 Flavonifractor plautii BCCM & CCUG Sanger_86 LMG 29408 & CCUG 68637 
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67 Eubacterium siraeum BCCM Sanger_87 LMG 29409 
68 Ruminococcus bromii       
69 Ruminococcus bromii_93% DSMZ Sanger_36 DSM 102803  
70 Ruminococcus bromii_94% CCUG Sanger_89 CCUG 68614 
71 Ruminococcus flavefaciens_93% DSMZ Sanger_06 DSM 102115 
72 Ruminococcus flavefaciens_95% BCCM & DSMZ Sanger_90 LMG 29410 & DSM 102167 
73 Ruminococcus albus_98% DSMZ Sanger_91 DSM 102227  
74 Ruminococcus albus_95% DSMZ Sanger_31 DSM 102216 
75 Clostridium methylpentosum_92% DSMZ Sanger_27 DSM 102153 
76 Anaerotruncus colihominis JCM Sanger_92 JCM 31255 
77 Anaerotruncus colihominis_91% DSMZ Sanger_05 DSM 102114 
78 Faecalibacterium prausnitzii CCUG Sanger_93 CCUG 68711 
79 Faecalibacterium prausnitzii CCUG Sanger_94 CCUG 68745 
80 Faecalibacterium prausnitzii_98%       
81 Faecalibacterium prausnitzii       
82 Clostridium xylanolyticum_95% DSMZ Sanger_04 DSM 102317 
83 Clostridium nexile_94% DSMZ Sanger_33 DSM 102154 
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84 Eubacterium fissicatens_95% CCUG & DSMZ Sanger_97 CCUG 68796 & DSM 102166 
85 Anaerostipes hadrus        
86 Anaerostipes hadrus_98% CCUG Sanger_99 CCUG 68539 
87 Ruminococcus gnavus CCUG Sanger_100 CCUG 68638 
88 Ruminococcus gnavus_98%       
89 Dorea formicigenerans_98% CCUG & JCM Sanger_102 CCUG 68540 & JCM 31256 
90 Dorea longicatena       
91 Clostridium oroticum_95% DSMZ Sanger_03 DSM 102260 
92 Clostridium oroticum_96% JCM Sanger_104 JCM 31257 
93 Eubacterium contortum JCM Sanger_105 JCM 31258 
94 Eubacterium contortum_97% DSMZ Sanger_02 DSM 102136 
95 Ruminococcus torques       
96 Clostridium oroticum_95% DSMZ Sanger_01 DSM 102316 
97 Ruminococcus torques JCM Sanger_107 JCM 31259 
98 Eubacterium ramulus       
99 Roseburia inulinivorans_94% DSMZ Sanger_109 DSM 102148 
100 Roseburia inulinvorans JCM Sanger_110 JCM 31260 
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101 Eubacterium rectale       
102 Roseburia faecis JCM Sanger_112 JCM 31261 
103 Roseburia faecis_95% DSMZ Sanger_19 DSMZ 102150 
104 Roseburia intestinalis JCM Sanger_113 JCM 31262 
105 Roseburia hominis       
106 Lachnospira pectinoschiza_91% DSMZ Sanger_20 DSM 102349 
107 Eubacterium eligens       
108 Lachnospira pectinoschiza       
109 Lachnospira pectinoschiza CCUG Sanger_117 CCUG 68639 
110 Eubacterium hallii_97%       
111 Eubacterium hallii JCM Sanger_119 JCM 31263 
112 Coprococcus comes JCM Sanger_120 JCM 31264 
113 Coprococcus eutactus_97% CCUG Sanger_121 CCUG 68541 
114 Coprococcus eutactus JCM Sanger_122 JCM 31265  
115 Blautia hydrogenotrophica_96%       
116 Blautia hydrogenotrophica JCM Sanger_124 JCM 31266 
117 Balutia luti_96% DSMZ Sanger_23 DSMZ 102163 
214 
 
118 Blautia wexlerae JCM Sanger_125 JCM 31267 
119 Blautia wexlerae       
120 Ruminococcus obeum_96% DSMZ Sanger_28 DSM 102165 
121 Ruminococcus obeum_96% CCUG Sanger_127 CCUG 68542 
122 Ruminococcus obeum       
123 Ruminococcus obeum_98% DSMZ Sanger_25 DSM 102164 
124 Blautia luti_95% CCUG Sanger_129 CCUG 68550 
125 Blautia luti_98% CCUG Sanger_130 CCUG 68551 
126 Blautia producta_94% DSMZ Sanger_32 DSM 102174 
127 Fusicatenibacter saccharivorans CCUG & JCM Sanger_131 CCUG 68552 & JCM 31268 
128 Fusicatenibacter saccharivorans_93% DSMZ Sanger_17 DSM 102348 
129 Clostridium clostridioforme_93% DSMZ Sanger_16  DSM 102825 
130 Clostridium hathewayi_92% DSMZ Sanger_18 DSM 102261 
131 Clostridium xylanolyticum_96% DSMZ Sanger_132 DSM 102147 
132 Clostridium saccharolyticum_94% DSMZ Sanger_29 DSM 102151 
133 Ruminococcus torques_97% DSMZ Sanger_15 DSM 102149 
134 Clostridium celerecrescens_93%       
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135 Clostridium celerescens_93% DSMZ Sanger_13 DSM 102317 
136 Clostridium clostridioforme CCUG Sanger_133 CCUG 68660 
137 Clostridium clostridioforme_98% CCUG Sanger_134 CCUG 68553 
138 Clostridium boltae_94% CCUG Sanger_135 CCUG 68615 
139 Clostridium hathewayi CCUG Sanger_136 CCUG 68736 
140 Clostridium hathewayi CCUG Sanger_137 CCUG 68640 
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Appendix 3 Validation of the sporulation signature 
Sporulation signature scores of ethanol-resistant and ethanol-sensitive isolates from 
this study are presented in addition to known spore-formers and known non-spore-
formers from different environments. This data was used to populate Figure 4.7. 
Note: Genomes were sequenced for multiple cultures from the same species in the 
culture collection. Subsequently multiple copies of the same species are included in 
the analysis here.
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Species Name                                                                                                         
(Closest BLAST Match, ≥98.7% match unless otherwise 
stated) 
Public identifier for species not cultured 
in this study 
Category signature score 
1 Akkermansia muciniphila GCA_000020225.1 known non-spore formers 0.25 
2 Alicyclobacillus acidocaldarius GCA_000024285.1 known spore formers 0.66 
3 Alistipes finegoldii cultured in this study Cultures from untreated plates 0.16 
4 Alistipes finegoldii cultured in this study Cultures from untreated plates 0.17 
5 Alkaliphilus oremlandii GCA_000018325.1 known spore formers 0.75 
6 Ammonifex degensii KC4 GCA_000024605.1 known spore formers 0.66 
7 Anaeromyxobacter dehalogenans GCA_000013385.1 known non-spore formers 0.17 
8 Anaerostipes hadrus cultured in this study Cultures from untreated plates 0.58 
9 Anaerostipes hadrus cultured in this study Cultures from untreated plates 0.56 
10 Anaerostipes hadrus cultured in this study Cultures from untreated plates 0.55 
11 Anaerostipes hadrus cultured in this study Cultures from untreated plates 0.55 
12 Anaerostipes hadrus cultured in this study Cultures from untreated plates 0.55 
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13 Anaerotruncus colihominis cultured in this study Cultures from ethanol treated plates 0.66 
14 Anaerotruncus colihominis_91% cultured in this study Cultures from ethanol treated plates 0.66 
15 Aquifex aeolicus GCA_000008625.1 known non-spore formers 0.17 
16 Bacillus amyloliquefaciens GCA_000015785.1 known spore formers 0.73 
17 Bacillus anthracis GCA_000007845.1 known spore formers 0.73 
18 Bacillus cereus GCA_000007825.1 known spore formers 0.73 
19 Bacillus clausii GCA_000009825.1 known spore formers 0.69 
20 Bacillus halodurans GCA_000011145.1 known spore formers 0.70 
21 Bacillus licheniformis GCA_000008425.1 known spore formers 0.72 
22 Bacillus pumilus GCA_000017885.1 known spore formers 0.72 
23 Bacillus subtilis GCA_000009045.1 known spore formers 0.73 
24 Bacillus thuringiensis serovar konkukian GCA_000008505.1 known spore formers 0.73 
25 Bacillus weihenstephanensis GCA_000018825.1 known spore formers 0.73 
26 Bacteroides caccae cultured in this study Cultures from untreated plates 0.19 
27 Bacteroides caccae cultured in this study Cultures from untreated plates 0.17 
28 Bacteroides finegoldi cultured in this study Cultures from untreated plates 0.17 
29 Bacteroides ovatus cultured in this study Cultures from untreated plates 0.17 
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30 Bacteroides salyersiae cultured in this study Cultures from untreated plates 0.17 
31 Bacteroides finegoldii_98% cultured in this study Cultures from untreated plates 0.17 
32 Bacteroides coprocola_94% cultured in this study Cultures from untreated plates 0.17 
33 Bacteroides plebius_95% cultured in this study Cultures from untreated plates 0.16 
34 Bacteroides intestinalis_98% cultured in this study Cultures from untreated plates 0.17 
35 Bacteroides thetaiotaomicron cultured in this study Cultures from untreated plates 0.19 
36 Bacteroides thetaiotaomicron cultured in this study Cultures from untreated plates 0.19 
37 Bacteroides thetaiotaomicron cultured in this study Cultures from untreated plates 0.19 
38 Bacteroides thetaiotaomicron cultured in this study Cultures from untreated plates 0.19 
39 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.19 
40 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.17 
41 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.17 
42 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.17 
43 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.17 
44 Bacteroides uniformis cultured in this study Cultures from untreated plates 0.19 
45 Bacteroides vulgatus cultured in this study Cultures from untreated plates 0.17 
46 Bacteroides vulgatus cultured in this study Cultures from untreated plates 0.17 
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47 Bacteroides vulgatus cultured in this study Cultures from untreated plates 0.17 
48 Bacteroides xylanisolvens cultured in this study Cultures from untreated plates 0.19 
49 Bacteroides fragilis GCA_000009925.1 known non-spore formers 0.17 
50 Bifidobacterium adolscentis cultured in this study Cultures from untreated plates 0.11 
51 Bifidobacterium adolescentis cultured in this study Cultures from untreated plates 0.13 
52 Bifidobacterium adolescentis cultured in this study Cultures from untreated plates 0.13 
53 Bifidobacterium bifidum cultured in this study Cultures from untreated plates 0.13 
54 Bifidobacterium pseudocatenulatum cultured in this study Cultures from untreated plates 0.11 
55 Bifidobacterium bifidum GCA_000165905.1 known non-spore formers 0.13 
56 Blautia hydrogenotrophica cultured in this study Cultures from ethanol treated plates 0.59 
57 Blautia luti_97% cultured in this study Cultures from ethanol treated plates 0.50 
58 Ruminococcus obeum_96% cultured in this study Cultures from untreated plates 0.55 
59 Blautia luti_96% cultured in this study Cultures from ethanol treated plates 0.50 
60 Blautia luti_95% cultured in this study Cultures from untreated plates 0.52 
61 Blautia hydrogenotrophica_96% cultured in this study Cultures from ethanol treated plates 0.61 
62 Blautia luti_96% cultured in this study Cultures from untreated plates 0.53 
63 Blautia luti_95% cultured in this study Cultures from untreated plates 0.50 
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64 Balutia luti_96% cultured in this study Cultures from untreated plates 0.45 
65 Blautia luti_98% cultured in this study Cultures from untreated plates 0.53 
66 Blautia producta_94% cultured in this study Cultures from untreated plates 0.58 
67 Blautia luti_96% cultured in this study Cultures from ethanol treated plates 0.48 
68 Blautia wexlerae cultured in this study Cultures from untreated plates 0.48 
69 Blautia wexlerae cultured in this study Cultures from untreated plates 0.48 
70 Bordetella parapertussis GCA_000317935.1 known non-spore formers 0.30 
71 Brevibacillus brevis GCA_000010165.1 known spore formers 0.70 
72 Brucella melitensis GCA_000022625.1 known non-spore formers 0.17 
73 Brucella suis GCA_000018905.1 known non-spore formers 0.19 
74 Butyricicoccus pullicaecorum_96% cultured in this study Cultures from ethanol treated plates 0.56 
75 Butyricicoccus pullicaecorum_94% cultured in this study Cultures from ethanol treated plates 0.56 
76 Caldanaerobacter subterraneus subsp tengcongensis GCA_000007085.1 known spore formers 0.81 
77 Caldicellulosiruptor bescii DSM6725 GCA_000022325.1 known spore formers 0.63 
78 Caldicellulosiruptor hydrothermalis 108 GCA_000166355.1 known spore formers 0.61 
79 Caldicellulosiruptor kristjanssonii I77R1B GCA_000166695.1 known spore formers 0.58 
80 Caldicellulosiruptor kronotskyensis 2002 GCA_000166775.1 known spore formers 0.61 
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82 Caldicellulosiruptor obsidiansis OB47 GCA_000145215.1 known spore formers 0.58 
83 Caldicellulosiruptor owensensis OL GCA_000166335.1 known spore formers 0.58 
84 Caldicellulosiruptor saccharolyticus DSM8903 GCA_000016545.1 known spore formers 0.59 
85 Campylobacter jejuni GCA_000009085.1 known non-spore formers 0.16 
86 Candidatus Desulforudis audaxviator MP104C GCA_000018425.1 known spore formers 0.67 
87 Carboxydothermus hydrogenoformans GCA_000012865.1 known spore formers 0.67 
88 Catenibacterium mitsuokai cultured in this study Cultures from untreated plates 0.25 
89 Catenibacterium mitsuokai cultured in this study Cultures from untreated plates 0.20 
90 Clostridium baratii cultured in this study Cultures from ethanol treated plates 0.77 
91 Clostridium baratii cultured in this study Cultures from untreated plates 0.77 
92 Clostridium bartlettii cultured in this study Cultures from ethanol treated plates 0.88 
93 Clostridium clostridioforme cultured in this study Cultures from ethanol treated plates 0.64 
94 Clostridium disporicum cultured in this study Cultures from untreated plates 0.77 
95 Clostridium disporicum cultured in this study Cultures from untreated plates 0.78 
96 Clostridium disporicum cultured in this study Cultures from ethanol treated plates 0.80 
97 Clostridium hathewayi cultured in this study Cultures from ethanol treated plates 0.67 
98 Clostridium hathewayi cultured in this study Cultures from ethanol treated plates 0.64 
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99 Clostridium innocuum cultured in this study Cultures from ethanol treated plates 0.48 
100 Clostridium orbiscindens cultured in this study Cultures from ethanol treated plates 0.72 
101 Clostridium paraputrificum cultured in this study Cultures from ethanol treated plates 0.77 
102 Clostridium paraputrificum cultured in this study Cultures from untreated plates 0.77 
103 Clostridium perfringens cultured in this study Cultures from ethanol treated plates 0.72 
104 Clostridium celerecrescens_94% cultured in this study Cultures from untreated plates 0.55 
105 Clostridium celerecrescens_94% cultured in this study Cultures from untreated plates 0.58 
106 Clostridium saccharolyticum_94% cultured in this study Cultures from untreated plates 0.53 
107 Clostridium methylpentosum_92% cultured in this study Cultures from ethanol treated plates 0.64 
108 Clostridium oroticum_95% cultured in this study Cultures from ethanol treated plates 0.61 
109 Clostridium clostridioforme_98% cultured in this study Cultures from ethanol treated plates 0.67 
110 Clostridium straminisolvens_89% cultured in this study Cultures from untreated plates 0.64 
111 Clostridium beijerinckii_96% cultured in this study Cultures from ethanol treated plates 0.73 
112 Clostridium cocleatum_93% cultured in this study Cultures from untreated plates 0.41 
113 Clostridium spiroforme_93% cultured in this study Cultures from untreated plates 0.42 
114 Clostridium orbiscindens_95% cultured in this study Cultures from ethanol treated plates 0.58 
115 Clostridium xylanolyticum_93% cultured in this study Cultures from untreated plates 0.63 
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116 Clostridium hathewayi_92% cultured in this study Cultures from untreated plates 0.53 
117 Clostridium oroticum_95% cultured in this study Cultures from untreated plates 0.58 
118 Clostridium saccharogumia_93% cultured in this study Cultures from untreated plates 0.41 
119 Clostridium lituseburense_98% cultured in this study Cultures from ethanol treated plates 0.86 
120 Clostridium boltae_93% cultured in this study Cultures from untreated plates 0.56 
121 Clostridium celerescens_93% cultured in this study Cultures from untreated plates 0.56 
122 Clostridium oroticum_96% cultured in this study Cultures from ethanol treated plates 0.52 
123 Clostridium xylanolyticum_92% cultured in this study Cultures from ethanol treated plates 0.58 
124 Clostridium xylanolyticum_95% cultured in this study Cultures from untreated plates 0.56 
125 Clostridium innocuum_95% cultured in this study Cultures from ethanol treated plates 0.47 
126 Clostridium glycolicum_97% cultured in this study Cultures from ethanol treated plates 0.88 
127 Clostridium nexile_94% cultured in this study Cultures from ethanol treated plates 0.67 
128 Clostridium oroticum_95% cultured in this study Cultures from untreated plates 0.56 
129 Clostridium clostridioforme_93% cultured in this study Cultures from untreated plates 0.52 
130 Clostridium celerecrescens_93% cultured in this study Cultures from ethanol treated plates 0.56 
131 Clostridium boltae_94% cultured in this study Cultures from ethanol treated plates 0.67 
132 Clostridium thermocellum_87% cultured in this study Cultures from ethanol treated plates 0.66 
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133 Clostridium orbiscindens_94% cultured in this study Cultures from ethanol treated plates 0.64 
134 Clostridium thermocellum_86% cultured in this study Cultures from ethanol treated plates 0.64 
135 Clostridium spiroforme_93% cultured in this study Cultures from untreated plates 0.39 
136 Clostridium ghonii_98% cultured in this study Cultures from ethanol treated plates 0.83 
137 Clostridium ghonii_98% cultured in this study Cultures from ethanol treated plates 0.83 
138 Clostridium disporicum_98% cultured in this study Cultures from ethanol treated plates 0.80 
139 Clostridium disporicum_98% cultured in this study Cultures from untreated plates 0.78 
140 Clostridium symbiosum cultured in this study Cultures from ethanol treated plates 0.67 
141 Clostridium acetobutylicum GCA_000008765.1 known spore formers 0.73 
142 Clostridium beijerinckii GCA_000016965.1 known spore formers 0.73 
143 Clostridium botulinum GCA_000017045.1 known spore formers 0.83 
144 Clostridium kluyveri GCA_000016505.1 known spore formers 0.78 
145 Clostridium novyi GCA_000014125.1 known spore formers 0.75 
146 Clostridium perfringens GCA_000009685.1 known spore formers 0.72 
147 Clostridium tetani E88 GCA_000007625.1 known spore formers 0.77 
148 Collinsella aerofaciens cultured in this study Cultures from untreated plates 0.17 
149 Collinsella aerofaciens cultured in this study Cultures from untreated plates 0.19 
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150 Collinsella aerofaciens cultured in this study Cultures from untreated plates 0.17 
151 Collinsella aerofaciens_92% cultured in this study Cultures from untreated plates 0.20 
152 Coprococcus comes cultured in this study Cultures from ethanol treated plates 0.52 
153 Coprococcus comes cultured in this study Cultures from untreated plates 0.52 
154 Coprococcus comes cultured in this study Cultures from untreated plates 0.50 
155 Coprococcus comes cultured in this study Cultures from untreated plates 0.50 
156 Coprococcus eutactus cultured in this study Cultures from untreated plates 0.52 
157 Coprococcus eutactus cultured in this study Cultures from ethanol treated plates 0.52 
158 Coprococcus eutactus cultured in this study Cultures from untreated plates 0.50 
159 Coprococcus eutactus cultured in this study Cultures from untreated plates 0.52 
160 Coprococcus eutactus_97% cultured in this study Cultures from ethanol treated plates 0.53 
161 Coprococcus nexile_95% cultured in this study Cultures from ethanol treated plates 0.50 
162 Desulfitobacterium hafniense GCA_000010045.1 known spore formers 0.75 
163 Desulfotomaculum acetoxidans GCA_000024205.1 known spore formers 0.72 
164 Desulfotomaculum kuznetsovii GCA_000214705.1 known spore formers 0.67 
165 Desulfotomaculum reducens GCA_000016165.1 known spore formers 0.72 
166 Desulfovibrio vulgaris GCA_000195755.1 known non-spore formers 0.27 
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167 Dorea longicatena cultured in this study Cultures from untreated plates 0.52 
168 Dorea longicatena cultured in this study Cultures from untreated plates 0.52 
169 Dorea longicatena cultured in this study Cultures from untreated plates 0.48 
170 Dorea longicatena cultured in this study Cultures from untreated plates 0.48 
171 Dorea longicatena cultured in this study Cultures from untreated plates 0.52 
172 Dorea formicigenerans_98% cultured in this study Cultures from untreated plates 0.55 
173 Eggerthella lenta GCA_000024265.1 known non-spore formers 0.17 
174 Enterococcus faecalis V583 GCA_000007785.1 known non-spore formers 0.23 
175 Escherichia coli GCA_000005845.2 known non-spore formers 0.22 
176 Ethanoligenens harbinense YUAN-3 GCA_000178115.2 known spore formers 0.66 
177 Eubacterium contortum cultured in this study Cultures from ethanol treated plates 0.63 
178 Eubacterium eligens cultured in this study Cultures from untreated plates 0.53 
179 Eubacterium eligens cultured in this study Cultures from untreated plates 0.55 
180 Eubacterium halii cultured in this study Cultures from ethanol treated plates 0.58 
181 Eubacterium hallii cultured in this study Cultures from untreated plates 0.58 
182 Eubacterium ramulus cultured in this study Cultures from untreated plates 0.52 
183 Eubacterium rectale cultured in this study Cultures from untreated plates 0.47 
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184 Eubacterium rectale cultured in this study Cultures from untreated plates 0.47 
185 Eubacterium rectale cultured in this study Cultures from untreated plates 0.47 
186 Eubacterium siraeum cultured in this study Cultures from untreated plates 0.47 
187 Eubacterium infirmum_91% cultured in this study Cultures from untreated plates 0.53 
188 Eubacterium fissicatens_95% cultured in this study Cultures from ethanol treated plates 0.64 
189 Eubacterium hallii_98% cultured in this study Cultures from ethanol treated plates 0.58 
190 Eubacterium contortum_97% cultured in this study Cultures from untreated plates 0.58 
191 Eubacterium hallii_98% cultured in this study Cultures from untreated plates 0.56 
192 Eubacterium infirmum_94% cultured in this study Cultures from ethanol treated plates 0.66 
193 Anaerostipes hadrum_98% cultured in this study Cultures from untreated plates 0.56 
194 Eubacterium hallii_97% cultured in this study Cultures from untreated plates 0.55 
196 Faecalibacterium prausnitzii cultured in this study Cultures from untreated plates 0.45 
197 Faecalibacterium prausnitzii cultured in this study Cultures from untreated plates 0.13 
198 Faecalibacterium prausnitzii cultured in this study Cultures from untreated plates 0.45 
199 Faecalibacterium prausnitzii_98% cultured in this study Cultures from untreated plates 0.45 
200 Faecalibacterium prausnitzii_98% cultured in this study Cultures from untreated plates 0.45 
201 Flavonifractor plautii cultured in this study Cultures from untreated plates 0.50 
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202 Flavonifractor plautii cultured in this study Cultures from ethanol treated plates 0.69 
203 Flavonifractor plautii cultured in this study Cultures from ethanol treated plates 0.69 
204 Flavonifractor plautii_95% cultured in this study Cultures from ethanol treated plates 0.58 
205 Flavonifractor plautii_95% cultured in this study Cultures from untreated plates 0.66 
206 Flavonifractor plautii_95% cultured in this study Cultures from untreated plates 0.64 
207 Flavonifractor plautii_95% cultured in this study Cultures from ethanol treated plates 0.61 
208 Flavonifractor plautii_96% cultured in this study Cultures from ethanol treated plates 0.67 
209 Fusicatenibacter saccharivorans cultured in this study Cultures from ethanol treated plates 0.55 
210 Fusicatenibacter saccharivorans cultured in this study Cultures from untreated plates 0.52 
211 Fusicatenibacter saccharivorans cultured in this study Cultures from untreated plates 0.53 
212 Fusicatenibacter saccharivorans_93% cultured in this study Cultures from ethanol treated plates 0.59 
213 Fusobacterium necrophorum GCA_000242215.1 known non-spore formers 0.22 
214 Fusobacterium nucleatum GCF 000007325.1 ASM732v1 GCA_000007325.1 known non-spore formers 0.20 
215 Geobacillus kaustophilus GCA_000009785.1 known spore formers 0.70 
216 Geobacillus thermodenitrificans GCA_000015745.1 known spore formers 0.73 
217 Geobacter sulfurreducens GCA_000007985.2 known non-spore formers 0.22 
218 Haemophilus influenzae GCA_000027305.1 known non-spore formers 0.17 
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219 Halothermothrix orenii H168 GCA_000020485.1 known spore formers 0.69 
220 Helicobacter pylori GCA_000008525.1 known non-spore formers 0.13 
221 Heliobacterium modesticaldum GCA_000019165.1 known spore formers 0.70 
222 Kyrpidia tusciae GCA_000092905.1 known spore formers 0.69 
223 Lachnoclostridium phytofermentans GCA_000018685.1 known spore formers 0.69 
224 Lachnospira pectinoschiza cultured in this study Cultures from untreated plates 0.52 
225 Lachnospira pectinoschiza cultured in this study Cultures from untreated plates 0.52 
226 Lachnospira pectinoshiza_91% cultured in this study Cultures from untreated plates 0.50 
227 Lactobacillus acidophilus GCA_000786395.1 known non-spore formers 0.22 
228 Leptospira interrogans GCA_000092565.1 known non-spore formers 0.16 
229 Listeria innocua GCA_000195795.1 known non-spore formers 0.33 
230 Lysinibacillus sphaericus GCA_000568835.1 known spore formers 0.58 
231 Megasphaera elsdenii_95% cultured in this study Cultures from untreated plates 0.25 
232 Mitsuokella jalaludinii cultured in this study Cultures from untreated plates 0.28 
233 Moorella thermoacetica GCA_000013105.1 known spore formers 0.72 
234 Mycobacterium avium GCA_000007865.1 known non-spore formers 0.23 
235 Mycobacterium bovis GCA_000195835.1 known non-spore formers 0.23 
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236 Mycobacterium leprae GCA_000195855.1 known non-spore formers 0.22 
237 Mycobacterium marinum GCA_000018345.1 known non-spore formers 0.23 
238 Mycobacterium smegmatis GCA_000015005.1 known non-spore formers 0.25 
239 Mycobacterium tuberculosis GCA_000195955.2 known non-spore formers 0.23 
240 Mycobacterium ulcerans GCA_000013925.1 known non-spore formers 0.22 
241 Myxococcus xanthus GCA_000012685.1 known non-spore formers 0.22 
242 Natranaerobius thermophilus JWNM-WN-LF GCA_000020005.1 known spore formers 0.66 
243 Neisseria meningtidis GCA_000008805.1 known non-spore formers 0.20 
244 Nitrosomonas europaea GCA_000009145.1 known non-spore formers 0.19 
245 Oceanobacillus iheyensis GCA_000011245.1 known spore formers 0.70 
246 Oscillibacter valericigenes_96% cultured in this study Cultures from untreated plates 0.64 
247 Oscillibacter valericigenes_95% cultured in this study Cultures from ethanol treated plates 0.66 
248 Paenibacillus polymyxa GCA_000146875.1 known spore formers 0.72 
249 Parabacteroides distasonis cultured in this study Cultures from untreated plates 0.17 
250 Parabacteroides distasonis cultured in this study Cultures from untreated plates 0.19 
251 Parabacteroides distasonis cultured in this study Cultures from untreated plates 0.20 
252 Parabacteroides distasonis cultured in this study Cultures from untreated plates 0.19 
232 
 
253 Parabacteroides merdae cultured in this study Cultures from untreated plates 0.20 
254 Pelotomaculum thermopropionicum GCA_000010565.1 known spore formers 0.69 
255 Peptoclostridium difficile GCA_000009205.1 known spore formers 0.97 
256 Photobacterium profundum GCA_000196255.1 known non-spore formers 0.25 
257 Prevotella copri cultured in this study Cultures from untreated plates 0.03 
258 Prevotella stercorea GCA_000235885.1 known non-spore formers 0.16 
259 Prochlorococcus marinus GCA_000007925.1 known non-spore formers 0.13 
260 Propionibacterium acnes GCA_000008345.1 known non-spore formers 0.19 
261 Proteus mirabilis GCA_000069965.1 known non-spore formers 0.25 
262 Pseudomonas fluorescens GCA_000006765.1 known non-spore formers 0.28 
263 Pseudomonas syringae GCA_000012245.1 known non-spore formers 0.28 
264 Roseburia faecis cultured in this study Cultures from untreated plates 0.55 
265 Roseburia hominis cultured in this study Cultures from untreated plates 0.59 
266 Roseburia intestinalis cultured in this study Cultures from untreated plates 0.61 
267 Roseburia inulinivorans cultured in this study Cultures from untreated plates 0.64 
268 Roseburia inulinvorans cultured in this study Cultures from untreated plates 0.63 
269 Roseburia faecis_95% cultured in this study Cultures from untreated plates 0.63 
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270 Roseburia inulinivorans_94% cultured in this study Cultures from ethanol treated plates 0.61 
271 Ruminiclostridium thermocellum GCA_000015865.1 known spore formers 0.81 
272 Ruminococcus bromii cultured in this study Cultures from untreated plates 0.56 
273 Ruminococcus gnavus cultured in this study Cultures from ethanol treated plates 0.58 
274 Ruminococcus obeum cultured in this study Cultures from untreated plates 0.47 
275 Ruminococcus obeum cultured in this study Cultures from untreated plates 0.50 
276 Ruminococcus obeum cultured in this study Cultures from untreated plates 0.50 
277 Ruminococcus obeum cultured in this study Cultures from untreated plates 0.48 
278 Ruminococcus obeum cultured in this study Cultures from untreated plates 0.50 
279 Ruminococcus bromii_94% cultured in this study Cultures from untreated plates 0.13 
280 Ruminococcus torques_96% cultured in this study Cultures from untreated plates 0.53 
281 Ruminococcus torques_97% cultured in this study Cultures from untreated plates 0.59 
282 Ruminococcus torques_97% cultured in this study Cultures from untreated plates 0.56 
283 Ruminococcus albus_95% cultured in this study Cultures from ethanol treated plates 0.64 
284 Ruminococcus albus_95% cultured in this study Cultures from ethanol treated plates 0.52 
285 Ruminococcus bromii_92% cultured in this study Cultures from ethanol treated plates 0.59 
286 Ruminococcus obeum_98% cultured in this study Cultures from untreated plates 0.47 
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287 Ruminococcus obeum_98% cultured in this study Cultures from untreated plates 0.53 
288 Ruminococcus gnavus_98% cultured in this study Cultures from untreated plates 0.61 
289 Ruminococcus torques_96% cultured in this study Cultures from untreated plates 0.53 
290 Ruminococcus albus_95% cultured in this study Cultures from untreated plates 0.50 
291 Ruminococcus obeum_96% cultured in this study Cultures from untreated plates 0.48 
292 Ruminococcus bromii_94% cultured in this study Cultures from ethanol treated plates 0.66 
293 Ruminococcus flavefaciens_95% cultured in this study Cultures from untreated plates 0.47 
294 Ruminococcus flavefaciens_93% cultured in this study Cultures from untreated plates 0.53 
295 Ruminococcus bromii_93% cultured in this study Cultures from ethanol treated plates 0.58 
296 Ruminococcus albus_95% cultured in this study Cultures from ethanol treated plates 0.48 
297 Ruminococcus albus_98% cultured in this study Cultures from ethanol treated plates 0.63 
298 Ruminococcus torques cultured in this study Cultures from untreated plates 0.52 
299 Ruminococcus torques cultured in this study Cultures from untreated plates 0.55 
300 Ruminococcus torques cultured in this study Cultures from untreated plates 0.53 
301 Ruminococcus torques cultured in this study Cultures from untreated plates 0.52 
302 Ruminococcus torques cultured in this study Cultures from untreated plates 0.58 
303 Eubacterium rectale cultured in this study Cultures from untreated plates 0.56 
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304 Salmonella enterica GCA_000006945.1 known non-spore formers 0.28 
305 Sarcina ventriculi cultured in this study Cultures from ethanol treated plates 0.69 
306 Shigella flexneri GCA_000006925.2 known non-spore formers 0.22 
307 Staphylococcus aureus GCA_000512505.1 known non-spore formers 0.23 
308 Streptococcus mutans UA159 GCA_000007465.2 known non-spore formers 0.20 
309 Streptococcus pneumoniae GCA_000007045.1 known non-spore formers 0.23 
310 Streptococcus pyogenes GCA_000006785.2 known non-spore formers 0.17 
311 Streptococcus thermophilus GCA_000011845.1 known non-spore formers 0.23 
312 Streptomyces avermitilis GCA_000009765.1 known non-spore formers 0.27 
313 Streptomyces coelicolor GCA_000203835.1 known non-spore formers 0.27 
314 Sulfobacillus acidophilus GCA_000219855.1 known spore formers 0.53 
315 Sutterella parvirubra GCA_000250875.1 known non-spore formers 0.16 
316 Symbiobacterium thermophilum GCA_000009905.1 known spore formers 0.66 
317 Synergistes jonesii GCA_000712295.1 known non-spore formers 0.22 
318 Syntrophothermus lipocalidus DSM12680 GCA_000092405.1 known spore formers 0.66 
319 Thermincola potens JR GCA_000092945.1 known spore formers 0.70 
320 Thermoanaerobacter ethanolicus CCSD1 GCA_000175815.1 known spore formers 0.80 
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321 Thermoanaerobacter pseudethanolicus ATCC33223 GCA_000192295.2 known spore formers 0.81 
322 Thermosediminibacter oceani DSM16646 GCA_000144645.1 known spore formers 0.77 
323 Thermus thermophilus GCA_000091545.1 known non-spore formers 0.17 
324 Turicibacter sanguinis cultured in this study Cultures from ethanol treated plates 0.56 
325 Turicibacter sanguinis cultured in this study Cultures from untreated plates 0.52 
326 Turicibacter sanguinis cultured in this study Cultures from ethanol treated plates 0.53 
327 Turicibacter sanguinis cultured in this study Cultures from ethanol treated plates 0.53 
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